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A b strac t
Sulfonamides constitute a vital and diverse class of therapeutic agents; hence the 
development of convenient and straightforward synthetic routes to such species is 
a valuable endeavour.
This thesis describes an exploration into the reactivity of the novel bifunctional 
acceptor pentafluorophenyl vinylsulfonate in the formation of biologically 
interesting sulfonamide species.
A variety of transformations were carried out effectively at the electron-deficient 
olefinic portion of pentafluorophenyl vinylsulfonate to provide functionalized 
pentafluorophenyl esters.
Subsequent displacement of the pentafluorophenyl moiety via an established 
aminolysis procedure then delivered the corresponding sulfonamide products. 
During the course of this investigation, it was established that both radical and 
cycloaddition routes were successful in furnishing desirable compounds.
I t  was found that intermolecular radical addition of alkyl halides occurred readily 
and permitted the formation of a number of sulfonamide addition products.
In addition, Diels-Alder cycloaddition with carbocyclic dienes and furan formed 
stable exo-bicyclic sulfonamides.
Notably, 1,3-dipolar cycloaddition with a diverse library of /V-methyl-nitrones 
gave the corresponding isoxazolidine species with unprecedented regio- and 
stereoselectivity. Subsequent aminolysis delivered functionalized heterocyclic 
sulfonamides with potential biological importance.
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Introduction
1.0 INTRODUCTION
This thesis describes the research undertaken on developing the sulfonamide 
motif as a modern and efficient element of current therapies. I t  builds on work 
originally developed in the Caddick laboratory and demonstrates the versatility of 
this methodology for the construction of biologically important sulfonamide 
libraries.
1.1 Sulfonamides as Potent Therapies for Disease
Sulfonamides are acknowledged as one of the most effective and diverse classes 
of therapeutic agents over the last fifty years. As management of disease has 
advanced and drug mode of action is better understood, sulfonamides have 
continued to be at the forefront of drug design through their ability to inhibit a 
wide range of therapeutic targets. The primary application of sulfonamides as 
valuable antibiotic agents has subsequently been extended to such targets as 
carbonic anhydrases (CAs); inhibition of which has been one route to successfully 
treating glaucoma, epilepsy and heart failure , 1 and the inhibition of CAs by 
sulfonamides is currently being recognised as a potential treatment for solid 
tumours ; 2 and more recently cysteine proteases (CPs), which are currently 
thought to be key targets for the treatment of arthritis, Alzheimer's Disease and 
cancer. 3 ,4
1.1.1 Sulfonamides as antibacterial agents
Sulfonamides were originally exploited as antibacterial drugs, the first being 
sulfanilamide ( 1 ), which was discovered to disrupt bacterial folic acid metabolism 
in 1935 (Figure l ) . 5
The revelation of sulfanilamide highlighted the sulfonamide motif as an important 
functionality in drug design, and instigated the development of sulfonamides from 
simple antibacterials to the potent treatments for an impressive variety of 
diseases presented today.
To emphasize the relevance of sulfonamides as potent antibacterial agents, it is 
noteworthy to underline the fact that some early sulfonamide antibacterials are 
still in clinical use. For example, sulfadiazine is currently incorporated in silver 
sulfadiazine (2) (Silvadene®), a topical treatment for severe burns, where its 
antimicrobial effects aid wound healing (Figure l ) . 6 Sulfadiazine has also found 
clinical use as a treatment for toxoplasmic encephalitis in AIDS patients . 7 
Sulfamethoxazole (3) (Gantanol®, Figure 1) has been prescribed since 1961, and 
works by inhibiting the production of bacterial dihydrofolic acid. However, due to
8
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the emergence of bacterial resistance, sulfamethoxazole is rarely administered 
alone today, and is more commonly prescribed in combination with another 
antibiotic, trimethoprim (Bactrim®), for the treatment of urinary tract infections . 8 
Sulfamethoxazole can also be used in conjunction with a variety of other 
medication to treat conditions such as malaria, conjunctivitis and toxoplasmosis . 8 
Finally, sulfathiazole (4) (Trysul®, Figure 1), is used to treat a number of vaginal 
bacterial infections . 9
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1.1.2 Sulfonamides as carbonic anhydrase inhibitors
Carbonic anhydrases are one of the most ubiquitous zinc-based enzymes in 
nature, found in bacterium and vertebrates alike. There are currently 14 known 
isoforms of carbonic anhydrase present in humans, namely cytosolic (CA I, CA II, 
CA III, CA V II), membrane bound (CA IV, CA IX, CA XII, CA XIV), one 
mitochondrial (CA V) and one secreted isoform (CA VI), with the sites of the 
remaining CA isoforms yet to be determined . 1
CA enzymes are involved in numerous physiological functions within the body, but 
are primarily concerned with catalyzing the essential process of C02 conversion to 
bicarbonate in the cell. This feature is critical for respiration, C02 transportation, 
electrolyte excretion, pH regulation and homeostasis among others . 1 
Due to the wide distribution of carbonic anhydrase in its various isoforms 
throughout the body and its important physiological function, there are a vast 
number of possible targets for inhibitors, making it an attractive candidate for 
exploitation.
The classic systemic carbonic anhydrase inhibitors (CAIs) developed in the 1950s, 
which include acetazolamide (AZA), methazolamide (MZA), ethoxzolamide (EZA) 
and dichlorophenamide (DCP) have enjoyed longstanding clinical success as
9
Introduction
antiglaucoma drugs (Figure 2), and instigated interest in the heterocyclic 
sulfonamide motif as a fruitful lead in developing therapies for other diseases. 
Notably, the topically acting antiglaucoma CAIs dorzolamide (DZA) and 
brinzolamide (BRZ) have been introduced clinically within the last 10 years . 1
NHEt
' " O "
N—N MeO(CH2)3 ^
AZA BRZ DCP
NHEt
EtO'
EZA DZA
10
Figure 2
Research into the many isoforms of calcium anhydrase has shown that each 
specific isoform often has a distinct physiological role in the body. Subsequently, 
potential inhibitors are currently being designed to selectively act on the certain 
isoforms of interest, thereby avoiding any detrimental side effects arising from 
non-selective inhibitors . 10
One of the most active areas of CAI research is concentrated on CA isoforms IX 
and XII, as the discovery that these isoforms are overexpressed in tumour cells 
makes them ideal targets for antitumour therapies. CA IX and XII are thought to 
be involved in the pH balance and intercellular communication of a wide variety of 
tumours, including cervix; kidney; lung; breast and colon carcinomas, yet are 
sparsely found in normal healthy cells. Thus specific inhibition of CA IX and/or XII 
could be of therapeutic benefit. 1
Studies on the inhibition of CA IX have resulted in the discovery of a number of 
potent, sub-nanomolar sulfonamide-based inhibitors with improved activity 
compared to currently administered drugs (a selection are displayed in Figure 3). 
The most developed compound at this stage is indisulam (E7070), developed in 
Japan by Ozawa et a l.f which is presently in advanced Phase I I  clinical trials for 
the treatment of solid tumours . 11
10
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CA II  is generally the most sensitive isoform to sulfonamide inhibition, and is the 
main isozyme involved in aqueous humour secretion in the eye, as well as the 
physiological processes of respiration and C02 transport common to all the 
carbonic anhydrases. The classic systemic antiglaucoma drugs (Figure 2 ) have 
exploited the sensitivity of CA II  for over 50 years, with their mode of action 
resulting in lowering of the intraocular pressure in the eye.
New sulfonamide antiglaucoma drugs are currently being developed which are CA 
II  specific and are reported to have greater bioavailability than BRZ and DZA, 
suggesting that superior therapies for the treatment of glaucoma could be 
forthcoming (Figure 4 ) . 12
r-N
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Figure 4
CA inhibitors are also thought to be potential anticonvulsants, for the treatment 
of epilepsy. This is due to the fact that CA is abundant in the brain neurones, 
primarily as the isoforms II , V II and XIV, which are associated with the secretion 
of cerebrospinal fluid. I t  has also been shown that the excitatory effect of 
bicarbonate anions in the brain, which contribute to the occurrence of seizures, is 
blocked by CAIs that can pass through the blood-brain barrier . 13
11
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A number of inhibitory sulfonamides have been designed for the treatment of 
epilepsy and depression via this mode of action (Figure 5). The most potent 
compounds in a study by Supuran et a\. were found to be highly selective for 
isoform CA II and displayed superior potency in comparison with the classic 
anticonvulsants AZA and MZA. 13
CH
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Figure 5
Obesity is also a condition that has the potential to be treated by sulfonamide 
CAIs. The mitochondrial isoform CA V is known to be associated with such 
physiological processes as ureagenesis, gluconeogenisis and lipogenesis. 14 
Inhibition of lipogenesis is thought to be the mode of action for antiobesity drugs, 
since it was discovered that the antiepileptic sulfamate drug topiramate ( 2 1 ) 
(Figure 6 ), which is a potent CA II  inhibitor, had the side effect of reducing body 
weight in administered patients. This is thought to be due to the drugs' efficient 
inhibition of both CA II and CA V, and topiramate has been patented as an 
antiobesity drug . 14
Studies on sulfonamides in the quest for selective CA V or dual CA II/V  inhibitors 
have been carried out recently, and a number of potent subnanomolar 
compounds have been identified for further investigation (Figure 6 ) . 14
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Figure 6
The regulation of bicarbonate anions by carbonic anhydrases is also prevalent in 
viral species, and CAIs have been suggested as novel treatments for diseases 
such as malaria. The mode of action in this case has been identified as the
12
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interception of pyrimidine biosynthesis, where bicarbonate is utilized throughout 
the metabolic pathway . 15
Plasmodium falciparum is the most widespread malarial parasite, and its CA has 
been isolated16 and known to be distinct to that of the human host. I t  is 
postulated that sulfonamide mediated inhibition of CA I and/or II, which are 
highly concentrated in red blood cells, would represent a novel route towards 
alleviating malaria as a serious health issue, without the toxicity and parasite 
resistance that is associated with current antimalaria treatm ents . 15 
Initial research has isolated one compound in particular, an ureido-sulfonamide 
that is almost four times as effective as AZA, the clinically used systemic CAI 
(Figure 7 ) . 15
H3CCONH s o 2n h 2
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Figure 7
1.1.3 Sulfonamides as cysteine protease inhibitors
Cysteine proteases (CPs) constitute a varied and important class of enzymes, 
which are involved in myriad physiological events such as apoptosis, antigen 
processing and the degradation of proteins. Cysteine proteases have been 
implicated in the pathology of several diseases, including rheumatoid arthritis, 
inflammatory bowel disease, osteoporosis, stroke, Alzheimer's disease, cancer, 
and parasitic diseases such as malaria. Consequently, developing CP inhibitors to 
potentially address these disorders represents an attractive opportunity . 3 ,4  
Interleukin-1|B is a cytokine concerned with both acute and chronic inflammation, 
and plays a role in septic shock, arthritis and Alzheimer's disease. This cytokine is 
regulated by the CP caspase-1 (also known as interleukin-10 converting enzyme, 
ICE); hence caspases have been investigated as potential targets for inhibitors . 3 ,4  
Harter et al. recently reported the synthesis of peptide-based sulfonamides that 
inhibited caspase-1 with nanomolar potency (Figure 8 ) . 4
13
Introduction
OH
23
Figure 8
Cathepsins are a class of CPs that are mainly involved with intracellular 
proteolysis, but have also shown to have other functions, for example cathepsin K 
has an important role in bone physiology, thereby offering itself as a target for 
osteoporosis treatments, and cathepin L, which is present in healthy cell 
lysosomes, is known to be secreted outside the lysosome in disease states such 
as muscular dystrophy, cancer, multiple sclerosis and Alzheimer's disease, hence 
cathepsin L is also an interesting target for inhibitors.
Sulfonamides have been involved in the quest for cathepsin inhibitors. Falguyeret 
et a/ have reported sulfonamide compounds that were shown to effectively inhibit 
cathepsins K and L in vitro (Figure 9 ) . 3 ,1 7
CNn=0,l
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Figure 9
Cysteine proteases are also important enzymes in nature, and are responsible for 
a variety of essential processes in protozoa. Hence, CPs represent novel targets 
for treating parasitic infections such as malaria and Chagas' disease (the leading 
cause of congestive heart failure and inflammation in South America, affecting 
over 18 million people and currently without adequate treatm ent) . 18  
Potential inhibitors of cruzain, the major CP of the parasite Trypanosoma cruzi 
that causes Chagas' disease, have been developed by Roush et al. Vinyl 
sulfonamides (such as structure (25), Figure 10) were shown to be selective and 
potent inhibitors of cruzain, with their mode of action identified as being 
irreversible binding to a cysteine residue within the CP active site . 4
14
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Analogous to the potential targets for calcium anhydrase inhibitors, malarial 
parasites are also of interest for CP inhibitors, especially since virulent strains 
such as Plasmodium falciparum are becoming resistant to current antimalarial 
drugs. One potentially fruitful target for inhibition is the papain family of cysteine 
proteases, specifically falcipain-2 and falcipain-3, which are required for the 
essential process of haemoglobin hydrolysis in the parasite . 19 
Shenai et al. have developed vinyl sulfonamides that display nanomolar inhibition 
of both falcipain-2 and falcipain-3, and consequently show potential as future 
antimalarial agents (Figure l l ) . 19
26 27
Figure 11
1.1.4 Sulfonamides as HIV protease inhibitors
Sulfonamides are widely established in the area of HIV protease inhibition, chiefly 
due to the successful antiviral drug amprenavir (28) (Figure 12), which boasts 
high oral bioavailability and a lengthy half-life. A number of compounds 
structurally related to amprenavir are currently in development, which display 
subnanomolar activity against previously resistant strains of mutant and wild type 
HIV proteases. For example, tipranavir (29) and DPC-681 (30) are in the process 
of Phase I clinical trials, and TMC-126 (31) and TMC-114 (32) (developed by 
Tibotec) are presently undergoing clinical human trials (Figure 12) . 3
15
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In addition, Stranix et at. have recently reported the formation of lysine 
sulfonamides which possess a high potency against wild type HIV proteases 
(Figure 13).20
OH HN-
33
Figure 13
1.1.5 Sulfonamides as COX-II specific inhibitors
The development of sulfonamide-based COX-II specific inhibitors has been a 
major breakthrough in the administration of anti-inflammatories for the treatment 
of osteoarthritis (OA), rheumatoid arthritis (RA) and post-surgical analgesia. 
Cyclooxygenase (COX) enzymes are involved in the synthesis of prostaglandins 
(PGIs) and thromboxane (TX) from arachidonic acid, and are present as two
16
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known isoforms in the body, namely COX-I, which is constitutive, and COX-II, 
which is induced in response to inflammation (although it is thought to be 
constitutively expressed in some tissues).
COX-I is involved in the synthesis of PGIs and TX in the gastric mucosa, platelets 
and kidneys. PGIs are important biological mediators and their roles include 
protecting the GI tract and maintaining renal homeostasis. TX promotes platelet 
aggregation in response to bleeding.
COX-II is generally induced when inflammation arises, and is thought to mainly 
affect those PGIs specifically involved in inflammation . 2 1
Analgesia has traditionally been relieved with the use of non-selective NSAIDs 
(non-steroidal anti-inflammatory drugs) such as ibuprofen, but their lack of 
selectivity is renowned to cause side effects such as ulcers, bleeding (especially 
post-operative), and gastroduodenal erosion in susceptible patients.
These side effects are due to the suppression of the constitutive COX-I enzyme, 
which synthesizes platelets (which are involved in blood clotting) and the gastric- 
protecting PGIs. Consequently, COX-II specific inhibitors were designed to give 
pain relief without the adverse affects associated with conventional NSAIDs. 2 2  
The first COX-II inhibitors were launched in 1999; the sulfone rofecoxib (Vioxx®, 
Figure 14), and the sulfonamide celecoxib (Celebrex®, Figure 14). Valdecoxib 
(Bextra®, Figure 14) followed in 2002 and has been prescribed to 7 million 
patients worldwide for the treatment of OA, RA and post-surgical analgesia. The 
drugs display highly selective COX-II inhibitory properties, have fast acting and 
long lasting analgesic effect, and exhibit higher tolerance than NSAIDs. 2 3
CH
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Figure 14
Despite these benefits, Merck withdrew rofecoxib (which had been prescribed to 
80 million patients) in September 2004 following concerns of an increased risk of 
myocardial infarction and stroke. This is possibly due to the sole inhibition of
17
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certain COX-II prostaglandins, whereas COX-I thromboxane is unaffected. Hence 
thromboxane effects are effectively exaggerated during administration, which is 
thought to potentially expose patients to cardiotoxicity.21,23c)
The chemistry of celecoxib and valdecoxib is thought to be distinct from that of 
rofecoxib so may not represent a similar hazard , 2 4  although fears of increased 
cardiovascular and gastrointestinal risk in patients administered valdecoxib2 2 ,2 3 ,2 5  
resulted in Pfizer withdrawing the drug in April 2005.
Nevertheless, coxibs are still considered valuable therapeutic agents, and there is 
evidence that their benefits reach further than just analgesia. For example, it has 
been observed that COX-II enzymes are often over expressed in tumour cells, 
particularly in colon carcinomas. Consequently, it has been postulated that COX- 
II  specific inhibitors could produce a chemoprotective effect, and Maier et al. have 
shown that celecoxib induces apoptosis in both animal and human models . 2 6  
In addition, Supuran et al. have demonstrated that both valdecoxib and celecoxib 
strongly inhibit CA IX, which (as previously described) is the CA isoform 
associated with tumours. Both coxibs were found to have greater efficacy than 
the systemic CAIs AZA and MZA. 2 4
Furthermore, celecoxib has been suggested as an add-on therapy in the 
treatment of neuropsychiatric disorders such as Alzheimer's disease, cerebral 
ischemia and schizophrenia. Reasoning for this is that the COX-II enzymes 
present in the brain tissue can be activated by cytokines, causing inflammation. 
Patients suffering from schizophrenia often display increased levels of cytokines in 
their spinal fluid, which possibly promotes incidences of inflammation-induced 
neuropsychiatric disorder. Celecoxib is thought to inhibit the COX-II activation by 
cytokines in the central nervous system, and consequently presents itself as a 
novel therapy for schizophrenia and other related diseases. 2 7
1.1.6 Sulfonamides as diuretics
Sulfonamides display efficacy as potent loop diuretics, and are exemplified by 
furosemide (Lasix®, Figure 15), which was introduced clinically over 30 years ago. 
Diuretics work by initiating the loss of water, minerals and electrolytes from the 
body via urination, and are crucial drugs for the treatment of oedema (water 
retention), which arises in conditions such as chronic heart failure, renal failure, 
and cirrhosis . 2 8
Furosemide is routinely prescribed for the long-term management of heart 
failure, and is often used in combination with other drugs to treat hypertension. 
Consequently, sulfonamides play a central role in this area, with more modern
18
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diuretics such as torsemide (Demadex®, Figure 15) continuing the trend . 2 9
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Figure 15
1.1.7 Sulfonamides as hypoglycaemic agents
Sulfonamides that act as hypoglycaemic drugs are of the sulfonylurea class, and 
include glibenclamide (Figure 16). These agents treat Type II  (non-insulin 
dependent) diabetes mellitus, and work by initiating the release of insulin from 
islet p-cells in the pancreas, resulting in the lowering of blood sugar levels . 3 0  
Put explicitly, glibenclamide is a potent and selective inhibitor of the cellular ATP 
sensitive K+ channel, and the subsequent depolarization of the cell membrane 
and influx of Ca2+ ultimately leads to insulin release. Its high affinity for this 
cellular binding site, deemed critical for ATP K+ channel regulation, has allowed 
glibenclamide to be implicated in further therapeutic roles as the process of 
intercellular communication and signalling is better understood . 31  
For example, glibenclamide has been shown to give enhanced survival after 
haemorrhagic shock and endotoxemia by increasing arterial pressure upon 
administration. Improved renal function was also reported . 3 2  This is an illustration 
of the fact that as disease states are more thoroughly understood, the concept of 
employing sulfonamides is often proposed, which underlines the broad 
applicability of sulfonamides in general.
glibenclamide
39
Figure 16
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1.1.8 Other sulfonamide agents
There are further sulfonamide drugs that do not come under the above headings, 
but are worthy of a citation.
Sulfasalazine (Azulfidine®, Figure 17) has been approved for clinical use since 
1950, and is an anti-inflammatory pro-drug. Once administered, sulfasalazine is 
metabolised in the colon to the active agent 5-aminosalicylic acid, and is used to 
treat disorders that are associated with inflammation of the colon, such as 
ulcerative colitis and Crohn's disease. Sulfasalazine is also prescribed for 
rheumatoid arthritis . 33
Finally, perhaps the most illustrious sulfonamide drug at present is sildenafil 
(Viagra®, Figure 17), which is used to treat erectile dysfunction. In brief, sildenafil 
works by inhibiting the enzyme phosphodiesterase-5, whose role is the 
metabolism of cyclic guanosine monophosphate, a substance that is ultimately 
responsible for the regulation of blood within the penis. This inhibition results in 
the prolongation of penile erection . 3 4
OH
// *
sildenafil
4 0
sulfasalazine
41
Figure 17
In conclusion, sulfonamides represent a diverse and relevant class of 
therapeutics. The sulfonamide motif commands recognition for its vital role in 
medicine over the last 50 years, and remains a potent tool for the delivery of 
modern and effective drugs to treat an increasing portfolio of diseases.
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1.2 The Role of Nitrones in [3+ 2 ] Cycloaddition to Olefins
This thesis predominantly focuses upon the 1,3-dipolar cycloaddition of nitrones 
to an olefin (PFP vinylsulfonate), in efforts towards the formation of sulfonamides. 
Consequently, it is important to discuss the general utility of nitrones in organic 
synthesis, in addition to the often perplexing selectivity displayed in nitrone-olefin 
cycloaddition products.
1.2.1 N itrones as valuable tools in natura l p roduct synthesis 
Nitrones have been utilized as important intermediates in a number of natural 
product syntheses, often to enable the introduction of nitrogen into a molecule 
with high regio- and stereo-selectivity.
Dondoni and co-workers used nitrone chemistry to convert furanoses into 
pyrrolidine homoazasugars via aminohomologation (Scheme l ) . 3 5  Pyrrolidines are 
recognised as potential drug candidates for conditions such as diabetes, viral 
infections and cancer metastasis, therefore an efficient route to their synthesis is 
evidently beneficial. The nitrone step in this synthesis concerned the 
stereoselective addition of 2-lithiothiazole to nitrone (43) generated in situ from 
the corresponding hydroxylamine (42), to give the open chain adduct (44). 
Further transformations furnished the target structures exemplified by (45).
BnO'^ V-O
I >"'N(OH)Bn
BnOs' \
OBn
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OH OBn
+ Bn
OBn N(OH)Bn
b,c BnO""*'
BnO
Bn
-NCi .  o —„> 4 1\  N
d,e,f BnO'
Bn
IN
BnO
.\
g,h HO'
H 
-N
OH HO
OBn 
44a
OBn
44b
.o  \
OH
OH
45
Th= 2-thiazolyl a. -70 °C, Et20, 75 % e. AgN03, MeCN/H20
b. (A c O )2C u, Zn, 78 % f. NaBH4, 74 % (over 3 steps)
c. Tf20, pyridine, 65 % g. H2/ 20 % Pd(OH2)C
d. TfOMe, NaBH4 h. DOWEX (OH'), 86 %
Scheme 1
Dondoni also used nitrones as a key element in the total synthesis of SPP-100, a 
renin inhibitor that acts as an antihypertensive by reducing blood pressure long
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term in vivo.36 The addition of nucleophillic species to N-benzyl nitrones was 
discovered to be a convenient method for the introduction of amino functionality 
into the system. The central step involved coupling the functionalized nitrone (46) 
to the Grignard reagent (47) to  furnish the (R)-hydroxy I amine (48) as the major 
diastereoisomer (Scheme 2).
The stereoselective coupling of a nitrone to a halide is the fundamental 
transformation in the total synthesis of kaitocephalin, a potent AMPA/KA receptor 
antagonist. Watanabe et al. found nitrone (50) underwent addition to the halide 
species (51) selectively, yielding hydroxylamine (52) as a single isomer in 
excellent yield (Scheme 3 ) . 37
Me0(CH2)30.
MeO(CH2)30 -< \ / )
48MeO
Scheme 2
ci
Cbz
BzIO
p-7ir* O Cbz
HN'Y '-" ^ 0 T E
+ V J ""OTMS
OTBDPS.OTBDPS a,b,c BzI0 2C
N.
v ° d
Bu 49
"N C02Bzl
~o
50
"OTMS 
N C02Bzl 
OH
kaitocephalin 53
a. 80 % AcOH, 60 °C, 62 %
b. TMSCI, imidazole, DMF, 0 °C, 80 %
c. MeRe03/ urea.H20 2, MeOH, rt, 85 %
d. Zn (8 eq.), Cul (3.6 eq.), THF/H20  (3.3:1), ultrasound, rt, 85 %
Scheme 3
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The asymmetric total synthesis of (+)-sparteine was accomplished by Aube and 
co-workers with the aid of nitrone intermediates (Scheme 4). Deprotection of the 
hydroxylamine (54) followed by intramolecular condensation gave the nitrone 
(55). Photolysis at 254 nm afforded rearrangement to lactam (57) in good yield, 
with further transformations furnishing the target molecule . 3 8
o-
54 55 56
57
a. TFA, 4A MS, NaHC03/ 74 - 98 %
b. hv 254 nm, benzene, 76 %
c. LAH, THF, reflux, 95 %
(+)-sparteine 58
Scheme 4
Goti and co-workers determined the total syntheses of hyacinthacine A2 and 7- 
deoxycasuarine with the use of trisubstituted chiral nitrones, formed from basic 
sugars (Scheme 5). Hyacinthacine A2 (64) and 7-deoxycasuarine (65) are 
alkaloids that possess potent glycosidase inhibitory activity; therefore they 
present themselves as candidates for the treatment of conditions such as cancer, 
diabetes and viral infections. The synthesis represents a simple yet wholly 
stereoselective route to these polyhydroxypyrrolizidine species. 3 9
a,b,c
PBn
OBn
OBn
d,e,f,g BnO,
DCM, rt, 78
a. Me0H/H2S 04, l\la2S 04, rt, 21 h
b. BnCI, KOH, Na2S04, reflux, 8 h
c. 6M HCI, MeC02H, 60-70 °C, 50 %  
(over 3 steps)
d. NH2OTHP, neat, rt, 6 d, 100 %
e. MsCI, TEA, DCM, rt, 24 h, 50-70 %
f. DOWEX 50W X8, MeOH, rt, 24 h, 96 %
g. 0.1M NaOH, dioxane, 0°C, 2 h, 55 %
h. Zn, MeC02H/H2O, 50°C, 4 h, 80 %
OBnL-xylose
CONMe2 .sOBn
Me2NOC
HO
HQ PH
OH
OH
HO''
hyacinthacine A2 64 7-deoxycasuarine 65
Scheme 5
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Holmes et al. reported the total syntheses of (-)-histrionicotoxin (6 8 ), (+ )- 
histrionicotoxin (69) and (-)-histrionicotoxin 235A (70), with the cycloaddition of 
styrene to protect cyclic nitrone ( 6 6 ) as a key step in the synthesis of their 
spirocyclic core (Scheme 6 ). The histrionicotoxin alkaloids are naturally derived 
from the skin of the Colombian poison arrow frog Dendrobates histrionicus, and 
are known for their selective inhibition of the nicotinic acetylcholine receptors . 40
OTBDPS
R= (Z)-CH=CHC=CH
(-)-histrionicotoxin 68 (+)-histrionicotoxin 69 (-)-histrionicotoxin 235A 70
a. styrene, quinol (cat.), 80 °C, 7 h, 85 % (over 2 steps)
Scheme 6
In conclusion, these examples illustrate the utility of nitrones in current organic 
synthesis, demonstrating that these species are important structures for the 
elucidation of interesting biologically active molecules.
1.2.2 Selectiv ity in n itrone [3 + 2 ] cycloaddition to  olefins 
Considering the versatility of nitrones as synthetic tools, the desire to achieve 
selective nitrone cycloaddition is a priority, especially considering that the 1,3- 
dipolar cycloaddition reaction is perhaps one of the most versatile routes to five- 
membered heterocycles. 4 1
Extensive mechanistic analysis by Huisgen and co-workers throughout the 1960's 
and 1970's introduced the concept of 1,3-dipolar cycloaddition, and established 
that the reaction takes place via a concerted (if slightly asynchronous) 
mechanism . 4 2  Despite initial objections , 4 3  Huisgen's findings continue to be the 
widely accepted view today . 4 4
However, in spite of theoretical calculations, the regio- and stereochemical 
outcome of nitrone-olefin cycloaddition can be difficult to predict in practice, 
especially considering that it is possible for the cycloaddition to occur in two 
orientations to give a number of isomeric products (Scheme 7 ) , 4 5  which are often 
dependent upon factors such as steric hindrance; solvent effects; substituents
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and electron density of the olefin. Fortunately, the application of frontier orbital 
theory has bestowed a degree of clarity to this issue.
endo approach
7 271
exo approach
73 7 4
Scheme 7
The principles of perturbation theory were first applied to nitrone-olefin selectivity 
by Houk and co-workers in 1973.47,48 This extensive theoretical and experimental 
study represented a turning point in the evaluation of 1,3-dipolar cycloaddition, 
as it could accurately predict the regio and stereochemical outcome in the 
majority of experimentally observed cycloadditions, many of which had previously 
been difficult to explain by other means. Today, it still remains the most reliable 
method to explain the generally complex mechanistic and selectivity issues 
presented in these reactions . 4 9
Perturbation theory is based on the HOMO'S (highest occupied molecular orbitals) 
and LUMO's (lowest unoccupied molecular orbitals) of both the dipolarophile and 
the 1,3-dipole. In brief, when the HOMO of the dipolarophile interacts with the 
LUMO of the dipole, and vice versa, a stabilisation of this transition state results. 
The magnitude of this stabilisation is a function of the energy difference between 
the interacting orbitals and so the closer these energies are, the higher the 
resulting stabilisation.
To take a simple [4+2] example, maleic anhydride undergoes cycloaddition with 
c/s-butadiene via the low energy LUMO of the dienophile and the high energy 
HOMO of the diene, as this combination gives superior overlap in the transition 
state and therefore greater stabilisation (Figure 18).
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Figure 18
Prior to Houk's seminal study utilizing 1,3-dipoles, Fukui had developed and 
applied perturbation theory to cycloaddition mechanisms, with subsequent 
workers expanding various applications of the theory . 5 0 ,5 1
A major step forward occurred when Houk recognised that perturbation theory 
could not only explain substituent effects, but also the reactivity and 
regioselectivity of 1,3-dipolar cycloaddition reactions.
Houk used the second order perturbation expression in his calculations, 
considering only the last term, relating to orbital mixing, and classified the 
reaction types in terms of orbital control, namely HO-controlled, HO/LU-controlled 
and LU-controlled.
Application of the frontier orbital model revealed that substituents that raised the 
dipole HO energy or lowered the dipolarophile LU energy accelerated HO- 
controlled reactions and decelerated LU-controlled reactions. Conversely, 
substituents that lowered the dipole LU energy or raised the dipolarophile HO 
energy accelerated HO-controlled reactions. HO/LU-controlled reactions could be 
accelerated by either frontier orbital interaction . 4 6
Calculations of frontier orbital energies and coefficients for a number of 
dipolarophiles and 1,3-dipoles carried out by Houk et a\. resulted in the 
conclusion that with unsubstituted dipoles, electron-deficient dipolarophiles have 
the smaller separation between the HOMO (dipole) and LUMO (dipolarophile) and
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electron-rich dipolarophiles have the smaller separation between the LUMO 
(dipole) and HOMO (dipolarophile). Once coefficient effects were taken into 
account, regioselectivity could then be assessed. 4 7 ,5 2
In terms of regioselectivity, Houk found that it was not necessary to include 
possible complications from closed-shell repulsions and electrostatic effects, as 
for most cases identification of the controlling frontier orbital interaction was 
sufficient in order to rationalise or predict the product regiochemistry. Theory 
suggested that all 1,3-dipoles would react with monosubstituted electron-rich 
dipolarophiles to form the product with the substituent adjacent to the 'anionic' 
atom (Figure 19). This was expected because perturbation theory predicted that 
all of these reactions were dipole LU-controlled (although for conjugated and 
electron-deficient dipolarophiles, the regiochemistry would depend on which 
frontier orbital interaction was dominant) . 4 6
R
Figure 19
Houk's orbital energy calculations for the nitrone class of 1,3-dipoles are shown 
diagrammatically below (Figure 20). The data suggested, upon comparison with 
the corresponding frontier orbital coefficients, that for reaction of the parent 
species A/-methyl nitrone (75) with electron-deficient dipolarophiles, the dipole 
HO interaction is the larger but does not contribute to regioselectivity. 
Consequently, the LU, which has a much larger coefficient on carbon, controls the 
regioselectivity with moderately electron-deficient and all other dipolarophiles, 
forming the 5-substituted cycloadduct. This conclusion has been verified 
experimentally, and indeed the majority of nitrone cycloaddition reactions result 
in production of the 5-substituted isoxazolidine . 4 6
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Ph= N
V==N
Me75 76
Z=electron withdrawing group 
X=electron donating group 
C interm ediate
Figure 20
However, for the most widely studied species, C-phenyl-/V-methyl nitrone, (76) 
frontier orbital energies indicate a crossover from LU control for electron-rich 
dipolarophiles to HO control with electron-deficient dipolarophiles (where the 
olefin substituent is Z; Figure 20 and Figure 21). Reasoning behind this is that the 
HO coefficient on carbon is decreased by the phenyl substituent on the nitrone, 
yet the methyl group increases the coefficient. Despite this disparity, the effect of 
the phenyl should predominate, leading to a larger coefficient on the oxygen than 
the carbon. Both substituents decrease the coefficient on carbon in the LU; hence 
the difference between the carbon and oxygen coefficients also decreases.
This led to the conclusion that with very electron-deficient dipolarophiles, dipole 
HO control ultimately predominates, so that 50:50 mixtures of cycloadducts 
would be expected with methylene nitrones (where terminal HO coefficients are 
similar), and complete reversal of regioselectivity would result with C-aryl-A/-alkyl 
nitrones giving 4-substituted isoxazolidines . 4 6
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Figure 21
Although Coulombic effects and closed-shell repulsions are not considered in 
Houk's frontier orbital treatment, it was acknowledged that these terms from the 
second order perturbation expression did have some influence on the relative 
rates of cycloaddition for particular 1,3-dipoles. I t  was estimated that for 
conjugated and electron-deficient dipolarophiles, closed-shell repulsion effects 
between HO orbitals would strengthen the inclination for formation of adducts 
favoured by LU control. Furthermore, it was calculated that for dipolarophiles with 
strongly electron-withdrawing substituents, Coulombic forces favoured reversal in 
regioselectivity with such 1,3-dipoles as nitrones, nitrile oxides and diazoalkanes. 
Hypothetically, if the dipole LU interaction became sufficiently small, the 
Coulombic interactions could dominate, allowing formation of the 4-substituted 
adduct all the more favourable . 4 6
Finally, Houk demonstrated that experimental observations vindicated his 
theoretical treatment. Regioselectivity could be predicted with confidence, 
whatever the electronic nature of the nitrone or dipolarophile. For example, it was 
shown experimentally that with mono-substituted electron-deficient dipolarophiles 
such as phenyl vinyl sulfone, nitroethylene and cyanoacetylene, reversal to give 
the 4-substituted cycloadduct as the major product occurred readily (Scheme 8 ). 
All these observations could be explained successfully using the frontier orbital 
hypothesis . 53 In addition, more recent experimental studies concerning electron- 
deficient dipolarophiles have justified the assertions of the frontier orbital 
model. 5 4 ,5 5
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Scheme 8
Moreover, Houk determined a general tendency in nitrone-dipolarophile 
cycloadditions for the amount of 4-substituted cycloadduct to increase as the 
ionisation potential (IP) of the nitrone decreased, or as the electron affinity of the 
dipolarophile increased. In terms of frontier orbital terminology, this would 
correspond to an increase in nitrone HO energy, or a decrease in dipolarophile LU 
energy respectively . 56
The effect was illustrated in reactions with the electron-rich nitrone C- 
cyclopropyl-/V-methylnitrone, which consequently has a significantly lower IP than 
C-phenyl nitrones. It was found that with electron-deficient dipolarophiles, the 
amount of 4-substituted cycloadduct increased as the electron deficiency of the 
dipolarophile increased. This observation was rationalised by frontier orbital 
theory, which proposed that since electron-rich nitrones have low-lying HO and 
LU orbitals, the HO (l,3-dipole)-LU (dipolarophile) interaction becomes wholly 
dominant, leading to formation of predominantly the 4-substituted adducts . 56
These results also led to the conclusion that regioselectivity in the cycloaddition 
was electronically rather than sterically controlled, as steric effects did not 
prevent formation of the more hindered adducts. This finding is supported by the 
work contained within this thesis, as we observed the formation of 4-substituted 
adducts from the cycloaddition of sterically demanding nitrones to electron- 
deficient dipolarophiles. In addition, the 1,3-dipolar cycloadditions we performed 
were found to be wholly compatible with the frontier orbital hypothesis . 57
Ever since 1969 when Huisgen first observed reversal of regioselectivity in nitrone 
cycloaddition with /V-phenyl-C-methyl nitrone and methyl propiolate , 58 a rational 
explanation for this phenomenon had been sought. Houk's moulding of
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perturbation theory towards the issue of 1,3-dipolar reactivity has been the most 
significant step in explaining experimental results. It has also bestowed much 
confidence in predicting the complex regiochemical outcomes prevalent in 1 ,3 - 
dipolar cycloaddition.
Despite the dominance of the frontier orbital treatment since it's development for 
the rationalisation of 1,3-dipolar regioselectivity, there has been continued 
discussions on the issue. Development of modern computer modelling 
programmes has allowed many workers to explore other facets of the 
cycloaddition that could determine regioselectivity.
In general, most of this work has concentrated on systems where perturbation 
theory fails or gives ambiguous results, and various methods have been 
employed to generate an accurate theoretical result. 5 9 ' 6 5
In conclusion, the pioneering and extensive research by Huisgen and co-workers 
led to the proposal of the concerted mechanism for 1,3-dipolar cycloaddition. I t  is 
to their credit that the theory has withstood time and rigorous opposing 
conjecture to remain as the most widely accepted view today.
The application of frontier orbital theory to the complex issue of regioselectivity in 
1,3-dipolar cycloadditions has proved to be so far the most successful and all 
encompassing of hypotheses in this field. The beauty is in its simplicity, and the 
numerous formerly perplexing cycloadditions it can explain with assurance. (This 
probably illustrates the dominance of frontier orbital stabilisation as the primary 
transition state factor in these reactions.)
Despite the supremacy displayed up to now by concerted mechanistic evidence 
coupled with frontier orbital theory in the rationalisation of selectivity, 
development of alternatives is a constant goal to explain exceptions to the rule. 
The evolution of modern computational techniques permits the vision that 
absolute resolution of selectivity in 1 ,3 -dipolar cycloaddition will be forthcoming.
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2 .0  RESULTS A ND  D IS C U S S IO N
2 .1  In tro d u c tio n
With the premise that sulfonamides continue to be at the forefront of drug 
development strategies, our remit was to widen the scope of previous work using 
pentafluorophenyl (PFP) vinylsulfonate within the Caddick group . 6 6 I t was initially 
envisaged that the electron-deficient nature of the olefinic portion would make 
this species a suitable candidate for cycloaddition reactions with a variety of 1,3- 
dipoles and dienes. This would then result in interesting cyclic compounds open to 
further manipulation.
2 .2  Radical A d d itio n  to  PFP V in y ls u lfo n a te
The investigation into PFP vinylsulfonate as a convenient building block for the 
synthesis of diverse sulfonamide products was originally developed using radical 
chemistry, whereby this bifunctional species (formed from the addition of a 
sulfonyl chloride to pentafluorophenol), readily underwent intermolecular tin- 
mediated radical addition to a number of alkyl halides, to give alkyl sulfonate 
esters. Subsequent displacement of the PFPO portion with a suitable amine was 
carried out smoothly in the presence of a strong base (DBU was favoured) to 
deliver the required sulfonamide in good yields (Scheme 9 ) . 6 6
V  a b 9wP ^  c ^  0v p  ^
c r s\ ^ G ► pfpo'  ► PFPO' ^N' ^ " ^ R
H
79  8 0  A B
a. PFPOH, NEt3, DCM, 0 °C, 1.5 h b. RX, Bu3SnH, AIBN, PhMe, reflux, 3-7 h 
C. R'NH2, DBU, THF, reflux-rt, 17-20 h
Scheme 9
Examples of the species formed via this protocol are displayed below (Table 1). 
This illustrates the initial promise shown by PFP vinylsulfonate as a bifunctional, 
activated acceptor, and gave us the confidence to investigate further the potential 
of this species in other transformations.
32
Results and Discussion
RX
(CH3)3CI
Yield 
A %
89
Product
A (8 1 -8 4 )
qw o 
c 6f 5cTs
r 'n h 2
Phe-OEt
Yield B
%
77
Product 
B (8 5 -8 6 )
Ph.
EtQ2C N'S n /N | \
CH3CH2 CH2 CH2 I 58 q  -o
c 6F5o '
(CH3)2CHBr 29 O O
C6F5crb'
Q
-0
O
71 o
V ° c6f5
° o 'b
o o o
CH2 CHCH2 NH; 69
.  OV-o-
H
;S'N' ° fo
O o
Table 1
2 .3  1 ,3 -D ip o la r C yc loadd ition  to  PFP V in y ls u lfo n a te
2.3.1 N itrones as 1,3-d ipo les
Investigation into the utility of PFP vinylsulfonate was then extended to focus on 
its ability to act as a dipolarophile in cycloaddition reactions.
The initial 1,3-dipoles to be examined were nitrones, primarily due to their ease 
of preparation, diversity and general stability. Nitrones are one of the most widely 
studied dipoles and undergo cycloaddition with a variety of olefins to form 
isoxazolidines. 5 7  They can be prepared in excellent yield via the condensation 
reaction of hydroxylamines with an appropriate aldehyde . 68
During this investigation, a variety of nitrones were synthesised in this way, and 
incorporated aromatic and alkyl substituents with electron-withdrawing, electron- 
donating, polycyclic, heterocyclic, and halogen functionalities (Scheme 10, Table 
2 ).
With these nitrone species in hand, the cycloaddition with pentafluorophenyl 
vinylsulfonate was attempted.
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= N
59 - 100 %
CH
a. MeNHOH. HCI, NaHC03, DCM, 40 °C, 1-2 h
Scheme 10
R Yield % No. R Yield % No.
Ph 92 76 Furyl 91 96
o-FPh 78 87 Naphthyl 8 6 97
m-CIPh 8 8 8 8 Cyclohexyl 99 98
p-CIPh 97 89 Cyclopropyl 1 0 0 99
p-BrPh 93 90 D-galactose 59 1 0 0
p-MeOPh 99 91 2,4,6-MeOPh 92 1 0 1
m-BrPh 1 0 0 92 2,4,6-MePh 98 1 0 2
p-N02Ph 93 93 C5 H11 62 103
o-N02Ph 97 94 p-Allyloxy 1 0 0 104
2-Br-Furyl 97 95
Table 2
2.3.1.1 Nitrone cycloaddition with PFP vinylsulfonate
Cycloaddition of nitrones to sulfonate species has been seldom reported , 6 9 despite 
the use of the comparable dipolarophile phenyl vinyl sulfone in a variety of 
cycloaddition transformations . 7 0 ,7 1  I t  was therefore of considerable interest for us 
to see if nitrone cycloaddition to our sulfonate species would be successful. 
Regarding literature precedent in this area, Houk et at. reported in 1973 that one 
of the most broadly used nitrones, C-phenyl-/V-methyl nitrone, underwent 
cycloaddition with phenyl vinyl sulfone at 80 °C to furnish the isoxazolidine 
product in a 68:32 mixture of regioisomers, the major product being the C-4 
substituted trans cycloadduct, and the minor a cis, trans mixture of the C-5 
substituted isoxazolidine . 53
The interest here for us lay primarily in the regiochemical outcome of this 
reaction. An extensive literature study revealed it is widely acknowledged that for 
the cycloaddition of a nitrone to an olefin, the C-5 cycloadduct is usually the 
achieved product (Scheme 11). Previous experimental observations coupled with 
comprehensive theoretical analysis has shown that formation of the C-4 
regioisomer is facilitated by the use of electron-deficient dipolarophiles, and in
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some cases, the C-4 substituted isoxazolidine is the major product in the 
cycloaddition . 4 6 ' 4 8 ,5 6 ' 6 7
C = N
CH CH;
C - 4
Scheme 11
Whilst this behaviour has been observed, it is still very much an exception to the 
rule, with only a handful of electron-deficient dipolarophiles inducing this so- 
called 'reversal' in regiochemistry (Scheme 12). This select group includes methyl 
propiolate, nitroethylene, and phenyl vinyl sulfone, whereas acrylonitrile and 
ethyl acrylate produce C-5 substituted isoxazolidines, despite their electron- 
deficient nature . 6 7
.o'
'==N
CH;
C-4 C-5
when R' = N 02 when R' = CN
s o 2r
Scheme 12
Considering that phenyl vinyl sulfone was known to induce this 'reversal', we 
postulated that PFP vinylsulfonate would also be likely to give the same outcome, 
furnishing C-4 substituted cycloadducts. To the best of our knowledge, the 
isoxazolidine product from an olefinic sulfonate has only been reported so far with 
sultones, which gave further impetus to test our theory . 69
Whereas Houk carried out the analogous cycloaddition using phenyl vinyl sulfone 
at 80 °C, we undertook our cycloadditions in refluxing toluene (110 °C). This was 
initially attempted for the simple reason that nitrone cycloaddition is generally 
carried out in inert solvent, and usually requires thermal assistance in order for a 
successful transformation; thus a higher boiling solvent could produce more rapid
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results. The significance of this action was not fully comprehended until later in 
our programme, and shall be discussed shortly.
The first cycloaddition reactions were carried out with C-phenyl-/V-methyl nitrone 
and phenyl vinyl sulfone (as a control experiment to compare our results with 
that reported), phenyl vinylsulfonate, and PFP vinylsulfonate. Initial attempts to 
optimise the reaction conditions and identify the products by tic (which tended to 
co-run with the starting materials) probably account for the longer than expected 
reaction times (up to 24 hours). Nevertheless, it was found that we could achieve 
cycloaddition with all the dipolarophiles in good yield, and x-ray crystallographic 
analysis of the major isomer from the phenyl vinylsulfonate cycloadduct revealed 
the regioselectivity to be C-4 trans, as we had envisaged.
In addition to these very pleasing results, an unexpected bonus was the excellent 
stereoselectivity displayed in the cycloadducts. I t  was expected that, akin to 
previous findings, a mixture of stereoisomers would be produced, although the C- 
4 cycloadduct would probably dominate. However, we found that with all three of 
these cycloadditions, the major C-4 trans stereoisomer was virtually the only 
isomer achieved, with it comprising over 94 % of the total products gained 
(Scheme 13). This was a significant improvement on earlier work with phenyl 
vinyl sulfone , 71 and indeed only a handful of nitrone cycloadditions, whatever the 
dipolarophile, give one stereo- and regio-isomer exclusively . 6 7
N
CH3
pfpo3s^ ^
PhMe, 110°C, 20h
PFPO3S*
.0
\
CH,
SO3PFP
C-4
98
Reported regioselectivity for PhS02CHCH2 68 : 32
Experimental regioselectivity for PhS02CHCH2 94 : 06
Experimental regioselectivity for PhS03CHCH2 99 : 01
C-5
Scheme 13
As the only notable difference between our reaction conditions and previous 
efforts was the elevated temperature, we presumed that the improved selectivity 
was primarily due to a thermodynamically controlled process. This is reasonable; 
especially in view of the fact that isoxazolidines are prone to cycloreversion at 
high temperatures . 6 7  Further experimental proof of the correlation between 
temperature and stereoselectivity will be forthcoming in the following discussion.
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Due to the success of cycloaddition with C-phenyl-/V-methyl nitrone, other more 
functionalized nitrone species were employed to discover how broad the scope 
was for the reaction. As previously shown in Table 2, a variety of C-aryl-/V-methyl 
and C-alkyl-/V-methyl nitrones were synthesised and subsequently utilized in the 
attempted cycloaddition to PFP vinylsulfonate. The employment of more 
functionalized nitrones revealed that a reaction time of 1-5 hours was sufficient to 
yield the isoxazolidine cycloadducts in good yield and with continued excellent 
regio- and stereo-selectivity (Scheme 14; Table 3). In fact, the C-4 substituted 
trans isomer could be achieved exclusively in all of these transformations.
+ /o  p fp o 3s ^ ;^
CH3 PhMe, 110 °C, 1-5 h
CH
C-4 C-5
Scheme 14
R Yield % C-4 : C-5 No.
Ph 67 98 : 2 105
p-N 02Ph 64 1 0 0  : 0 106
p-MeOPh 78 1 0 0  : 0 107
2-Furyl 75 1 0 0  : 0 108
m-CIPh 6 6 1 0 0  : 0 109
o-FPh 46 1 0 0  : 0 1 1 0
C5 Hh 6 6 1 0 0  : 0 1 1 1
Cyclohexyl 54 1 0 0  : 0 1 1 2
2-Naphthyl 65 1 0 0  : 0 113
Cyclopropyl 54 1 0 0  : 0 114
p-Allyloxy-Ph 8 8 1 0 0  : 0 115
2-Br-furyl 55 1 0 0  : 0 116
m-BrPh 60 1 0 0  : 0 117
Table 3
In support of our findings, nOe analysis of a typical example, 2-methyl-3- 
naphthalen-2-yl-isoxazolidine-4-sulfonic acid pentafluorophenyl ester (113), 
indicated our anticipated regio- and stereo- chemistry to be accurate (Figure 22).
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I t  was discovered that irradiation of Hb produced no enhancement of Ha. Equally, 
irradiation of Ha created no enhancement of Hb, but did produce enhancement of 
the c/'s proton Hc, which is indicative of the proposed trans stereochemistry.
2.7 %
6.3 %
CH
3.1%  1.5%1 1 3
Figure 22
Cycloaddition could be achieved with the majority of the nitrones synthesised, the 
few exceptions being a nitrone incorporating a sugar substituent; 2,4,6- 
substituted aryl groups; and para-halogen substituted aryl nitrones. The reason 
for this lack of addition is not fully understood, especially considering that 
cycloaddition was successful with both ortho- and meta-halogen substituted aryl 
nitrones, and with other para-substituted deactivating groups.
Whereas the cycloaddition products were achieved in respectable yields (Table 3), 
there is no obvious correlation between the yield and substituent type. All 
reactions were followed until completion (i.e. complete consumption of the 
dipolarophile, using a slight excess of the 1,3-dipole). However, the depleted 
yields for some of the cycloadducts could be due to thermal instability of the 
nitrone in question, or of any other products formed during the course of the 
reaction. Like isoxazolidines, nitrones are prone to undergo reverse reactions to 
reform their starting materials, and their thermal stability is not necessarily 
predictable. Finally, because these cycloadditions were carried out in refluxing 
toluene for up to 5 hours, the occurrence of decomposition products was perhaps 
inevitable.
It  was previously stated that our increased reaction temperature improved the 
selectivity of the reaction; hence it was deemed that this hypothesis required 
qualification. A control reaction was carried out whereby the cycloaddition of C- 
(4-allyloxy-phenyl)-/V-methylnitrone (104) to PFP vinylsulfonate was undertaken, 
first using our established conditions in refluxing toluene, and then at the lower 
temperature of 60 °C (also in toluene). The results are displayed in Scheme 15, 
which shows that conditions A gave the desired cycloadduct in 88 % yield after 
only 1 hour, whereas conditions B produced just 12 % of the same cycloadduct 
(plus decomposition products) after 12 hours.
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88 %
110°C CH
115
+"CH
PhMe
104 60 °C 
12 h
12 %
CH;
115
Scheme 15
From this experiment, it is reasonable to suggest that the most 
thermodynamically stable cycloadduct is formed rapidly and exclusively at 
elevated temperatures, whereas at lower temperatures and over an extended 
period of time, there is modest formation of the most favourable C-4 isomer, and 
possibly also the less favourable C-5 isomer. During the 12 hour timescale of the 
reaction, it is likely that the remaining nitrone present would have decomposed 
down to its aldehyde and hydroxylamine starting reagents, as these were 
identified in the reaction mixture by tic. In addition, as no 5-C product was 
isolated, it was presumed that this isomer also underwent cycloreversion followed 
by decomposition of the resulting nitrone and olefin. This was suspected because 
pentafluorophenol was also isolated from the reaction mixture (Scheme 16).
If  this is the case, previously reported cycloaddition reactions of this type with 
inferior selectivity could possibly be improved by the use of higher reaction 
temperatures.
cycloreversion
0“
PFPO^'^^ PFPOH
OH
Scheme 16
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2.3.1.2 Aminolysis of isoxazolidine cycloadducts
With a diverse variety of PFP-isoxazolidine cycloadducts in hand, aminolysis could 
then be attempted, whereby the PFPO portion is displaced by a suitable amine 
(Scheme 17). As this methodology is established within our laboratory,66 it was 
thought wise to employ consistently reliable amines for this procedure.
ch3
a. R'NH2 (3.0 eq.), DBU (1.0 eq.). THF, 65 °C, 1-5 hrs
Scheme 17
It  was pleasing to discover that aminolysis proceeded smoothly with all the 
cycloadducts to furnish the corresponding sulfonamide products (118 - 135) in 
good yield within 5 hours in refluxing THF (Figure 23).
122 (73 % )120 (84 % ) 121 (62 % )119 (88 %)118 (86 %)
s;;;
MeO'MeO'
127 (69 % )123 (91 % ) 124 (61 % ) 126 (81 % )125 (80 % )
Br
132 (56 % )131 (47 % )129 (61 % ) 130 (64 % )128 (50 % )
Ph
Si.
E t02C'
135 (58 % )134 (69 % )133 (58 % )
Figure 23
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X-ray crystallographic analysis of an example sulfonamide structure, 2-methyl-3- 
(4-nitro-phenyl)-isoxazolidine-4-sulfonic acid 4-methyl-benzylamide (128, Figure
24), confirmed the relative stereochemistry of the products.
128
Figure 24
Notably, our previous work on the aminolysis procedure has raised interest 
regarding the mechanism. Because the displacement is only successful in the 
presence of a strong base, we have postulated that the sulfonamide is formed via 
a sulfene intermediate, rather than the conventional nucleophillic displacement of 
the leaving group with an amine (Scheme 18).66
V
PFPO’ PFPO"
CHCH;
R'HN
R'-NH-
Scheme 18
Due to the consistent and straightforward nature of the aminolysis method, it was 
postulated that this would be an ideal transformation to be employed in diversity 
orientated organic synthesis. Consequently, the procedure was carried out using 
an automated microwave instrument (the CEM Explorer™)72 with a number of 
stock PFP-sulfonate esters and a variety of /V-methyl amines all previously unused 
in the aminolysis study (Scheme 19, Table 4). In this way, it was thought that the
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rapid incorporation of diversity via this method would improve the practicality and 
appeal of the transformation.
a. R'NMe (3.0 eq.), DBU (2.0 eq.), THF/NMP, MW, 110 °C, 30 - 45 m
Scheme 19
Entry R R' Yield % No.
1 p-MeOPh PhCH2 53 136
2 Cyclopropyl C6Hn 70 137
3 Naphthyl (c h 3)3c 25 138
4 o-FPh CH2 CHCH2 54 139
Table 4
As the results show, an automated microwave procedure for the aminolysis step 
gives yields comparable to the thermal equivalent, but in half the reaction time. 
The lone exception is for the sterically demanding tert-butylmethylamine (entry 
3), however, it would be unlikely for the yield to be improved under standard 
thermal conditions as this is a trend that occurs in other examples with sulfonate 
esters.73
2.3.2 Azides as 1,3-dipoles
Considering the opening success in the cycloaddition of PFP vinylsulfonate to 
nitrones, it was anticipated that cycloaddition to other 1,3-dipolar species could 
be achieved in a similar fashion.
The prospect of using azides in our cycloaddition study was of interest here, as 
the formation of sulfonamide triazolines was appealing from a biological 
perspective.
Azides are established 1,3-dipoles and have been shown to undergo cycloaddition 
with a variety of dipolarophiles (particularly alkynes).74 In order to investigate the 
reactivity of PFP vinylsulfonate towards azides, a number of aryl-based species 
were synthesised in excellent yield (Scheme 20, structures 140 -  144).
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NH2 a) 50 % H2S04, NaN02, -5 °C
b) NaN3, NaOAc, H20, -5°C
R= MeO 140  (77 %)
N02 141  (95 %)
NaN3, KI, CH3CN
reflux 16 h
R= H 142  (89 %)
143  (91 %) 
MeO 144  (95 %)
X= B r/ Cl
Scheme 20
The cycloaddition of these azides to PFP vinylsulfonate was then attempted 
(Scheme 21). I t  was found that the required cycloaddition could not be achieved, 
despite tic analysis indicating the consumption of PFP vinylsulfonate during the 
reaction, and the adjustment of reaction temperature and conditions (Table 5). 
Nmr analysis of the products attained revealed that pentafluorophenol was 
present in some instances, and that no heterocyclic ring protons were observed 
(i.e. the protons originating from the vinyl portion of the sulfonate).
This led to the conclusion that cycloaddition had possibly taken place, but was 
immediately followed by rearrangement resulting in the expulsion of PFP, and 
maybe also N2. In validation of this premise, it is well documented that triazolines 
are prone to react further under the reaction conditions, exhibiting decomposition 
patterns that involve the loss of nitrogen to give an aziridine or imine species 
(Scheme 22).74
p fp o 3s.PFPOoS.
Scheme 21
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R n Reaction conditions
MeO 0 PhMe, 80 °C, 2 h
MeO 0 THF, reflux 24 h
n o 2 0 THF, reflux 48 h, then rt 48 h
H 1 PhMe, reflux 20 h
F 1 CH3CN, reflux 24 h
MeO 1 CH3CN, reflux 4 d
Result
Decomposition products obtained 
Decomposition products obtained 
SM recovered 
Decomposition products obtained 
Decomposition products obtained 
Decomposition products obtained
Table 5
RN'
triazoline
RN—
RN: RN—
Scheme 22
In fact, azide cycloaddition with alkenes to form the primary triazoline product 
can be problematic, as the reaction is known to take over a week at ambient 
temperature. Increasing the temperature is perilous as most triazolines are 
thermally labile, and consequently decomposition products such as aziridines are 
achieved.74'76 The stability of sulfur-based triazolines is unknown, although our 
study suggests that sulfonate species of this type are rather unstable. In addition, 
it has been reported that steric bulk of the olefin can contribute to lower yields 
and longer reaction times, which would also imply that PFP vinylsulfonate is not 
completely suited to the necessary reaction conditions.75,76
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2.3.3 Nitrile oxides as 1,3-dipoles
Following the difficulties encountered with azide cycloaddition, it was decided to 
attempt the cycloaddition with nitrile oxides, which are particularly reactive 1,3- 
dipoles and undergo cycloaddition to olefins to give isoxazolines. The precedent 
for alkene cycloaddition with nitrile oxides is much greater than for azides,74,77 so 
it was hoped that the desired transformations could be achieved with similar 
success to that enjoyed with nitrones.
A drawback in the use of nitrile oxides is that the majority are very unstable 
(dimerisation to give a furoxan is rapid in the absence of a trapping agent, see 
Scheme 23) so the requisite species is generated slowly in situ using an amine 
base such as triethylam ine.78 In addition, a number of synthetic steps are 
required to form the dipole, and the preparatory methods are not always 
reliable.79
dimerisation
N O-^ = N  O
R
Scheme 23
There are three major routes to the synthesis of nitrile oxides, namely base 
treatment of hydroxamic acid chlorides;80 oxidation of aldoximes;81 or 
dehydrogenation of primary nitroalkanes.82 In this investigation it was found that 
formation of the hydroximoyl chloride precursor was successful with conjugated 
nitro-olefins, using TiCI4 as the source of Cl+,83 in a modification of the more 
usual NCS method first reported by Liu.84 Unfortunately, in situ generation of the 
nitrile oxide was either ineffective or led to immediate dimerisation, as none of 
the dipolarophile was consumed during the course of the attempted cycloaddition 
(Scheme 24).
NOH
N'iNO
146 (5 5 % ) 147145 (5 3  % )
a. MeN02, NaOH, 4M HCI, MeOH, -10 °C
b. TiCI4, Et3SiH, DCM, rt, 1 h
c. PFPSO3CHCH2, NEt3, DCM, rt
Scheme 24
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At this time, it was thought prudent to perform a controlled experiment, in order 
to make sure the nitrile oxide species was being formed successfully. Thus, an 
analogous reaction was attempted using the electron-deficient and widely used 
dipolarophile ethyl acrylate. This gave the desired cycloadduct in reasonable yield 
(Scheme 25), which somewhat confirmed that the nitrile oxide was being 
generated in situ effectively, and the difficulty observed was in all probability due 
to PFP vinylsulfonate.
146 148 (3 8 % )
Scheme 25
At this point, it was noted that nitrile oxide cycloaddition to phenyl vinyl sulfone 
had been previously reported by Rai and co-workers.85 The group found that 
generating the nitrile oxide from the initial aldoxime using Chloramine-T (/V- 
chloro-p-toluenesulfonamide) allowed the species to be stable for up to 8 hours in 
solution, whereby it was added to the olefin. In this way, isoxazolines were 
produced in good yields.85 Subsequently, this method was attempted with both 
phenyl vinylsulfone and PFP vinylsulfonate, but it was found that the cycloaddition 
results achieved by Rai et ai. could not be repeated or applied to sulfonates 
(Scheme 26).
C hloram ine-T
EtOH, rt 30m D C M ,rt 24h
150149
(8 5 %  crude)
DCM, rt, 
48h
151
Scheme 26
Considering that the inherent instability of nitrile oxides in situ seemed to be 
problematic in this investigation, it was speculated as to whether stable, 
crystalline nitrile oxides could be generated. In this way, it would be certain that
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the requisite reactive species was present in the reaction medium, and the 
possibility of dimerisation could be eliminated.
Subsequently, it was discovered that a small number of nitrile oxides are infinitely 
stable solids. These are generally sterically hindered aromatic species, due to 
substitution at both ortho positions, which greatly increases their stability (Figure
25) and are formed through oxidation of the corresponding aldoximes.81 We 
utilized this route to produce a selection of nitrile oxides as stable crystalline 
white solids in excellent yield (Scheme 27).
MeO'Me'
1 5 2
Me
1 5 3
OMe
OMe
15 4
Figure 25
Cycloaddition was then attempted with PFP vinylsulfonate (Scheme 27). However, 
these endeavours were not successful, despite the apparent stability of the 1,3- 
dipole. Tic analysis indicated no consumption of the dipolarophile, whereas the 
concentration of nitrile oxide almost immediately depleted, giving rise to other 
compounds. Nmr analysis signified these were likely to be decomposition 
products, and the reason for decomposition of these stable 1,3-dipoles in the 
presence of PFP vinylsulfonate is perplexing and not fully understood.
At this stage it is noteworthy to mention that 2,4,6-substituted aryl nitrones were 
also unsuccessful in cycloaddition with PFP vinylsulfonate, perhaps due to steric 
hindrance, although there are likely to be additional factors. This illustrates that 
highly substituted dipoles are unlikely to undergo cycloaddition with PFP 
vinylsulfonate, although does not explain the apparent decomposition of the 
nitrile oxides in this case.
Me 156 (79 %) Me 152 (91 %)
a. NH2OH.HCI, NaHC03, EtOH, H20, reflux 1 h
b. Br2, dil. NaOH, 0 °C, 1.5 h
c. PFPS03CHCH2( THF, rt 18 h then reflux 6 h
Scheme 27
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2.3 .4  Azom eth ine ylids and n itro  com pounds as 1,3-d ipoles 
Azomethine ylids were thought to be potentially useful dipoles in our investigation 
into sulfonate cycloaddition. These are unstable species derived from imines, so 
are generated in situ. There are few examples of intermolecular cycloadditions of 
this type involving sulfur-based olefins, although they have been primarily used 
intramolecularly.86 Harwood et at. reported that unlike other electron-deficient 
dipolarophiles employed in their study with cyclic azomethine ylids, phenyl vinyl 
sulfone did not trap the generated dipole and consequently no cycloadduct was 
obtained.87 This result suggested that analogous attempts with PFP vinylsulfonate 
would also be unsuccessful, and provided grounds to defer endeavours in this 
area.
Nitro compounds were another type of 1,3-dipole considered during this 
investigation, as the potential cycloadducts could be of interest. Nitro species are 
isoelectronic with the 1,3-dipole ozone, and studies suggest that nitro 
functionalities will undergo a degree of cycloaddition to olefins.88 To assess this 
the cycloaddition of nitromethane to PFP vinylsulfonate was attempted, but it was 
found that no discernable transformation took place upon stirring the reaction 
mixture at ambient temperature for several days. As a result, this 1,3-dipole was 
not investigated further.
2 .4  D ie ls -A ld er C yc lo ad d itio n  to  PFP V in y ls u lfo n a te
Despite the lack of success in the cycloaddition of PFP vinylsulfonate to the 
majority of 1,3-dipoles, it was anticipated that the scope of the reaction could be 
extended to dienes that are known to readily undergo Diels-Alder type 
cycloaddition.
2.4.1 Form ation o f b icarbocyclic species via D ie ls-A lder cycloaddition 
This section of the investigation was begun with the attempted cycloaddition of 
carbocyclic species to PFP vinylsulfonate. It was encouraging to find that the 
addition was undertaken readily with the dienes employed, with electron donating 
groups on the diene facilitating the reaction (Scheme 28; Table 6).
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SOoPFP
a. PFPS03CHCH2, PhMe, 110 °C, 4 h
b. R’NH2, THF, DBU, 65 °C, 2 h
Scheme 28
However, it was evident that the addition was not as selective as previously 
experienced with nitrone cycloaddition. The reaction with cyclic dienes yielded 
both endo and exo isomers, with the exo isomer confirmed as the major product 
from nmr analysis.
R n Yield A %  
exo
H I  78
H I
H I
H 2 47
OCH3 2 87
OCH3 2
No. R'
157a CH2CHCH2 
H-Phe-OEt 
CH3PhCH2
160a CH3PhCH2
161a CH2CHCH2 
CH3PhCH2
Table 6
Yield B %  No.
52 157b
44 158
67 159
66 160b
56 161b
53 162
2.4.1.1 Aminolysis of bicarbocyclic cycloadducts
Aminolysis of the bicyclic cycloadducts was carried out as previously described. In 
all cases, the major exo product was employed in the displacement reaction. 
Table 6 illustrates that aminolysis could be achieved for all cycloadducts, although 
the moderate yields are due to some formation of the alternative isomer to B as a 
byproduct (Scheme 28). On the basis of previous theoretical considerations,66 it 
was anticipated that the displacement reaction would proceed to yield the more 
thermodynamically favourable exo stereoisomer B as the major product, and this 
was confirmed by nOe studies (Figure 26). Irradiation at endo proton Ha results in 
enhancement of Hb; Hc and Hd, but no enhancement is observed in exo proton
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Hg. Irradiation at Hd produces enhancement of Ha; He and Hf, which suggests the 
product is of exo conformation.
S 0 2NH PhMe
S 0 2NH PhMe
160b
Figure 26
2.4.2 Heterodienes as 4n species
Considering that cycloaddition could be undertaken fru itfu lly with carbon dienes, 
it was postulated that an interesting tw ist on this reaction would be to attempt 
the cycloaddition with heterodienes, especially as it has been established that the 
Diels-Alder reactions of such species follow a similar pattern to their carbon 
equivalents.49 The task here was to synthesise heterodienes sufficiently electron- 
rich to undergo cycloaddition to PFP vinylsulfonate.
As a starting point, 2-azabutadienes were investigated as potential heterodienes 
for the required transformation; primarily due to their established reputation as 
willing participants in the Diels-Alder reaction.49 The most common electron-rich 
2-azadienes are oxazoles, and our cycloaddition attempts with these heterocycles 
is discussed in the following section. A number of acyclic 2-azadienes also act as 
electron-rich dienes and have been used successfully in cycloaddition reactions. 
Bayard et at. employed activated electron-rich 2-azadienes in their studies to 
form piperidones (Scheme 29).89
, chci3Ph.
HN.HN
MeOH PhPh
165 (87 %)164 (92 %)163
Scheme 29
Considering the highly activated nature of this diene, we hoped that it would also 
be a dynamic participant in an attempted cycloaddition with PFP vinylsulfonate.
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Consequently, the azadiene was synthesised from benzaldehyde via a reported 
one-pot procedure,90 and cycloaddition was undertaken (Scheme 30).
o^ h
1) LiHMDS, Et20, 0 °C
2) MeCOCI, NEt3, Et20, rt
Ph :N
r *
o,
SiMe3 
163  (34 %)
PFP03S ^
— x —
See Table 7
S03PFP
Ph N O 
166
SiMe^
Scheme 30
Unfortunately this was unsuccessful, with tic analysis indicating no consumption 
of the reagents after more than 48 hours (Table 7). An increase in the 
temperature and pressure with the aid of microwave irradiation led to the 
acquisition of decomposition products. As a result, this avenue of investigation 
was curtailed at this point.
Eq. azadiene Reaction conditions Result
1.20 DCM, rt 12 h, then reflux 8 h, then rt 12 h SM recovered
1.55 PhMe, MW (200 °C), 40 min decomposition
1.50 THF, MW (150 °C), 30 min decomposition
Table 7
2.4.3 Oxazoles as dienes
As has been previously highlighted, oxazoles are one of the most widely used 
electron-rich 2-azadienes.49 Despite the unproductive results obtained with acyclic 
2-azadienes, it was hoped that cycloaddition with activated oxazoles would be 
more successful, especially as they have been shown to undergo cycloaddition 
with electron-deficient dienophiles.49
A typical method for synthesising oxazoles is via cyclodehydration of a-acylamino 
ketones (the Robinson-Gabriel synthesis). Wipf has recently developed a more 
efficient route through this method, and it was this procedure that we used in our 
investigation for the formation of substituted oxazoles (Scheme 31).91
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OH OH
Ph' Ph 1) DMP, DCM, rt, 1 hCH
Ph'
NEt3, DCM, 0 UC, 3 h 2) PhP3, I 2, NEt3, DCM, CH
167 169 (50 %)168 (68 %)
Scheme 31
Norephedrine was first acylated in good yield following a procedure by Contreras 
et al.92 This species was then oxidised with Dess-Martin periodinane and 
cyclodehydrated in the one-pot procedure outlined by Wipf. This furnished the 
substituted oxazole in moderate yield, which was then subjected to cycloaddition 
conditions with PFP vinylsulfonate (Scheme 32). I t  was found that the addition 
could not be achieved, with complete recovery of the starting reagents. This 
negative result provided ground to suspend activity in this area.
Ph
X / / -Ph 
CH3 
169 (1.2 eq.)
PFP03S ^ ^
— x —
H3C °v  -Ph3L'y ^C r -S03PFP
Ph
170
a. PhMe, reflux 6 h, then rt 12 h, then MW (200 °C) 30 min
Scheme 32
2.4.4 Danishefsky's diene
Due to the lack of success with heterocyclic dienes, it was thought prudent to 
attempt the cycloaddition with a carbon-based diene. Danishefsky's diene (trans- 
l-m ethoxy-3 -trim e thy ls iloxy-l,3-butadiene) was considered a suitable diene to 
employ at this stage, as the species is very electron rich, commercially available9 3  
and is known to be a willing partner is a variety of cycloaddition reactions. 9 4  
Subsequently, cycloaddition was attempted with PFP vinylsulfonate (Scheme 33), 
but under reflux conditions of 2 to 4 hours, it was discovered that no identifiable 
products could be obtained (Table 8 ).
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•OTMS
OTMS
MeO
OPFP OMe
171
a. PFPSO3CHCH2, solvent, reflux 2 - 4 h
Scheme 33
Entry Conditions Result
1 PhMe, reflux 4 h decomposition products isolated
2 THF, reflux 2 h decomposition products isolated
3 THF, reflux 4 h decomposition products isolated
Table 8
2.4.5 2AY-Pyrones as dienes
2 F/-pyran-2 -ones have been shown from their reactivity to be considerably non- 
aromatic, and the parent unsaturated lactone a-pyrone is known to be a good 
diene in Diels-Alder reactions with both electron-deficient and electron-rich 
dienophiles . 4 9 , 9 5  This prompted us to investigate the diene for possible 
cycloaddition with PFP vinylsulfonate.
a-pyrone was prepared according to literature procedures9 6  to give the diene 
(173) in reasonable yield over two steps (Scheme 34). Cycloaddition was then 
attempted, but unfortunately no reaction was observed and only starting 
materials were recovered (Scheme 34).
NBS
(PhCO)20 2 
CCI4 reflux 90 min
reflux 30 min
174173
(37 %, 1.2 eq.)
172
a. PhMe, reflux 7 h, then MW (200 °C) 30 min
Scheme 34
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2.4.6 Furans as dienes
Furan has low aromaticity compared to both pyrrole and thiophene, consequently 
it was postulated that furan would be the most likely of these five membered 
species to undergo cycloaddition to PFP vinylsulfonate. Indeed, furan will actively 
participate in cycloaddition reactions with dienophiles of high reactivity , 4 9  perhaps 
the most famous example being maleic anhydride (Scheme 35).
o
Scheme 35
However, cycloaddition reactions involving furan are prone to retroaddition, 
especially at higher temperatures, so low yielding transformations cannot usually 
be improved through thermal assistance. Nevertheless, attempts to 
circumnavigate this problem have included the exploitation of high pressures, 
which favours the formation of cycloadducts (although pressures in the region of 
8000-20,000 atm are required to improve the yield), and Lewis acid catalysis . 4 9  
Notably, zinc iodide has been shown to considerably reduce reaction times in 
cycloaddition with acrylonitrile even at atmospheric pressure . 97
Consequently, cycloaddition of furans to PFP vinylsulfonate was attempted under 
a variety of conditions (Scheme 36, Table 9). Microwave radiation was employed 
as this allowed reactions to  be carried out at increased pressure, hence making 
the conditions more favourable to addition. Unfortunately, it was found that the 
microwave-mediated conditions did not aid the cycloaddition, with the greatest 
yield of the cycloadduct obtained being only 15 % (when the reaction was carried 
out in neat furan). Lewis acids such as BF3 .Et2 0  were also found not to assist the 
transformation.
FNr°\
P F P ° 3 S \ ;Sss .
I> - R p fp o 3s - - ^ L - -3 '
Scheme 36
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R Eq. 
diene
Reaction conditions Result
H 2.0
H 1.5
PhMe, reflux 24 h 
PhMe, MW (200 °C) 2.5 h
SM recovered 
15 % product, 60 % SM 
recovered
CH3 5.0
CH3 5.0
BF3 .Et2 0, PhMe, MW (180 °C) 35 m 
BF3 .Et2 0 , THF, -78 °C ^rt 2 h, then 
reflux 24 h 
PhMe, MW (200 °C) 1 h 
1,4-dioxane, MW (200 °C) 20 m
SM recovered
SM recovered
H 5.0 SM recovered
H 3.0 SM recovered
Table 9
It was postulated that the relatively high temperatures employed in these 
attempts were possibly causing substantial retroaddition of any cycloadduct 
formed, which could explain the low yields achieved. Subsequently, the prospect 
of carrying out the addition at ambient temperature and pressure was a 
possibility. In related work from 1985, Klein and Deeb successfully used phenyl 
vinylsulfonate in cycloaddition with furans to give the cycloadduct quantitatively 
after 20 days at room temperature, and in 50 % yield after 4 days at 70 °C. 9 8  We 
anticipated that the reduced yield in the latter case was probably due to 
retroaddition complications, which had evidently not been a problem at ambient 
temperatures. This led to the conclusion that cycloaddition of furan to PFP 
vinylsulfonate could indeed be improved if carried out at lower temperatures, 
although the prospect of 3 week-long reactions did not give us the desired 
impetus to attempt the cycloaddition without catalysis, due to its impracticability. 
The value of using a Lewis acid catalyst once again came into play at this 
juncture. Despite the limited success that had been achieved so far with the 
species tried, we hoped that this could be improved with the modification in 
reaction conditions.
As previously stated, zinc iodide has been used successfully in furan cycloaddition 
to olefins. Brion found that heating the neat addition components with catalytic 
Znl2 (0.3 eq.) at 40 °C for 48 hours, yielded mixtures of endo and exo 
cycloadducts in excellent yields with a variety of olefinic species. 9 7  
In accordance with this result, we attempted to repeat the procedure with PFP 
vinylsulfonate. I t  was very pleasing to discover that Brion's conditions were also 
compatible with our olefin, hence cycloaddition was complete after 4 days at 40
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°C with Z n l2, giving a 1.2:1 mixture of exo'.endo cycloadducts in excellent yield. 
The isomers could be separated by column chromatography and were isolated as 
white solids (Scheme 37).
0 0
l i
pfpo3s^
Znl2/ 40 °C, 4 d
- PFP03S ^ d Q 7
s o 3pfp
1 7 5  exo (43 %) 1 7 6  endo (35 %)
Scheme 37
It  was anticipated that this procedure could be applied to substituted furans, in 
order to produce more functionalized cycloadducts. Consequently, addition was 
attempted with a number of commercially available 2,5-substituted furans 
(Scheme 38, Table 10). I t  was discovered that reaction conditions required a 
degree of optimisation depending on the furan in question, although despite this 
cycloaddition could not be achieved in some cases, even after prolonged reaction 
times. A notable exception was with 2-methoxyfuran, where the endo isomer was 
formed exclusively after 3 days, but in only 25 % yield (the remaining material 
being decomposition products). This result suggested (as would be expected with 
a very electron-deficient dipolarophile) that activated, electron-rich furans react 
most successfully, whereas less activated or electron-deficient furans give 
depleted yields or don't participate in the cycloaddition.
It  has been postulated that the equilibrium in these reactions lies predominantly 
to the left, consequently adjustments have to be made to drive the equilibrium to 
cycloadduct fo rm a tion ." This makes the scope of furyl cycloaddition difficult to 
assess, as favourable conditions for cycloaddition don't seem to be predictable, 
especially considering the typical reaction time of these reactions, and the specific 
conditions likely to be required for each species.
p fp o 3s^
\ j T  - p fp o 3s ^ ^ /
Scheme 38
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R R' Eq. Z n l2 Reaction conditions Result
Me Me 0.3 40 °C 5 d decomposition
Me COMe 0.3 40 °C 5 d SM recovered
>C(0)Me CHO 0.3 Et2 0, rt 3 d SM recovered
H OMe 0.3 40 °C 12 h decomposition
H OMe 0.3 Et20, rt 3 d decomposition
H OMe 0.3 Et20, rt 3 d 25 % product
Table 10
2.4.6.1 Aminolysis of furanyl cycloadducts
Our protocol for amine displacement of the PFP portion was then carried out on 
the successfully produced furanyl cycloadducts to give the corresponding 
sulfonamide products (Scheme 39). It was encouraging to find that the bridging 
oxygen structure survived the reaction process, and the resulting sulfonamides 
were formed in excellent yield and good selectivity.
?\ ^ N H 2 OwO |L
3 DBU, THF, reflux 3 h
17 5  177  (76 % )
o f ^ NH2 o
% ~
s o 3pfp DBU' THF' reflux 3 h H
1 7 6  178  (54 % )
Scheme 39
Notably, nOe studies confirmed that both the endo- and exo- PFP sulfonates 
yielded the more thermodynamically stable exo sulfonamide species upon 
aminolysis (Figure 27). Irradiation at endo proton Ha produced enhancement of 
Hb; Hc and Hd, but no enhancement of the exo proton He. Irradiation at Hb 
generated enhancement of Ha and Hc Hence this is indicative of an exo 
sulfonamide product.
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MePh
MePh
1 .8%
0.5%0.4%1 7 81.4%
Figure 27
The sulfene mechanism for sulfonamide formation highlighted earlier (Scheme 
1 8 )66 is also thought to apply with these structures. Consequently, the selectivity 
for exo products is considered to  be due to the conformation of the sulfene 
intermediate being more favourable towards amine attack from the least hindered 
top face, which generates the exo sulfonamide (Scheme 40).
s
OPFP OPFP
amine attacks from least 
hindered top face
RHN
exo product formed
Scheme 40
2.4.7 Pyrrole and thiophene as dienes
Pyrrole and thiophene are much more aromatic species than furan, so do not 
undergo cycloaddition readily. They are generally poor dienes so require forcing 
conditions to undergo cycloaddition even with highly activated dienophiles . 4 9  
Therefore, it was anticipated that cycloaddition of these species to PFP 
vinylsulfonate would not be successful. However, for the purposes of completion, 
addition was attempted with both thiophene and pyrrole, and as expected no 
cycloadducts were obtained after prolonged heating.
Subsequently it was hypothesised that substitution of the pyrrole ring with 
electron-withdrawing groups would make the system less aromatic, and hence
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more receptive to cycloaddition. Consequently, we synthesised a tosyl-substituted 
pyrrole and attempted cycloaddition to PFP vinylsulfonate (Scheme 41), initially in 
toluene at reflux for 6  hours, which resulted in no consumption of any starting 
materials. This m ixture was then stirred at ambient temperature for a further 12 
hours, but no progression in the reaction occurred.
Ts
17 9 1 8 0
Scheme 41
In a further attempt, we modified the reaction conditions and performed the 
transformation with reagents successful in previous work using furan, namely 
catalytic (0.3 eq.) Z n l2, heated at 40 °C in THF. Unfortunately, product formation 
could not be achieved even after 3 days, and so any further exploration was 
suspended here.
2 .5  M ichael A d d itio n  to  PFP V in y ls u lfo n a te
The previous work with PFP vinylsulfonate has shown that the olefinic portion is 
activated towards both cycloaddition and radical addition. In order to uncover 
further potentially useful transformations, it was thought that investigation into 
Michael addition would be fru itfu l, as this could lead to a considerable number of 
varied and interesting species.
2.5.1 Phosphine addition to PFP vinylsulfonate
The Michael addition of phosphines to PFP vinylsulfonate (Scheme 42) was of 
interest as this could lead to potentially valuable products, and the addition has 
previously been successful with electron-deficient olefins . 10 0
a. phosphine, BSTFA, DCM, rt, 3 h
b. phosphine, Na2C03, EtOH, rt, 18 h 1. R= Ph, R,= OH; 2. R, R'= OEt
a or b
P -R
Scheme 42
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The reaction was initially attempted with phenyl phosphinic acid (1) and diethyl 
phosphite (2), using BSTFA as the base in DCM at ambient temperature. It was 
found that after 3 hours the starting materials were consumed, but analysis of 
the crude mixture indicated that only decomposition products were present (Table 
11, entries 1 and 2). The reaction was then repeated under the modified 
conditions of sodium carbonate as the base with a polar solvent (EtOH), in the 
anticipation that decomposition could be prevented, but the result after 18 hours 
at ambient temperature was ultimately negative (Table 11, entry 3).
Entry Phosphine Conditions Result
1 1  a decomposition
2  2  a decomposition
3 1 b decomposition
Table 11
2.5.2 Lactone formation via ROH Michael addition
An investigation within the literature revealed that electron deficient olefins can 
form y-lactones in reaction with carboxylic acids in the presence of Mn(OAc) 3 , 101 
and it was thought worthwhile to attempt this reaction with PFP vinylsulfonate 
using the easily obtainable acetic acid (Scheme 43).
^  -O
0
181
182
a . KOAc, AcOH, M n (III)0 A c 3.2H20 / reflux, 5 h
Scheme 43
It  was found that complete consumption of PFP vinylsulfonate occurred over 5 
hours in refluxing acetic acid in the presence of an excess of Mn(OAc).2H20 and 
catalytic KOAc, to give a product isolated in 46 % yield. However, nmr analysis 
revealed that the Michael addition product (182) was solely obtained rather than 
the expected y-lactone (181). Despite this unforeseen result, the transformation 
has shown that PFP vinylsulfonate is a willing participant in the Michael addition
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to oxygen nucleophiles, an ability that could be exploited in further research.
2 .6  H eck C oupling  to  PFP V in y ls u lfo n a te
The coupling of aryl halides to PFP vinylsulfonate was an attractive prospect, as 
the Heck reaction has significant value in organic synthesis, and the resulting 
species could represent useful intermediates for further transformations.
The Heck reaction coupling PFP vinylsulfonate and the simple aryl halides 
iodobenzene and l-bromo-4-nitrobenzene (Scheme 44, Table 12, entries 1-4) 
was attempted under argon using the established combinations of cesium 
carbonate or dicyclohexylmethylamine as the base; Fu's air-stable phosphonium 
salt [( fBu)3 PH]BF4 as the ligand ; 1 0 2  and Pd2 (dba ) 3 as the palladium (0) source, in 
refluxing dioxane for up to 24 hours, but it was found that under these conditions 
no product could be isolated and only PFPOH as a decomposition product was 
obtained. This was also the result when the reaction was carried out at room 
temperature (Table 12, entry 7) and in neat solvent (Table 12, entry 8 ).
a. base, dioxane, RX, 5mol% Pd(dba)3, 6mol% [(fBu)3PH]BF4, reflux 4 - 24 h
Scheme 44
itry RX Pd Solvent Ligand Base T Result
1 Phi Pd2 (dba ) 3 dioxane [('Bu)3 PH]BF4 Cs2 C03 reflux decomposition
2 pN02PhBr Pd2 (dba ) 3 dioxane [('B u)3 PH]BF4 Cs2 C03 reflux decomposition
3 Phi Pd2 (dba ) 3 dioxane [('B u)3 PH]BF4 CyNMe2 reflux decomposition
4 pN02PhBr Pd2 (dba ) 3 dioxane [( fBu)3 PH]BF4 CyNMe2 reflux decomposition
5 ROTf Pd(OAc) 2 DMF -- NEt3 rt-
reflux
SM recovered
6 RONf Pd(OAc) 2 DMF -- NEt3 rt-
reflux
SM recovered
7 Phi Pd2 (dba ) 3 dioxane [( fBu)3 PH]BF4 Cs2 C03 rt-65
° r
decomposition
8 Phi Pd2 (dba ) 3 neat [( fBu)3 PH]BF4 Cs2 C03 rt decomposition
Table 12
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Consequently, it was thought prudent to attempt the coupling using other leaving 
groups such as triflates and nonaflates. The commercially available ethyl-2- 
(trifluoromethane sulfonyloxy)-l-cyclohexene-l-carboxylate was employed as a 
model triflate species with which to test the coupling procedure (Table 12, entry 
5; R = C6 H8 C (0)0E t). Standard triflate coupling conditions were used (Pd (OAc)2; 
DMF; NEt3 ) , 1 0 3  and the reaction was stirred first at ambient temperature for 6  
hours, then at 60 °C for 18 hours, but no reaction was observed.
Lastly, a nonaflate was utilized in this coupling protocol (Table 12, entry 6 ; R = 
C6 H9). In this case, the species was prepared in situ from the reaction of 1- 
cyclohexenyloxytrimethylsilane with perfluoro-l-butanesulfonyl fluoride (NfF) in 
the presence of catalytic TBAF. 1 0 4  The nonaflate intermediate was prepared 
successfully within 18 hours at ambient temperature, but following the addition of 
PFP vinylsulfonate and the Heck reagents described above, no coupling was 
observed.
At this stage, it was perceived that PFP vinylsulfonate was not inclined to undergo 
Heck coupling under any kind of conditions, and subsequently this area of study 
was curtailed.
2 .7  Cross M e ta th e s is  w ith  PFP V in y ls u lfo n a te
The next facet to be investigated was cross metathesis (CM). Success in this 
reaction would also be of interest, as products resulting from a CM transformation 
with PFP vinylsulfonate were likely to be varied and open to further manipulation. 
The olefins employed in this study have been reported to undergo CM with phenyl 
vinyl sulfone, so were thought to be suitable substrates in this case. 1 0 5 ,1 0 6
Consequently the metathesis was attempted (Scheme 45), whereby PFP 
vinylsulfonate was added to 1.5 equivalents of the selected olefin in a non-polar 
solvent (usually DCM, or DCE if a higher reflux temperature was desired) followed 
by addition of a ruthenium catalyst (either Grubbs second generation catalyst, or 
the Hoveyda-Grubbs second generation catalyst, which have both been shown to 
be effective with sulfones105,106). The reaction was then stirred at reflux for up to 
24 hours, but in each case it was found that only starting materials could be 
recovered, with no desired product in evidence (Table 13, entries 1-4). The 
reaction was then repeated in refluxing DCE, but this made no difference to the 
outcome (Table 13, entry 5). Finally, it was reasoned that a constructive way to 
force the reagents towards product formation was by performing the reaction at 
high temperature and pressure in a microwave. Consequently, the transformation
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was attempted at 130 °C in DCM for 40 minutes under microwave radiation 
(Table 13, entry 6 ), but no product could be identified and only starting materials 
were isolated.
a. RCHCH2, DCM /  DCE, 5 - 10mol% Ru cat., reflux 18 - 24 h (or 30 - 40 m in MW)
Scheme 45
Due to the unsuccessful results in this study, it was decided to attempt a control 
experiment in order to ensure the reaction protocol was valid. Hence the 
metathesis was undertaken with phenyl vinyl sulfone using the literature 
procedure followed for some previous attempts with PFP vinylsulfonate, namely
1-octene and 5mol% Grubbs second generation catalyst in refluxing DCM for 18 
hours (Table 13, entry 7 ) . 1 0 6  This resulted in quantitative yield of the metathesis 
product, which vindicated the procedure, thereby isolating PFP vinylsulfonate as 
the troublesome reagent in this case. As a result, this area of research was 
suspended at this point.
Entry Olefin Ru catalyst Solvent T Result
1 styrene Grubbs II DCM reflux SM recovered
2 5-hexen-l-o l Grubbs II DCM reflux SM recovered
3 styrene Hoveyda DCM reflux SM recovered
4 5-hexen-l-o l Hoveyda DCM reflux SM recovered
5 1 -octene Grubbs II DCE reflux SM recovered
6 1 -octene Grubbs II DCM 130 °C in MW SM recovered
7 1 -octene Grubbs II DCM reflux 1 0 0  % yield
Table 13
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2.8 Heck Coupling and Cross Metathesis with Vinyl Sulfonamides
2.8.1 Form ation o f v iny l su lfonam ides via the  d irec t am inolysis o f PFP 
v inylsu lfonate
Due to the lack of success in the Heck and cross metathesis reactions when using 
PFP vinylsulfonate, it was postulated that the acceptor could be adapted in a way 
that could facilitate the desired transformations. I t  was suggested that converting 
PFP vinylsulfonate into its more stable sulfonamide form, (via the established 
aminolysis procedure ) 6 6  before attempting any derivatization, could be a simple 
way to circumnavigate the problems encountered with the PFP ester (Scheme
46).
RHN"
a. amine, DBU, THF, rt 10 m
Scheme 46
Consequently, aminolysis was carried out with a variety of amines and /V-methyl 
amines, and it was discovered tha t PFP vinylsulfonate underwent the reaction 
very rapidly at room temperature (within 1 0  minutes), to furnish the 
corresponding sulfonamides in moderate to good yields (Table 14, entries 1-4).
An intriguing feature in this procedure was the formation of disubstituted product 
during aminolysis with benzylmethylamine (Table 14, entry 2 & Figure 28), which 
accounted for the modest yield of monosubstituted product achieved, the 
remainder being isolated as the disubstituted product. Notably, it was discovered 
that benzylmethylamine was the only species in this study with a propensity to 
undergo disubstitution; the moderate yield isolated from L-proline (Table 14, 
entry 3 ) was not due to disubstitution reactions, but decomposition and solubility 
issues.
Figure 28
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In addition, the reaction was attempted with /V-methylaniline (Table 13, entry 5), 
but it was found that no desired product could be isolated. Conceivably, this 
result was expected as our studies have shown that alternative procedures are 
often required for PFPO displacement with anilines . 6 6 ' 10 7
Entry Amine Yield %
1 4-methylbenzylamine 58
2 benzylmethylamine 55
3 /.-proline 27
4 /V-methylpropylamine 79
5 /V-methylaniline 0
Comments
45 % disubstituted 
product also isolated 
PFPOH also isolated
possibly expected
No.
183
184
185
186 
187
Table 14
2.8.2 Heck and cross m eta thesis  reactions w ith  v iny l sulfonam ides 
Once a number of vinyl sulfonamides had been synthesised, both Heck and CM 
procedures were attempted using the previous conditions and reagents (Scheme
47).
Heck or CM conditions
Scheme 47
Unfortunately, it was found that neither Heck coupling (Table 15, entries 1 and 2) 
nor cross metathesis (Table 15, entries 3-5) could be carried out with much 
success. In the Heck reactions it was found that, unlike in the analogous reaction 
with PFP vinylsulfonate whereby decomposition occurred, the sulfonamide starting 
materials were not consumed, with no indication of reaction taking place.
In the cross metathesis, it was discovered that as previously, the reaction was 
difficult to drive toward product formation. The only (minor) success (Table 15, 
entry 5 ) occurred when the sulfonamide was subjected to microwave irradiation 
at 130 °C for 40 minutes with 1-octene, which delivered an 8  % yield of isolated 
product (188) (Scheme 48). However, further microwave heating combined with 
an excess of reagents failed to increase the yield.
As a consequence of these results, it was decided that this area of study would be 
suspended at this stage.
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Reagent Catalyst Solvent Ligand Base T
°C
Phi Pd2(dba)3 dioxane [( tBu)3 PH]BF4  Cs2C03 70 
Phi Pd2 (dba ) 3 dioxane [( fBu)3 PH]BF4  Cs2 C03 rt
1-octene Grubbs II DCE — — 50
1-octene Grubbs II  DCE — — 50
1-octene Grubbs II  DCM — — 130
[MW]
Table 15
0 0 0 0
188 (8 %)
a. 1-octene, 5mol% Grubbs I I  cat., DCM, MW (130 °C) 40 m
Scheme 48
2 .9  D iam in e  A d d itio n  to  PFP V in y ls u lfo n a te
One positive result from the preceding sulfonamide work was the possibility for 
amine addition at both activated portions of PFP vinylsulfonate. This principle was 
of importance, as it suggested that species such as diamines could be used to 
produce cyclic sulfonamides (Scheme 49).
Substrate Yield
%
0
0
0
0
8
(188)
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N— S;NH
NH
•NH
a. DBU, THF, rt, 15 m
Scheme 49
Hence, aminolysis was attempted stepwise with a selection of diamines using a 
similar protocol as that used to form the vinyl sulfonamides (Table 16). I t  was 
discovered that, despite rapid consumption of PFP vinylsulfonate, no desired 
product could be identified. This was perhaps inevitable for entries 1 and 2, which 
potentially have aniline character, but even the benzyl-based diamine (Table 16, 
entry 3) gave no discernible product. LCMS analysis indicated just the presence of 
DBU and PFPOH in the crude m ixture after work-up, and nmr analysis delivered 
the same conclusion.
Moreover, the actual mechanism for this transformation was not clear, although it 
was assumed that displacement of PFPO in the first step would be the most 
favourable, based upon the previous vinyl sulfonamide work. I t  was also a 
possibility that steric hindrance played a part in the failure of PFP vinylsulfonate 
to undergo aminolysis.
Entry Diamine Result
1  anthranilamide decomposition products obtained
2  o-phenylenediamine decomposition products obtained
3  2-aminobenzylamine decomposition products obtained
Table 16
2.10 Heck Coupling and Cross Metathesis with PFP Phenyl 
Vinylsulfonate
With the evident incompatibility of PFP vinylsulfonate and sulfonamides with both 
Heck and CM conditions, it was thought that modification of the common olefinic 
portion would be an appropriate step. Incorporation of a phenyl group into the 
structure was thought a feasible synthetic step, as this would curb the electron- 
deficient nature of the olefin, which could have been a contributing factor to the 
previous lack of success.
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Formation of PFP phenyl vinylsulfonate was carried out using an analogous 
procedure to that employed for PFP vinylsulfonate. 7"ra/?s-(3-styrenesulfonyl 
chloride was added to PFPOH in the presence of NEt3 at 0 °C, and stirred at room 
temperature for two hours to give a white solid in good yield (190) (Scheme 50).
189 F 190  (68 %)
a. PFPOH, NEt3, DCM, 2h, 0 °C - rt
Scheme 50
This substrate was then employed in Heck coupling and cross metathesis under 
similar conditions to that formerly attempted (Table 17). Unfortunately, it was 
found that no desired products could be obtained, with both transformations 
delivering the same results as previously, namely decomposition during the Heck 
coupling, and recovery of starting materials in the cross metathesis.
Reaction Conditions Result
Heck Phi, Pd2 (dba)3, [( tBu)3 PH]BF4, decomposition
Coupling Cs2 C03, dioxane, reflux 26 h
Cross 1-octene, Hoveyda, DCM, SM recovered
Metathesis reflux 24 h
Cross 1-octene, Grubbs II, DCM, SM recovered
Metathesis reflux 24 h
Table 17
2.11 Application of PFP Vinylsulfonate to Protein Chemistry
2.11.1 Th ioester fo rm a tio n  via PFP v iny lsu lfona te
Our primary interest in thioester formation using PFP vinylsulfonate was the 
potential for incorporation of the acceptor into peptides (and ultimately proteins) 
via a procedure developed by Kent and Dawson known as Native Chemical 
Ligation . 10 8
This technique for the construction of synthetic proteins allows the formation of a 
native peptide bond through a series of chemoselective and spontaneous
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reactions between a terminal thioester on one peptide fragment, and the thiol 
side chain from a terminal cysteine residue on another peptide fragment (Scheme 
51).
peptide 1 |— ^ peptide 2 peptide 2
SR ^  I peptide 1 ~1— ^
Os ^
( Cys residue’
chemoselective
reaction
peptide 1 j— ^  
HN-
peptide 2
HS
Native Chemical Ligation
Scheme 51
It was postulated that we could exploit the proven reactivity of PFP vinylsulfonate 
by coupling thioester functionality onto the olefinic portion. This would then 
enable us to attempt chemical ligation between this species and a peptide 
fragment containing a terminal cysteine residue. In this way, it would be possible 
to incorporate PFP sulfonate esters and sulfonamides into proteins and 
consequently assess the ir biological impact.
Considering that this premise required formation of a thioester on the vinyl 
portion of PFP vinylsulfonate, a possible procedure to achieve this was formulated 
(Scheme 52).
HS OH
PFP03S ^
80
Na2S03, EtOH, 15 m
pfpo3s^ ^ c
191
OH
O DBU, H20, 65 °C
S
RHN0 2S ^ ^ s/ ^ O H  (COCI)2, NEt^  RHN0 2S - ^ ^ s/ ^ C I  nh2
O PhMe, 0°C O base192 193
HS
EtO
RHN02S ^ ^ ^ s ^ ^ S H  o  Nh2 r h n o 2s ^ ^ s
194
sulfonamide thioester
native chemical ligation 195 Shs
OEt
sulfonamide-linked amino acid
Scheme 52
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As displayed above, the procedure devised firstly required Michael addition to a 
thioacid, followed by aminolysis to the more stable sulfonamide (192) before acid 
chloride formation, then conversion to the thioester (194).
Practically, it was discovered that the initial addition to mercaptoacetic acid 
occurred very rapidly at ambient temperature to give the product (191) as a 
white, tacky solid in quantitative yield without need for purification.
This product was then taken onto the next step of aminolysis (as it was thought 
the PFP ester would not survive the following step intact). I t  was initially found 
that standard aminolysis conditions were unsuitable for this step as the starting 
material was significantly insoluble in THF. However, by replacing this solvent 
with water, it was found that the displacement could be completed in less than 2 
hours at 65 °C to give the corresponding crude sulfonamide (192) in moderate 
yield (Scheme 53, Table 18).
However, due to the ir high polarity, it required much effort to extract the 
products from the reaction m ixture (which could explain the modest yields). In 
addition, they did not survive purification by column chromatography and were 
generally difficult to  handle. Consequently, the sulfonamides formed were carried 
forward crude.
PFP03S ^ ^ s ^ . 0 H ________a ^  RHN02S ^ ^ s ^ ^ 0 H
191  0  192  0
a. amine (2 .0  eq .), DBU (2 .0  eq .), solvent, 65 °C
Scheme 53
Amine Conditions Result No.
4-methylbenzylamine THF, reflux no product isolated
4-methylbenzylamine H20, 65 °C crude product 55 % 192a
piperidine H20 , 65 °C crude product 41 % 192b
Table 18
Acid chloride formation was then carried out on the crude thio-acid. Although a 
product was isolated, purificaton was challenging, and determination as to 
whether the desired product was obtained was without confidence. At this point, 
the programme was terminated in order to find a similar but more straightforward 
route to a sulfonamide thioester.
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I t  was considered that with a slight modification in the starting material used, we 
would gain direct access to the thioester without need for functional group 
modification. Consequently a new strategy was outlined (Scheme 54), whereby 
chloroacetyl chloride was reacted with sodium hydrosulfide hydrate in ethanol at 
-10°C to give mercapto-thioacetic acid109 (196) in 41 % isolated yield (at best) 
within 1 hour (Table 19, entries 1 and 2). In addition, using a non-polar solvent 
did not improve the outcome of the reaction due to miscibility problems (Table 
19, entry 3). The Michael addition to PFP vinylsulfonate was then attempted, but 
it was found that only starting materials could be isolated. (Table 19, entries 1 
and 2). Subsequently, the two-step reaction was carried out in situ, but a yield of 
only 9 % of confirmed product (197) could be isolated (Table 19, entry 4). 
Consequently, this area of research was curtailed.
o o
Cl ------------------- ^  n ^ s H     ►  p f p o 3s ^ s ^ y s h
o196 197
i. NaSH, solvent, -10 °C
ii. PFPS03CHCH2, Na2C 03, EtOH
Scheme 54
Entry Conditions Step i
1 EtOH, 1 h
2 EtOH, 1 h
3 DCM, 3 h
4 1. EtOH, 2 h;
2. Na2C03, PFPVS, rt 30 m
Yield %  196
41
23
7
formed 
in situ
Result Step ii
reflux 1 h, 97 % 
(196) recovered 
rt 5 h, 77 % 
(196) recovered
9 % (197) isolated
Table 19
2.11.2 Form ation o f b ifunctiona l PFP species
Despite the lack of success in the formation of PFP-thioesters, the notion of using 
PFP species as linkers between amino acids in proteins remained an intriguing 
proposition. The prospect of bifunctional PFP species, whereby the functionality 
appears at both ends of the structure, were of interest as this would allow for two 
points of tether within a protein, which could possibly affect biological activity.
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A strategy for the production of bifunctional PFP species was planned 
incorporating radical chemistry, which had been successful previously in our 
programme (Scheme 55).66
O a O O
X - V * '  -----------------   PFPCrHtf'    P F P ( A ) ^ S03PFP
X, X' = Cl, Br A B
n = 1, 3, 4 1 9 8  -  2 0 1  2 0 2
a . PFPOH, NEt3, Et20 ,  rt, lh
b. PFPS03CHCH2, Bu3SnH, AIBN, PhMe, reflux
Scheme 55
It  was found that pentafluorophenol readily underwent addition to acetyl halides 
to give the corresponding PFP esters as colourless, fluid oils in moderate to 
excellent yield in 1 hour (Table 20).
X X' n Yield %  A No.
Cl Cl 1 36 198
Br Br 1 61 199
Cl Br 3 85 200
Cl Br 4 88 201
Table 20
The proposed radical addition of PFP vinylsulfonate to the esters synthesised was 
then carried out. Although it has been shown that PFP vinylsulfonate will undergo 
radical mediated addition to simple acids,66 it was found that addition could not 
be achieved very successfully in this case, with little or no consumption of the 
starting materials during any of the coupling attempts (Table 21).
n Conditions Result No.
3 3 h reflux SM recovered
4 4 h reflux 6 % B achieved 202
4 4 h reflux 8 % B achieved 202
Table 21
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Although our investigation was suspended at this stage, it would be a reasonable 
step to repeat the reaction under modified radical conditions with alternative 
reagents to possibly improve the yield, as the encouraging results obtained here 
appear worthy of further study.
2 . 1 2  S u m m ary  and C onclusions
This research intended to demonstrate the capacity of pentafluorophenyl 
vinylsulfonate as a useful motif in organic synthesis, and subsequently emphasize 
the enduring importance of sulfonamides in current medical opinion.
Initial exploration using PFP vinylsulfonate as a radical acceptor6 6  allowed us to 
attempt other avenues of investigation such as cycloaddition, thus exploiting the 
electron-deficient nature of our olefin.
I t  was discovered that PFP vinylsulfonate was a willing participant in Diels-Alder 
reactions with simple carbocycles, and also underwent cycloaddition with a 
variety of nitrones to form isoxazolidines . 57 However, it was found that 
cycloaddition was unsuccessful with all other 1,3-dipoles investigated such as 
azides and nitrile oxides, as well as a number of heterodienes. I t  was concluded 
from this research that PFP vinylsulfonate appeared to be a dienophile that 
required specific conditions or properties in the diene/dipole in order to 
successfully undergo cycloaddition.
Hence the scope of PFP vinylsulfonate as a dienophile is limited, but the cyclic PFP 
sulfonate esters formed from successful transformations are biologically attractive 
structures, especially the modest library of isoxazolidines produced from our 
research into nitrone cycloaddition. Furthermore, the aminolysis step to form a 
sulfonamide from the ester cycloadduct was found to be a reliable procedure and 
the resulting products are also appealing from a medicinal perspective . 57  
Behaviour of the olefinic portion of PFP vinylsulfonate was explored further by 
experimentation with procedures such as Michael addition, Heck coupling and 
cross metathesis. Although it was found that PFP vinylsulfonate would not 
undergo coupling or metathesis, it was encouraging to discover that Michael 
addition to oxygen nucleophiles occurred readily, prompting the conclusion that 
this promising area requires further attention in anticipation of fruitful results.
The propensity for PFP vinylsulfonate to undergo Michael addition with suitable 
nucleophiles was recognised in subsequent research on protein chemistry. The 
successful addition of thiol species to PFP vinylsulfonate further demonstrated the 
scope of this transformation, and reinforces the case for further investigation into 
PFP vinylsulfonate Michael addition, as initial efforts suggest this has potential to 
be a productive avenue of study.
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In conclusion, the research described in this thesis was undertaken in an attempt 
to explore the reactivity of the bifunctional acceptor pentafluorophenyl 
vinylsulfonate in the formation of novel PFP sulfonate esters and sulfonamides. 
Our investigation delivered a greater knowledge on the limitations of the olefin 
portion of PFP vinylsulfonate, and resulted in the development of a variety of 
novel compounds. The most successful work involved cycloaddition of PFP 
vinylsulfonate with an array of functionalized nitrones, followed by aminolysis to 
furnish heterocyclic sulfonamides. These species are considered to be of biological 
importance and will presently be assessed for their applicability as therapeutic 
agents.
This work has also aimed to support the continuing capability of sulfonamides as 
diverse medicinal agents, and the straightforward and reliable methodology 
developed in our laboratory6 6  has not only resulted in the formation of a variety 
of interesting sulfonamide species, but has also permitted the vision of further 
development in this area as the potential for PFP sulfonate esters in synthesis is 
acknowledged.
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3 .0  EXPER IM EN TA L DATA
3 .1  G enera l E x p e rim e n ta l P rocedures
XH nmr spectra were recorded on a Bruker 300 MHz machine operating at 
ambient probe temperature using an internal deuterium lock. Chemical shifts are 
reported in parts per million (ppm), using residual CHCI3 as an internal standard.
Standard abbreviations are used throughout (s singlet; bs broad singlet; d
doublet; dd doublet of doublets; ddd double doublet of doublets; dq doublet of 
quartets; dt doublet of trip lets; t trip le t; q quartet; m multiplet). Coupling
constants are reported in Hertz (Hz).
13C nmr spectra were recorded at 75 MHz. Chemical shifts are reported in parts 
per million (ppm) using residual CHCI3 as an internal standard.
Mass spectra (EI+, ES+, CI+, FAB) were recorded on a Kratos MS25 
spectrometer and a Fisons autospectrometer. Mass spectra undertaken at the 
EPSRC mass spectrometry centre at the University of Wales Swansea were 
carried out on a Thermoquest Finnigan MAT 900XT spectrometer. Infra red 
spectra were recorded on a Perkin-Elmer FT-IR 298 spectrometer.
Melting points were recorded using a Gallenkamp melting point apparatus and are 
uncorrected.
Flash column chromatography was carried out using Merck 60 silica gel. Analytical 
thin layer chromatography was carried out using SIL G/UV254 plates with 
visualisation by UV light; iodine; alkaline potassium permanganate and 
anisaldehyde.
Reaction solvents were purified and dried according to literature methods . 11 0  
Tetrahydrofuran and diethyl ether were distilled from sodiumbenzophenone ketyl, 
dichloromethane was distilled from calcium hydride, and toluene was distilled 
from sodium.
Preparations were performed under an inert (nitrogen or argon) atmosphere 
unless otherwise stated, and all glassware was flushed with nitrogen prior to use.
3 .2  Fo rm atio n  o f PFP V in y ls u lfo n a te  [8 0 ]  66
To triethylamine (3.0 eq., 12.83 mL, 92.01 mmol) in dichloromethane (30 mL) at 
-10 °C (ice/acetone cold bath) was added pentafluorophenol (1.05 eq., 5.93 g, 
32.21 mmol) dropwise, followed by 2 -chloroethylsulfonyl chloride (1.0 eq., 3.21 
mL, 30.67 mmol) cautiously over a 15 min period. The reaction was stirred at -  
10 °C for 1 hr, then quenched with 2M HCI (30 mL). The mixture was extracted 
with DCM (3 x 50 mL) then washed with water (2 x 50 mL) and brine (2 x 50 
mL). The organic phase was separated, dried (MgSCU), filtered and the filtrate
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concentrated in vacuo. The crude residue was purified by flash column 
chromatography (50:1 Petroleum ether 40-60 °C:Ether) to give the title  
compound as a colourless oil (4.60 g, 16.78 mmol, 55 %).
Rf 0.60 (3:1 P:Et20 )
8h (CDCI3, 300M H z) 6.75-6.55 (m, 1H, S02CH), 6.42 (dd, J 17.1, 0.6, 1H, 
CHCH2), 6.29 (dd, J 9.8, 0.5, 1H, CHCH2).
5C (CDCI3, 75M Hz) (Aromatic peaks not observed due to 19F coupling). 133.8 
(CH2), 131.7 (CH).
LRMS (E I+ )  274 (M+, 33 % ), 184 (C6F5OH, 76 % ), 136 (CHS03C2F, 38 %), 117 
(CHS03C2, 25 %), 105 (CHS03C, 17 % ), 91 (S02CHCH2, 77 % ), 27 (CHCH2, 100 
%).
3 .3  Radical A d d itio n  P rocedures 66
3.3.1 Radical addition reactions
3,3-D im ethylbutane-l-sulfonic acid pentafluorophenyl ester [8 1 ]
To pentafluorophenyl vinylsulfonate (400 mg, 1.46 mmol) in dry toluene (10 mL) 
was added t-butyl iodide (3.0 eq., 0.52 mL, 4.38 mmol), the mixture was heated 
to reflux and tributyltinhydride (0.41 mL, 1.53 mmol) followed by AIBN (20 mg) 
were added. The reaction was refluxed for a further 4 hours then cooled. KF (50 
mg) was added and the mixture was stirred at ambient temperature for 12 hours, 
filtered through Celite-545, concentrated in vacuo, and the crude residue was 
purified by flash column chromatography (10:1 Petroleum ether 40-60 °C:Ether) 
to give the title  compound as a white solid (430 mg, 1.30 mmol, 89 %).
Rf 0.75 (3:1 P:Et20).
8h (CDCI3, 300M Hz) 3.37-3.32 (m, 2H, S02CH2), 1.89-1.84 (m, 2H,
S02CH2CH2), 0.93 (s, 9H, C (CH3)3.
5C (CDCI3, 75M Hz) (Aromatic peaks not observed due to 19F coupling). 144.3 
(PhC), 50.1 (CH2), 36.9 (CH2), 30.6 (C (CH3)3), 29.2 (C(CH3)3).
LRMS (E I+ )  332 (M+, 6 % ), 183 (C6F50, 49 % ), 155 (S03HC3F2, 66 %), 85 
(C2H4C(CH3)3, 56 %), 69 (C2(CH3)3, 84 %), 57 (C(CH3)3, 100 %), 41 (C3H5 78 
%).
H exane-l-sulfonic acid pentafluorophenyl ester [8 2 ]
To pentafluorophenyl vinylsulfonate (200 mg, 0.73 mmol) in dry toluene (10 mL) 
was added n-butyl iodide (3.0 eq., 0.25 mL, 2.19 mmol), the mixture was heated 
to reflux and tributyltinhydride (0.21 mL, 0.77 mmol) followed by AIBN (20 mg)
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were added. The reaction mixture was refluxed for a further 5 hours then cooled. 
KF (50 mg) was added and the mixture was stirred at ambient temperature for 
12 hours, filtered through Celite-545, concentrated in vacuo, and the crude 
residue was purified by flash column chromatography (8:1 Petroleum ether 40-60 
°C:Ether) to give the title  compound as a yellow oil (140 mg, 0.42 mmol, 58 %). 
Rf 0.50 (5:1 P:Et20 ).
8h (CDCI3, 300M H z) 3.39-3.34 (m, 2H, S02CH2), 2.01-1.91 (m, 2H,
S02CH2CH2), 1.52-1.31 (m, 2H, S02CH2CH2CH2), 1.30-1.26 (m, 2H, CH2CH3), 
0.84 (s, 3H, CH3).
8C (CDCI3, 75M H z ) (Aromatic peaks not observed due to 19F coupling). 144.1- 
136.6 (PhC), 53.2 (S02CH2), 31.4 (S 02CH2CH2), 28.1 (S 02CH2CH2CH2), 23.8 
(CH2CH3), 22.6 (CH2CH3), 14.2 (CH3).
LRMS (E I+ )  333 (M+, H, 39 %), 183 (C6F50, 67 %), 155 (S03HC3F2, 55 %), 84 
(C6H12, 70 % ), 43 (C3H7, 100 % ), 29 (C2H5, 51 %).
3-M ethylbutane-l-su lfon ic  acid pentafluorophenyl ester [83 ]
To pentafluorophenyl vinylsulfonate (200 mg, 0.73 mmol) in dry toluene (10 mL) 
was added 2-bromopropane (3.0 eq., 0.21 mL, 2.19 mmol), the mixture was 
heated to reflux and tributyltinhydride (0.21 mL, 0.77 mmol) followed by AIBN 
(20 mg) were added. The reaction mixture was refluxed for a further 7 hours 
then cooled. KF (50 mg) was added and the mixture was stirred at ambient 
temperature for 12 hours, filtered through Celite-545, concentrated in vacuo, and 
the crude residue was purified by flash column chromatography (8:1 Petroleum 
ether 40-60 °C:Ether) to give the title  compound as a colourless oil (66 mg, 0.21 
mmol, 29 %).
Rf 0.60 (5:1 P:Et20 ).
8h (CDCI3/ 300M H z ) 3.40-3.34 (m, 2H, S02CH2), 1.82-1.90 (m, 2H,
S02CH2CH2), 0.93 (d, 6H, CH(CH3)2).
8C (CDCI3, 75M H z ) (Aromatic peaks not observed due to 19F coupling). 144.3 
(PhC), 136.7 (PhC), 51.6 (S 02CH2), 32.2 (S02CH2CH2), 27.5 (CH3), 22.3 (CH3). 
LRMS (E I+ )  319 (M+, H, 36 % ), 231 (C6F5S02, 14 % ), 184 (C6F5OH, 42 %), 86 
(SC4H6, 100 % ), 71 (C5Hn , 68 %), 55 (C4H7, 73 %).
5 - Io d o m e th y l -2 ,2 ,7 ,7 - t e t r a m e th y l - t e t r a h y d r o -b is  [1 ,3 ] d io x o lo  [4 ,5 -0 ,4 ', 
5'-a] p y ra n
To 2,2,7,7-tetram ethyl-tetrahydro-bis [1 ,3 ] dioxolo [4,5-(3, 4 ',5 '-a] pyran-5-yl- 
methanol (5.00 g, 19.23 mmol) in dry toluene (40 mL) was added 
triphenylphosphine (2.0 eq., 10.08 g, 38.46 mmol) followed by imidazole (3.0
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eq., 3.92 g, 57.69 mmol) and iodine (2.0 eq., 9.77 g, 38.46 mmol), and the 
mixture was refluxed for 4 hours. The mixture was diluted with ether (50 mL), 
and the filtrate was decanted and concentrated in vacuo. The crude residue was 
purified by flash column chromatography (8:1 Petroleum ether 40-60 °C:Ether) to 
give the title  compound as a white solid (3.50 g, 9.46 mmol, 49 %).
Rf 0.75 (2:1 P:Et20 ).
SH (CDCI3 , 300M H z ) 5.74 (d, J 4.9, 1H, ICH2CHOCH), 4.81 (dd, J 7.8, 2.4, 1H, 
ICH2CHCHCH), 4.57 (dd, J 7.9, 1.7, 1H, ICH2CHCH), 4.49 (dd, J 5.0, 2.5, 1H, 
ICH2CHOCHCH), 4.13 (dd, J 12.4, 7.1, 1H, ICH2CH), 3.55-3.38 (m, 2H, ICH2), 
1.74-1.53 (m, 12H, 2 x C(CH3)2).
8C (CDCI3/ 75M H z ) 109.9 (C(CH3)2), 109.3 (C(CH3)2), 97.1 (ICH2CHOCH), 72.0 
(ICH2CHCHCH), 71.5 (ICH2CHCH), 71.0 (ICH2CHOCHCH), 69.3 (ICH2CH), 26.4 
(CH3), 26.4 (CH3), 25.3 (CH3), 24.8 (CH3), 2.7 (ICH2).
LRMS (FAB+) 371 (M+, H, 16 %), 355 (M+ -CH3, 36 %), 313 (M+ -(CH3)2CO, 26 
%), 237 (C50 2H4CH2I, 11 % ), 209 (ICH2C(CO)2, 16 %), 169 (ICH2CO, 12 %), 127 
(I, 14 %), 113 (C50 3H5, 13 %), 59 (CH3C02, 100 %).
3-(2 ,2 ,7 ,7 -Tetram ethy l-te trah yd ro -b is  [1 ,3 ] dioxolo [4 ,5 -p ,4 ',5 '-a ]pyran -
5-y l)-p ropane-l-su lfon ic  acid pentafluorophenyl ester [84 ]
To pentafluorophenyl vinylsulfonate (260 mg, 0.95 mmol) in dry toluene (15 mL) 
was added 5-iodomethyl-2,2,7,7-tetramethyl-tetrahydro-bis [1,3] dioxolo [4,5-3, 
4',5'-oc] pyran (2.5 eq., 880 mg, 2.37 mmol), the mixture was heated to reflux 
and tributyltinhydride (0.27 mL, 0.98 mmol) followed by AIBN (30 mg) were 
added. The reaction m ixture was refluxed for a further 3 hours then cooled. KF 
(50 mg) was added and the m ixture was stirred at ambient temperature for 12 
hours, filtered through Celite-545, concentrated in vacuo, and the crude residue 
was purified by flash column chromatography (2:1 Petroleum ether 40-60 
°C:Ether) to give the title  compound as a white solid (350 mg, 0.68 mmol, 71 %). 
Rf 0.40 (2:1 P:Et20 ).
8h (CDCIs, 300M H z ) 5.45 (d, J 5.1, 1H, CH2CHOCH), 4.52 (dd, J 7.9, 2.7, 1H, 
CH2CHCHCH), 4.23 (dd, J 5.1, 2.3, 1H, CH2CHOCHCH), 4.05 (dd, J 7.9, 1.6, 1H, 
CH2CHCH), 3.68 (dd, J 7.7, 1.5, 1H, CH2CH), 3.57-3.37 (m, 2H, S02CH2), 2.18- 
2.04 (m, 2H, S02CH2CH2), 1.86-1.65 (m, 2H, CH2CHO), 1.51-1.25 (m, 12H, 2 x 
(CH3)2).
8C (CDCI3/ 75M H z )  (Aromatic peaks not observed due to 19F coupling). 121.8 
(PhC), 109.6 (C(CH3)2), 108.8 (C(CH3)2), 96.9 (CH2CHOCH), 73.1 (CH2CHCHCH), 
71.3 (CH2CHOCHCH), 70.7 (CH2CHCH), 67.0 (CH2CH), 52.6 (S02CH2), 28.4 
(S02CH2CH2), 26.3 (CH3), 25.1 (CH3), 24.7 (CH3), 23.7 (CH3), 20.8 (CH2CHO).
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LRMS (E I+ )  503 (M+ -CH3, 37 % ), 461 (M+ -(CH3 ) 3C, 16 % ), 445 (M+ -(CH3 ) 3CO, 
6  %), 385 (M+ -C2 (CH3 )4 0 3, H, 12 %), 357 (M+ -C2 (CH3 )4 0 4, CH, 30 %), 335 (M+ 
-C6 F50 , 7 % ), 184 (C6 F5 OH, 10 % ), 100 (C2 (CH3 )4 0, 6 8  % ), 85 (C2 (CH3 )30 , 29 
%), 59 (CH3 C02/ 49 % ), 43 (CH3CO, 100 %).
3.3.2 Aminolysis procedures for radical addition products
2-(3,3-d im ethylbutane-l-su lfonylam ino)-3-phenylpropion ic  acid ethyl 
ester [85 ]
To 3,3-dim ethylbutane-l-sulfonic acid pentafluorophenyl ester [81] (69 mg, 0.21 
mmol) in dry toluene (10 mL) was added phenylalanine ethyl ester (5.0 eq., 200 
mg, 1.04 mmol) followed by DBU (1.00 eq., 0.03 mL, 0.21 mmol), and the 
mixture was refluxed for 8  hours, then stirred at ambient temperature for 1 2  
hours. The reaction was diluted with dichloromethane (50 mL) and washed with 
2M HCI (2 x 20 mL), water (2 x 20 mL) and brine (2 x 20 mL). The organic phase 
was separated, dried (MgS04) filtered and the filtrate concentrated in vacuo. The 
crude residue was purified by flash column chromatography (1:1 Petroleum ether 
40-60 °C:Ether) to  give the title  compound as a yellow solid (50 mg, 0.16 mmol, 
77 %).
Rf 0.30 (1:1 P:Et2 0).
Mp 85-87 °C
5h (CDCI3, 300M H z ) 7.27-7.12 (m, 5H, PhH), 4.77 (d, J 9.4, 1H, NH), 4.27-4.21 
(m, 1H, CHCH2 Ph), 4.14 (q, J 7.1, 2H, CH3 CH2), 3.08-2.89 (m, 2H, S02CH2), 
2.69-2.59 (m, 2H, CH2 Ph), 1.47-1.41 (m, 2H, CH2 (CH3)3), 1.20 (t, J 7.1, 3H, 
CH3), 0.74 (s, 9H, (CH3)3).
8c (CDCI3, 75M Hz) 172.0 (CO), 136.0-127.8 (PhC), 62.4 (CH3 CH2), 57.7 
(CHCH2 Ph), 50.7 (S0 2 CH2), 40.1 (CH2 Ph), 36.7 (CH2 (CH3)3), 30.3 (C(CH3)3), 29.3 
((CH3)3), 14.5 (CH3).
LRMS (E I + ) 268 (M+ -C2 H5C02, 74 %), 250 (M+ -Ph, CH3, 72 %), 194 (M+ - 
S02 C6 Hn , 29 %), 176 (M+ -PhCH3C02 C2 H5/ 78 % ), 120 (PhC2 H4 NH, 70 %), 102 
(C4 H8 N02, 8 8  % ), 91 (PhCH2, 6 6  %), 69 (C(CH3 )3 C, 27 %), 57 (C(CH3)3, 100 %), 
43 (CH(CH3)2, 54 %).
3 - ( 2 , 2 ,7 ,7 -te tram ethyl-te trahydro-b is  [1 ,3 ] dioxolo [4 ,5 -p , 4 ',5 '-a ]pyran-
5 -y l)-p ropan e-l-su lfon ic  acid allylam ide [ 8 6 ]
To 3 -( 2 ,2 ,7 ,7 -tetram ethyl-tetrahydro-bis [1 ,3 ] dioxolo [4,5-p, 4 ',5 ,-oc] pyran-5- 
yl)-propane-l-sulfonic acid pentafluorophenyl ester [84] ( 6 8  mg, 0.13 mmol) in 
dry THF (10 mL) was added allylamine (5.0 eq., 0.05 mL, 0.66 mmol) and DMAP
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(1.0 eq., 0.13 mmol, 17 mg), and the mixture was refluxed for 5 hours, then 
stirred at ambient temperature for 12 hours. The reaction was diluted with 
dichloromethane (50 mL) and washed with 2M HCI (2 x 20 mL), water (2 x 20 
mL) and brine (2 x 20 mL). The organic phase was separated, dried (MgS04) 
filtered and the filtra te  concentrated in vacuo. The crude residue was purified by 
flash column chromatography (1:4 Petroleum ether 40-60 °C:Ether) to give the 
title compound as a yellow oil (35 mg, 0.09 mmol, 69 %).
Rf 0.10 (1:1 P:Et20 ).
Vmax (th in film , cm '1) 3583 w, 3287 w, 2987 m, 1724 m, 1645 m, 1383 m, 1319 
m, 1256 m, 1211 m, 1070 m.
8 h (CDCI3, 300M H z) 6.11-5.98 (m, 1 H, CHCH2 NH), 5.70 (d, J 4.8, 1 H, 
CH2CHOCH), 5.47 (d, J 16.9, 1H, CH2CHCH2 NH), 5.38 (d, J 10.1, 1H, 
CH2CHCH2 NH), 4.77 (dd, J 5.8, 2.1, 1H, CH2 CHCHCH), 4.62 (dd, J 5.5, 4.0, 1H, 
CH2CHCH), 4.48 (dd, J 4.9, 2.3, 1H, CH2 CHOCHCH), 4.29 (dd, J 7.9, 1.9, 1H, 
CH2CHO), 3.92-3.91 (m, 3H, CH2 NH), 3.26-3.24 (m, 2H, S0 2CH2), 2.17-1.86 (m, 
4H, S0 2 CH2 CH2 CH2), 1.70-1.51 (m, 12H, 2 x C(CH3)2).
5C (CDCI3, 75M H z ) 134.1 (CHCH2 NH), 118.1 (CH2 CHCH2 NH), 109.5 (C(CH3)2),
108.8 (C(CH3)2), 96.9 (CH2 CHOCH), 73.1 (CH2 CHCHCH), 71.2 (CH2 CHCH), 70.8 
(CH2 CHOCHCH), 67.1 (CH2 CHO), 53.0 (S 0 2CH2), 46.1 (CH2 NH), 28.8
(S02 CH2 CH2), 26.4 (CH3), 26.4 (CH3), 25.3 (CH3), 24.7 (CH3), 20.7 (CH2 CHO). 
LRMS (FA B +) 414 (MNa+, 21 % ), 392 (M+, H, 100 %), 376 (M+ -CH3, 37 %), 
334 (M+ -C3 H6 NH, 52 % ), 258 (CuH 1 7 0 5 (CH2) 2 H, 29 %), 173 (C5 H50 5CH2 CH2, 29 
%), 154 (C6 H2 0 5, 89 % ), 137 (C8 H9 0 2, 100 %), 77 (C5 OH, 44 %).
HRMS (E S +) MNa+ Calcd for C i7 H2 9 N0 7S, 414.1562, found 414.1551.
3.4 Nitrone Cycloaddition Procedures
3.4.1 Typical procedure for the preparation of nitrones68 
C-Phenyl-JV-methylnitrone [7 6 ]68
To /V-methyl hydroxyl amine hydrochloride (1.2 eq.) in dry dichloromethane (20 
mL) was added benzaldehyde (1.0 eq.) and sodium hydrogen carbonate (3.0 
eq.). The mixture was refluxed at 40 °C for 2 hours, and the resulting suspension 
was filtered and washed with dichloromethane (4 x 20 mL). The organic fractions 
were combined and concentrated in vacuo to yield a white solid which was 
recrystallised (5:1 Petroleum ether 40-60 °C: Ethyl acetate) to give the title 
compound as white needles (92 %).
Rf 0.45 (Et20:AcOH 20:1).
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8 h (CDCh, 30 0  M Hz) 8.38-8.35 (m, 2H, PhH), 7.58-7.41 (m, 4H, CHN, PhH),
4.04 (s, 3H, CH3).
8 C (CDCI3 , 75 MHz) 135.6 (CH), 130.8 (PhC), 128.9 (PhC), 128.8 (PhC), 54.8 
(CH3).
LRMS (E I+ )  134 (M+, 100 % ), 118 (M+-0 , 40 %), 89 (PhC, 30 %), 77 (Ph, 27 
%), 28 (CO, 25 %).
C -(2 -F lu o ro p h e n y l)-/V -m e th y ln itro n e  [8 7 ]68 (white solid 78 %)
8 h (CDCI3/ 300  MHz) 9.15 (t, J 7.7, 1H, PhH), 7.60 (s, 1H, CHN), 7.36-7.24 (m, 
1H, PhH), 7.20-7.10 (m, 1H, PhH), 7.00 (t, J 10.0, 1H, PhH), 3.80 (s, 3H, CH3).
8 C (CDCI3/ 75 MHz) 161.9 (PhC), 158.6 (PhC), 132.1 (CHN), 129.0-114.9 
(PhCH), 55.3 (CH3).
LRMS (E I+ )  153 (M+, 100 %), 134 (M+-F, 85 %), 125 (M+-CO, 90 %), 107 (M+- 
NHCH30, 85 % ), 77 (Ph, 40 % ), 28 (CO, 15 %).
C -(3 -C h lo ro p h e n y l)-/V -m e th y ln itro n e  [88]68 (white solid 8 8  %)
§H (CDCI3 , 300  M Hz) 8.15 (s, 1H, PhH), 7.19 (d, J 7.0, 1H, PhH), 7.18-7.12 (m, 
3H, PhH, CHN), 3.56 (s, 3H, CH3).
8 C (CDCI3 , 75  M Hz) 134.9 (CHN), 134.2 (PhC), 132.4 (PhC), 130.7-126.8 
(PhCH), 55.0 (CH3).
LRMS (E I+ )  171 (M+, 3 7 CI, 35 %), 170 (M+-H 3 7 CI, 40 %), 169 (M+, 3 5 CI, 95 %), 
168 (M+-H ,3 5 CI, 100 % ), 141 (M+-CO, % ), 111 (CIPh, 15 %), 89 (PhCH, 35 %), 
77 (Ph, 35 % ), 42 (CNO, 60 %).
C -(4 -M e th o xyp h e n y l)-/V -m e th y ln itro n e  [9 1 ]68 (pale yellow solid 99 %)
SH (CDCI3 , 300  MHz) 8.15 (d, J 8.9, 2H, PhH), 7.20 (s, 1H, CHN), 6.85 (d, J9 .0 , 
2H, PhH), 3.71 (s, 6 H, OCH3, NCH3).
8 C (CDCI3 , 75 MHz) 161.4 (PhCH), 135.3 (CHN), 130.8 (PhCH), 123.8 (PhC), 
114.7- 114.2 (PhCH), 55.7 (NCH3), 54.3 (OCH3).
LRMS (E I+ )  165 (M+, 100 % ), 135 (M+-CH30 , 50 % ), 91 (OPh, 15 %), 42 (CNO, 
15 %).
C -(3 -B ro m o p h e n y l)-/V -m e th y ln itro n e  [9 2 ]68 (pale brown solid 100 %)
8 h (CDCI3 , 300  MHz) 8.27 (s, 1H, PhH), 7.82 (d, J 7.9, 1H, PhH), 7.40 (d, 1H, J
8.1, PhH), 7.34 (s, 1H, CHN), 7.07 (t, J 7.9, 1H, PhH), 3.63 (s, 3H, CH3).
8 C (CDCI3 , 75 MHz) 134.1 (CHN), 133.6 (PhCH), 132.6 (PhC), 131.1-127.2 
(PhCH), 123.0 (PhC), 55.0 (CH3).
LRMS (E I+ )  214 (M+, 45 % ), 184 (8 1 BrPhCHN, 30 % ), 84 (92 %), 49 (100 %).
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C -(4-N itrophenyl)-A /-m ethylnitrone [9 3 ] 68 (yellow solid 93 %)
8 h (CDCI3 , 300  MHz) 8.23-8.06 (m, 4H, PhH), 7.11 (s, 1H, CHN), 3.75 (s, 3H, 
CH3).
5C (CDCI3 , 75 MHz) 129.1 (CHN), 124.2 (PhCH), 55.6 (CH3).
LRMS (E I+ )  179 (M+, 100 % ), 133 (M+-CH3ON, 2H, 15 %), 105 (NOPh, 25 %), 
77 (Ph, 25 % ), 42 (CNO, 40 % ).
C-(5-Brom o-2-furyl)-VV-m ethylnitrone C95] 68 (white solid 97 %)
8 h (CDCI3 , 300  MHz) 7.61 (d, J 3.4, 1H, CHCO,), 7.40 (s, 1H, CHN), 6.39 (d, J 
3.4, 1H, CHCBr), 3.74 (s, 3H, CH3).
8 C (CDCI3, 75 MHz) 149.1 (CO), 125.6 (CBr), 124.7 (CHN), 117.8 (CHCBr), 
114.5 (CHCO), 53.2 (CH3).
LRMS (E I+ )  203 (M+, 92 % ), 124 (M+-Br, 10 %), 79 (M+-Br, NOCH3, 100 %), 51
(C4 H3, 90 %), 42 (CHNCH3, 96 %).
C -(2-Furyl)-/V -m ethylnitrone [9 6 ]68 (yellow needles 91 %)
8 h (CDCI3, 300 MHz) 7.70 (d, J 3.4, 1H, CHCOCHN,), 7.48 (s, 1H, CHO), 7.40 
(s, 1H, CHN), 6.45 (s, 1H, CHCHCOCHN), 3.70 (s, 3H, CH3).
8 C (CDCI3 , 75  M Hz) 147.0 (CO), 144.1 (CHO), 126.8 (CHN), 115.7 (CHCHO),
112.7 (CHCHCHO), 53.1 (CH3).
LRMS (E I+ )  125 (M+, 100 % ), 108 (M+-OH, 20 % ), 95 (M+-CHOH, 35 %), 52 
(CO, 2C, 45 % ), 42 (CNO, 75 % ), 28 (CO, 27 %).
C -(2-N aphthyl)-/V -m ethylnitrone [9 7 ] 68 (yellow solid 8 6  %)
8 h (CDCI3 , 300  MHz) 9.10 (s, 1H, CHN), 7.89-7.40 (m, 7H, PhH), 3.88 (s, 3H, 
CH3).
8 c (CDCI3 , 75 MHz) 135.6 (CHN), 134.5-133.5 (PhC), 129.6-126.0 (PhCH), 54.9 
(CH3).
LRMS (E I+ )  185 (M+, 100 % ), 168 (M+-OH, 45 % ), 139 (M+-NHCH30, 65 %), 
127 (CioH7, 65 % ), 115 (C9 H7, 90 % ), 42 (CNO, 70 % ), 28 (CO, 10 %).
C -(Cyclohexyl)-N -m ethylnitrone [9 8 ]68 (pale yellow oil 99 %)
8 h (CDCI3f 300 MHz) 6.42 (d, J 7.5, 1H, CHN,), 3.49 (s, 3H, CH3), 1.70-1.61 
(m, 1H, CH2 CH), 1.60-1.40 (m, 4H, CH2), 1.21-0.90 (m, 6 H, CH2).
8 C (CDCI3/ 75 MHz) 147.0 (CHN), 52.8 (CH3), 35.6 (CH2CH), 29.0-25.4 (CH2). 
LRMS (E I+ )  141 (M+, H, 25 % ), 124 (M+-0 , 15 % ), 95 (M+-CH3 NO, 60 %), 84 
(C6 H12, 85 % ), 49 (100 % ), 42 (CNO, 40 %).
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C-(Cyclopropyl)-/V-methylnitrone [9 9 ] 6 8  (yellow oil 1 0 0  %)
SH (CDCI3, 300  MHz) 5.90 (d, J 8.7, 1H, CHN,), 3.25 (s, 3H, CH3), 2.00-1.87 
(m, 1 H, CHCHN), 0.70-0.60 (m, 2H, CH2), 0.39-0.30 (m, 2H, CH2).
8 c (CDCI3 , 75 MHz) 143.6 (CHN), 52.0 (CH3), 9.5 (CHCHN), 7.2 (CH2), 6 . 8  
(CH2).
LRMS (E I+ )  99 (M+, 100 %), 84 (C3H5CHNO, 36 % ), 6 8  (C3H5CHN, 35 %), 42 
(CNO, 67 % ), 28 (CO, 42 %).
C-(Pentyl)-/V-methylnitrone [1 0 3 ]68 (colourless oil 62 %)
8 h (CDCI3, 300 MHz) 6.45 (t, J 5.8, 1H, CHN,), 3.40 (s, 3H, CH3), 2.21-2.10 (m, 
2H, NCHCH2), 1.30-1.16 (m, 2H, NCHCH2 CH2), 1.09-0.97 (m, 4H, CH3 CH2 CH2), 
0.60 (s, 3H, CH2 CH3).
8 C (CDCI3/ 75 MHz) 140.2 (CHN), 51.8 (NCH3), 31.0(CH2CHN), 26.2
(CH2 CH2 CHN), 24.6 (CH2 CH2 CH3), 21.8 (CH2CH3), 13.4 (CH2 CH3).
LRMS (E I+ )  130 (M+, H, 70 % ), 84 (CH3 (CH2 )4 CH, 85 %), 49 (100 %), 42 (CNO, 
25 %).
C -(4-A lly loxy-phenyl)-N -m ethyln itrone [1 0 4 ]68 (white solid 1 0 0  %)
8h (CDCI3, 300  MHz) 8.08 (d, J 8.9, 2H, PhH), 7.17 (s, 1H, CHN), 6.82 (d, J 9.0, 
2H, PhH), 6.01-5.87 (m, 1H, CHCH2 0 ), 5.38-5.16 (m, 2H, CH2 0 ), 4.46 (d, J 5.3, 
2H, CH2 CHCH2 0 ), 3.70 (s, 3H, CH3).
8 C (CDCI3 , 75 MHz) 160.4 (PhCO), 135.2 (CHN), 133.1 (PhCH), 130.7 (PhCH),
124.0 (PhC), 118.4 (CH2 CH), 114.9 (CH2CH), 69.2 (CH2 0), 54.3 (CH3).
LRMS (E I+ )  191 (M+, 80 % ), 175 (M+-0 , 20 %), 150 (M+-C3 H5, 30 %), 133 
(PhCNOCH3, 25 %), 105 (PhOCH, 12 % ), 84 (C4 H6 NO, 23 %), 77 (Ph, 15 %), 42 
(CNO, 100 %).
3.4.2 1 ,3 -d ipo la r cyc loadd ition  reactions 5 7  
4 -B e n z e n e s u lfo n y l-2 -m e th y l-3 -p h e n y l- is o x a z o lid in e
To phenyl vinyl sulfone (622 mg, 3.70 mmol) in dry toluene (15 mL) was added 
C-phenyl-/V-methylnitrone [76] (1.0 eq., 500 mg, 3.70 mmol) and the mixture 
was heated to reflux for 10 hours. The reaction was concentrated in vacuo, and 
the crude residue was purified by flash column chromatography (8:1 Petroleum 
ether 40-60 °C:Ethyl acetate) to give the title  compound as a white solid (733 
mg, 2.42 mmol, 65 %).
Rf 0.50 (2:1 P:EtOAc).
Mp 96-98 °C
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V m a x  (th in  film , cm '1) 3433s, 3063 s, 1633 s, 1447 m, 1306 m, 1149 m.
§H (CDCI3, 300  MHz) 7.73-7.08 (m, 5H, PhH), 4.41 (dd, J 10.0, 3.4, 1H, CH2), 
4.18 (dd, J 10.0, 8.3, 1H, CH2), 4.03-3.97 (m, 1H, CHCH2), 3.78 (d, J 6.7, 1H, 
CHN), 2.51 (s, 3H, CH3).
8C (CDCI3, 75 MHz) 138.4-128.2 (PhC), 76.0 (CHCH2), 73.9 (CHN), 6 6 . 6  (CH2),
43.1 (CH3).
LRMS (E I+ )  303 (M+, 30 % ), 160 (M+-PhS02, 2H, 75 % ), 134 (PhCNCH3 0, 35 
%), 117 (M+-PhS02, Ph, 47 % ), 84 (M+-C6 H5 S02, PhH, 85 %), 49 (SO, H, 100 
%).
HRMS (E S +) MH+ Calcd for C i6 Hi7 N0 3 S, 304.1002, found 304.1001.
2-M ethyl-3-phenyl-isoxazolidine-4-sulfonic acid phenyl ester
To phenyl vinylsulfonate (109 mg, 0.59 mmol) in dry toluene (10 mL) was added 
C-phenyl-/V-methylnitrone [76] (2.5 eq., 200 mg, 1.48 mmol) and the mixture 
was heated to reflux for 24 hours. The reaction was concentrated in vacuo, and 
the crude residue was purified by flash column chromatography (6:1 Petroleum 
ether 40-60 °C:Ether) to give the title  compound as a white solid (145 mg, 0.45 
mmol, 77 %).
Rf 0.55 (1:1 P:Et2 0 ).
Mp 72-75 °C
V m a x  (th in film , cm"1) 3435 s, 1641 s, 1487 m, 1378 m, 1192 m, 1142 m.
8 h (CDCI3, 300  MHz) 6.40-5.54 (m, 10H, PhH), 4.43 (dd, J 10.0, 3.4, 1H, CH2), 
4.30 (dd, J 9.8, 8.1, 1H, CH2), 4.10 (dt, J 7.9, 2.8, 1H, CHCH2), 3.97 (d, J 6.9, 
1H, CHN), 2.60 (s, 3H, CH3).
8C (CDCI3, 75 MHz) 149.1-122.0 (PhC), 74.5 (CHCH2), 71.9 (CHN), 66.9 (CH2), 
42.9 (CH3).
LRMS (E I+ )  319 (M+, 100 % ), 160 (M+-PhS03, 2H, 75 % ), 242 (M+-Ph, 10 %), 
134 (PhCNCH3 0 , 65 % ), 117 (M+-PhOB, Ph, 52 %), 91 (M+-C6 H50 3, PhCN, 35 %), 
77 (Ph, 25 %), 65 (S 02, H, 28 %).
HRMS (E S +) MH+ Calcd for C i6 H1 7N0 4 S, 320.0951, found 320.0945.
Elemental analysis Anal, calcd for Ci6 Hi7 N04 S: C 60.17, H 5.37, N 4.39, S 
10.04; found: C 59.95, H 5.38, N 4.29, S 9.89.
2 -M e th y l-3 -p h e n y l- is o x a z o lid in e -4 -s u lfo n ic  a c id  p e n ta f lu o ro p h e n y l e s te r  
[105]
To pentafluorophenyl vinylsulfonate [80] (120 mg, 0.44 mmol) in dry toluene (10 
mL) was added C-phenyl-/V-methylnitrone [76] (2.5 eq., 148 mg, 1.09 mmol) 
and the m ixture was heated to reflux for 20 hours. The reaction was concentrated
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in vacuo, and the crude residue was purified by flash column chromatography 
(8:1 Petroleum ether 40-60 °C:Ether) to give the title  compound as a colourless 
oil ( 1 2 0  mg, 0.29 mmol, 67 %).
Rf 0.45 (3:1 P:Et2 0 ).
Vmax (thin film , cm-1) 2969s, 2881 s, 1650 s, 1519 m, 1458 m, 1393 m, 1183 
m.
$ h (CDCI3, 300  MHz) 7.41-7.18 ( m ,  5H, PhH), 4.53 (dd, J 10.2, 3.0, 1 H, CH2), 
4.41 (dd, J 10.0, 7.9, 1H, CH2), 4.25 (dt, J 7.7, 2.8, 1H, CHCH2), 3.98 (d, J 6 .8 , 
1H, CHN), 2.62 (s, 3H, CH3).
8 C (CDCI3 , 75 MHz) (Aromatic peaks not observed due to 19F coupling). 144.2-
128.4 (PhC), 74.5 (CHCH2), 74.2 (CHN), 67.2 (CH2), 43.1 (CH3).
LRMS (E I+ )  409 (M+, 100 %), 183 (C6 F50 , 15 %), 162 (M+-C6 F50 3 S, 60 %), 134 
(PhCNCH3 0 , 57 % ), 117 (M+-C6 F50 3, Ph, 100 %), 91 (M+-C6 F50 3, PhCN, 58 %). 
HRMS (E S +) MH+ Calcd for C i6 H i2 N0 4 F5S, 410.0480, found 410.0461.
2-M ethyl-3-(4-n itro -phenyl)-isoxazo lid ine-4-su lfon ic  acid pentafluoro­
phenyl ester [1 0 6 ]
To pentafluorophenyl vinylsulfonate [80] (331 mg, 1.21 mmol) in dry toluene (10 
mL) was added C-(4-nitrophenyl)-A/-methylnitrone [93] (1.5 eq., 238 mg, 1.81 
mmol) and the m ixture was heated to reflux for 2 hours. The reaction was 
concentrated in vacuo, and the crude residue was purified by flash column 
chromatography (2:1 Petroleum ether 40-60 °C:Ether) to give the title  compound 
as a yellow solid (355 mg, 0.78 mmol, 65 %).
Rf 0.35 (2:1 P:Et2 0 ).
Mp 126-128 °C
vmax (th in film , cm '1) 3432 s, 1642 s, 1520 m, 1352 w, 1183 w, 997 w.
8h (CDCI3, 300  MHz) 8.19 (d, J 8.7, 2H, PhH), 7.62 (d, J 8.7, 2H, PhH), 4.53 
(dd, J 10.2, 3.2, 1H, S0 2 CHCH2), 4.42 (t, J 9.1, 1H, S0 2CHCH2), 4.21 (dt, J 7.2,
3.2, 1H, S0 2 CH), 4.11 (d, J 7.0, 1H, S0 2 CHCH), 2.63 (s, 3H, CH3).
8 C (CDCI3, 75 MHz) (Aromatic peaks not observed due to 19F coupling). 148.8 
(PhC), 143.5 (PhC), 129.4 (PhCH), 124.7 (PhCH), 74.1 (CHS02), 73.3
(S02 CHCH), 67.3 (CH2), 43.2 (CH3).
LRMS (E I+ )  454 (M+, 90 % ), 207 (M+-C 6 H5 S03, 75 %), 161 (M+-C6 H5S03, N02, 
55 %), 133 (M+-C6 H50 2, PhN02, 35 % ), 116 (C4 H6 NOS, 100 %), 69 (C3 H3 NO, 6 6
%).
HRMS (E S +) MH+ Calcd for Ci6 Hi2 N2 0 6 F5S, 455.0336, found 455.0307. 
Elemental analysis: Anal, calcd for Ci6 HnN 2 0 6 F5S: C 42.30, H 2.44, N 6.17; 
found C 42.38, H 2.44, N 5.83.
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3 - ( 4 -M ethoxy-phenyl)-2 -m ethyl-isoxazolidine-4 -sulfonic acid penta­
fluorophenyl ester [1 0 7 ]
To pentafluorophenyl vinylsulfonate [80] (201 mg, 0.73 mmol) in dry toluene (5 
mL) was added C-(4-methoxyphenyl)-/V-methylnitrone [91] ( 1 . 2  eq., 145 mg, 
0.88 mmol) and the m ixture was heated to reflux for 1 hour. The reaction was 
concentrated in vacuo, and the crude residue was purified by flash column 
chromatography (2:1 Petroleum ether 40-60 °C:Ether) to give the title compound 
as a yellow solid (250 mg, 0.57 mmol, 78 %).
Rf 0.50 (2:1 P:Et2 0).
Mp 64-68 °C
Vmax (th in  film , cm '1) 3440 m, 2967 m, 2842 m, 1684 m, 1612 m, 1519 s, 1469 
m, 1392 s, 1305 m, 1392 s, 1305 m, 1251 s, 1181 s, 996 s.
8h (CDCI3, 300  MHz) 7.18 (d, J 8.7, 2H, PhH), 6.67 (d, J 8.7, 2H, PhH), 4.42 
(dd, J 10.4, 3.4, 1H, S 0 2 CHCH2), 4.32 (t, J 9.0, 1H, S 0 2CHCH2), 4.15 (dt, J 7.5, 
3.0, 1H, S0 2 CH), 3.81 (d, J 7.2, 1H, S0 2 CHCH), 3.60 (s, 3H, OCH3), 2.49 (s, 3H, 
NCH3).
8C (CDCI3/ 75 MHz) (Aromatic peaks not observed due to 19F coupling). 165.1 
(PhC), 160.6 (PhC), 132.3-114.8 (PhCH), 74.1 (CHS02), 67.1 (CH2), 55.6 
(S02CHCH), 42.8 (NCH3), 15.5 (OCH3).
LRMS (E I+ )  439 (M+, 95 % ), 165 (CH3 OPhCHNOCH3, 97 %), 147 
(CH3 OPhCHCHCH2, 100 % ), 135 (CH3 OPhCH2 N, 77 % ), 121 (CH3 OPhCH2, 40 %), 
77 (Ph, 50 %).
HRMS (E S +) MH+ Calcd for C17H15NO5F5S, 440.0591, found 440.0612.
3-Furan-2-yl-2-m ethyl-isoxazo lid ine-4-su lfon ic acid pentafluorophenyl 
ester [1 0 8 ]
To pentafluorophenyl vinylsulfonate [80 ] (164 mg, 0.60 mmol) in dry toluene (10 
mL) was added C-(2-furyl)-/V-methylnitrone [96] (2.0 eq., 150 mg, 1.20 mmol) 
and the mixture was heated to reflux for 1 hour. The reaction was concentrated in 
vacuo, and the crude residue was purified by flash column chromatography (4:1 
Petroleum ether 40-60 °C:Ether) to give the title compound as a yellow oil (180 
mg, 0.45 mmol, 75 %).
Rf 0.50 (2:1 P:Et2 0).
Vmax (th in  film , cm '1) 2970 m, 2882 m, 1518 s, 1392 s, 1190 s, 997 s.
8h (CDCI3, 300 MHz) 7.30 (s, 1H, CHO), 6.29 (d, J 3.2, 1H, CHCHCHO), 6.16 
(dd, J 3.2, 1.9, 1H, CHCHO), 4.51 (dt, J 7.9, 3.2, 1H, S0 2CH), 4.38 (dd, J 10.2,
2.8, 1H, S0 2 CHCH2), 4.28 (d, J 8.7, 1H, S0 2CHCH), 3.91 (s, 1H, S0 2CHCH2),
2.54 (s, 3H, CH3).
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Sc (CDCI3 , 75 M Hz) (Aromatic peaks not observed due to 19F coupling). 147.2 
(CO), 144.3 (CHO), 111.4 (CHCO), 111.1 (CHCHO), 70.1 (CHS02), 67.9 
(CHCHSO2 ), 67.1 (CH2), 43.1 (CH3).
LRMS (E I+ )  399 (M+, H, 90 % ), 353 (M+-CH 3 NO, H, 20 %), 150 (C8 H8 N02, 30 
%), 125 (C6 H7 N02, 95 % ), 107 (C7 H7 O, 100 %), 79 (C5 H3 0, 45 %), 42 (CNO, 45 
%).
HRMS (E S +) MH+ Calcd for C1 4 HUNO4 F5 S, 400.0278, found 400.0262.
3-(3-C hloro-phenyl)-2-m ethyl-isoxazo lid ine-4-su lfon ic  acid pentafluoro- 
phenyi ester [1 0 9 ]
To pentafluorophenyl vinylsulfonate [80] (606 mg, 2.21 mmol) in dry toluene (5 
mL) was added C-(3-chlorophenyl)-/V-methylnitrone [ 8 8 ] (1.5 eq., 562 mg, 3.32 
mmol) and the m ixture was heated to reflux for 6  hours. The reaction was 
concentrated in vacuo, and the crude residue was purified by flash column 
chromatography (20:1 Petroleum ether 40-60 °C:Ether) to give the title 
compound as a pale orange oil (649 mg, 1.46 mmol, 6 6  %).
Rf 0.40 (3:1 P:Et20 ).
Vmax (th in film , cm"1) 3275 w, 2880 m, 1736 m, 1517 m, 1395 m, 1184 m, 995 
m.
SH (CDCI3 , 300  MHz) 7.52 (s, 1H, PhH), 7.41-7.30 (m, 3H, PhH), 4.62 (dd, J
10.2, 3.0, 1H, S0 2 CHCH2), 4.49 (t, J 7.9, 1H, S0 2CHCH2), 4.31 (dt, J 7.5, 3.2, 
1H, S0 2 CH), 4.08 (d, J 7.0, 1H, S0 2 CHCH), 2.69 (s, 3H, CH3).
8 C (CDCI3/ 75 MHz) (Aromatic peaks not observed due to 19F coupling). 138.2 
(PhC), 135.4 (PhC), 130.8-126.8 (PhCH), 74.1 (CHS02), 73.7 (S0 2CHCH), 67.2 
(CH2), 43.0 (CH3).
LRMS (E I+ )  443 (M+, 3 5 CI, 90 % ), 196 (M+-C6 F5 S03, 75 %), 168 (CIPhC3 H50, 65 
%), 151 (CIPhCHCHCH2, 85 % ), 115 (PhC3 H3, 80 % ), 102 (PhCHCH, 22 %), 85 
(M+-C6 F5S03, CIPh, 65 % ), 42 (CNO, 100 %).
HRMS (E S +) MH+ Calcd for C i6 H i2 N0 4 F5 SCI, 444.0096, found 444.0083.
3 - ( 2 - F lu o r o -p h e n y l ) - 2 - m e th y l - is o x a z o l id in e -4 -s u l fo n ic  ac id  p e n ta f lu o ro ­
p h e n y l e s te r  [ 1 1 0 ]
To pentafluorophenyl vinylsulfonate [80] (598 mg, 2.18 mmol) in dry toluene (5 
mL) was added C-(2 -fluorophenyl)-/V-methylnitrone [87] (1.5 eq., 501 mg, 3.27 
mmol) and the m ixture was heated to reflux for 6  hours. The reaction was 
concentrated in vacuo, and the crude residue was purified by flash column 
chromatography (2:1 Petroleum ether 40-60 °C:Ether) to give the title  compound 
as a pale brown oil (429 mg, 1.00 mmol, 46 %).
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Rf 0.50 (3:1 P:Et20 ).
Vmax (th in  film , cm '1) 2969 m, 2882 m, 1736 m, 1590 m, 1520 s, 1520 s, 1395 
s, 1186 s, 998 s.
8 h (CDCI3, 300 MHz) 7.50-7.03 (m, 4H, PhH), 4.64 (m, 1H, S0 2CH), 4.55 (m, 
2H, S02 CHCH2), 4.34 (s, 1H, S 0 2CHCH), 2.69 (s, 3H, CH3).
8 C (CDCI3, 75 MHz) (Aromatic peaks not observed due to 19F coupling). 163.2 
(PhC), 159.9 (PhC), 131.5-116.6 (PhCH), 72.6 (CHS02), 68.9 (S0 2 CHCH), 67.3 
(CH2), 43.1 (CH3).
LRMS (E I+ )  427 (M+, 90 % ), 180 (M+-C 6 H5S03, 75 %), 135 (FPhCHCHCH2, 100 
%), 109 (FPhCH2, 70 % ), 84 (C4 H6 NO, 50 %), 49 (NO, F, 65 %).
HRMS (E S +) MNa+ Calcd for C i6 HnN 0 4 F6 SNa, 450.0211, found 450.0213.
2-M ethyl-3-pentyl-isoxazolid ine-4-sulfonic  acid pentafluorophenyl ester 
[111]
To pentafluorophenyl vinylsulfonate [80] (520 mg, 1.90 mmol) in dry toluene (5 
mL) was added C-(pentyl)-/V-methylnitrone [103] (1.5 eq., 367 mg, 2.85 mmol) 
and the mixture was heated to reflux for 2 hours. The reaction was concentrated 
in vacuo, and the crude residue was purified by flash column chromatography 
(4:1 Petroleum ether 40-60 °C:Ethyl acetate) to give the title  compound as a 
yellow oil (508 mg, 1.26 mmol, 6 6  %).
Rf 0.75 (2:1 P:EtOAc).
Vmax (th in  film , cm-1) 3400 w, 2931 m, 1775 m, 1519 m, 1390 m, 1184 m, 997 
m.
8 h (CDCI3, 300  MHz) 4.61-4.53 (m, 1H, S0 2CHCH2), 4.45-4.38 (m, 1H, 
S02CHCH2), 4.25-4.15 (m, 1H, S 0 2 CH), 3.40 (s, 1H, S0 2CHCH), 2.82 (s, 3H, 
NCH3), 1.59-1.47 (m, 2H, CH2 CHNCH3), 1.39-1.19 (m, 6 H, CH3 CH2, CH3CH2 CH2, 
CH2 CH2CHNCH3), 0.82 (s, 3H, CH2 CH3).
8 C (CDCI3, 75 MHz) (Aromatic peaks not observed due to 19F coupling). 71.5 
(CHS02), 70.1 (S 0 2 CHCH), 66.7 (S 0 2CHCH2), 61.4 (CH2 CHNCH3), 43.9 (NCH3), 
32.2 (CH2CH2 CHNCH3), 25.8 (CH3CH2 CH2), 22.8 (CH3 CH2), 13.9 (CH3 CH2).
LRMS (E I+ )  403 (M+, 60 % ), 332 (M+-C5 Hn , 100 %), 156 (C9 Hi8 NO, 55 %), 135 
(C8 H9 NO, 75 % ), 109 (C5 HuC3 H2, 53 %), 85 (C5 Hn CH2, 93 %), 42 (CNO, 52 %). 
HRMS (E S +) MH+ Calcd for C i5 Hi9 N04 F5 S, 404.0955, found 404.0945.
3 -C y c lo h e x y l-2 -m e th y l- is o x a z o l id in e -4 -s u lfo n ic  a c id  p e n ta f lu o ro p h e n y l  
e s te r  [ 1 1 2 ]
To pentafluorophenyl vinylsulfonate [80] (450 mg, 1.64 mmol) in dry toluene (5 
mL) was added C-cyclohexyl-/V-methylnitrone [98] (2.0 eq., 460 mg, 3.28 mmol)
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and the mixture was heated to reflux for 2 hours. The reaction was concentrated 
in vacuo, and the crude residue was purified by flash column chromatography 
(6:1 Petroleum ether 40-60 °C:Ether) to give the title  compound as a brown oil 
(370 mg, 0.89 mmol, 54 %).
Rf 0.50 (2:1 P:Et20 ).
Vmax (th in  film , cm*1) 2930 s, 1519 s, 1388 m, 1158 m, 997 s.
5h (CDCI3, 300  MHz) 4.60-4.50 (m, 1H, S0 2CH), 4.32-4.11 (m, 2H, S02CH2), 
3.25-3.18 (m, 1H, S 0 2 CHCH), 2.78 (s, 3H, CH3), 1.81-1.47 (m, 6 H, CH2), 1.20- 
0.94 (m, 5H, CH2, CH).
8 c (CDCI3, 75 M Hz) (Aromatic peaks not observed due to 19F coupling). 73.2 
(CHS02), 67.6 (S 0 2 CHCH), 65.7 (S0 2 CHCH2), 44.1 (CH3), 40.4 (CHCHN), 28.9-
24.0 (CH2).
LRMS (E I+ )  415 (M+, 35 %), 332 (M+-C6 Hn , 95 % ), 184 (C6 F5OH, 65 %), 85 
(CHCHCH2ONCH3, 100 % ), 41 (CH2CHCH2, 55 %).
HRMS (E S +) MH+ Calcd for Ci6 H i9 N0 4 F5 S, 416.0949, found 416.0948.
2-M ethyl-3-naphthalen-2-yl-isoxazolid ine-4-sulfonic acid pentafluoro­
phenyl ester [1 1 3 ]
To pentafluorophenyl vinylsulfonate [80] (375 mg, 1.37 mmol) in dry toluene (5 
mL) was added C-(2-naphthyl)-/V-methylnitrone [97] (1.5 eq., 380 mg, 2.05 
mmol) and the m ixture was heated to reflux for 6  hours. The reaction was 
concentrated in vacuo, and the crude residue was purified by flash column 
chromatography (10:1 Petroleum ether 40-60 °C:Ethyl acetate) to give the title 
compound as a yellow solid (406 mg, 0.88 mmol, 65 %).
Rf 0.40 (3:1 P:Et2 0 ).
Mp 91-97 °C
Vmax (th in film , cm*1) 3432 bs, 2091 w, 1646 s, 1522 s, 1395 m, 1184 m, 996 s. 
8h (CDCI3, 300  M Hz) 8.06-7.81 (m, 4H, PhH), 7.65-7.48 (m, 3H, PhH), 4.68-
4.55 (m, 2H, CH2), 4.48 (dt, J 7.7, 3.0, 1H, S0 2 CH), 4.30 (d, J 6 .8 , 1H, 
S02CHCH), 2.79 (s, 3H, CH3).
5C (CDCI3, 75 MHz) (Aromatic peaks not observed due to 19F coupling). 136.9-
125.1 (PhCH), 74.7 (S 0 2 CH), 74.1 (S 0 2 CHCH), 67.4 (CH2), 43.1 (CH3).
LRMS (E I + ) 459 (M+, 30 % ), 184 (C6 F5OH, 80 %), 155 (M+-Ci0 H7/ 100 %), 127 
(C1 0H7, 95 %).
HRMS (E S +) MH+ Calcd for C2 oHi4 N0 4 F5S, 459.0558, found 459.0561.
Elemental analysis: Anal, calcd for Q 0 H1 4 NO4 F5 S: C 52.29, H 3.07, N 3.05; 
found C 52.20, H 2.99, N 2.92.
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3-Cyclopropyl-2-methyl-isoxazolidine-4-sulfonic acid pentafluorophenyl 
ester [114]
To pentafluorophenyl vinylsulfonate [80] (213 mg, 0.78 mmol) in dry toluene (5 
mL) was added C-cyclopropyl-/V-methylnitrone [99] (1.5 eq., 115 mg, 1.17 
mmol) and the m ixture was heated to reflux for 2 hours. The reaction was 
concentrated in vacuo, and the crude residue was purified by flash column 
chromatography (2:1 Petroleum ether 40-60 °C: Ether) to give the title  compound 
as a pale yellow oil (156 mg, 0.42 mmol, 54 %).
Rf 0.40 (2:1 P:Et2 0 ).
Vmax (th in  film , cm ’1) 3011 m, 2881 s, 2463 w, 1651 w, 1520 s, 1471 m, 1387 
s, 1185 s, 997 s.
§H (CDCI3, 300  MHz) 4.40 (d, J 6 .6 , 1H, S0 2CHCH), 4.31-4.20 (m, 2H, 
S02 CHCH2), 2.79 (s, 3H, CH3), 1.02-0.90 (m, 1H, CHCH2 CH2), 0.73-0.52 (m, 3H, 
CH2 CH2), 0.41-0.31 (m, 1H, CH2).
8C (CDCI3, 75 M Hz) (Aromatic peaks not observed due to 19F coupling). 72.2 
(CHS02), 69.8 (S 0 2CHCH), 64.5 (S 0 2CHCH2), 42.0 (CH3), 10.9 (CH2 CH2 CH), 2.6 
(CH2CH2), 0.0 (CH2 CH2).
LRMS (E I+ )  373 (M+, 95 % ), 332 (M +-C3H5, 35 % ), 184 (C6F5OH, 15 %), 126 
(M+-C6F5S03, 40 % ), 99 (C5H9NO, 37 %), 85 (C4H7NO, 82 %), 49 (SO, H, 100 
%).
HRMS (E S +) MH+ Calcd for Ci3 Hi3 N04 F5 S, 374.0480, found 374.0478.
3-(4-A lly loxy-phenyl)-2-m ethyl-isoxazolid ine-4-sulfonic  acid penta­
fluorophenyl ester [1 1 5 ]
To pentafluorophenyl vinylsulfonate [80] (725 mg, 2.65 mmol) in dry toluene (10 
mL) was added C-(4 -allyloxyphenyl)-/V-methylnitrone [104] (1.1 eq., 556 mg, 
2.91 mmol) and the m ixture was heated to reflux for 1 hour. The reaction was 
concentrated in vacuo, and the crude residue was purified by flash column 
chromatography (4:1 Petroleum ether 40-60 °C:Ether) to give the title  compound 
as a yellow oil (1.09 g, 2.34 mmol, 8 8  %).
Rf 0.45 (2:1 P:Et20 ).
Vmax (thin film , cm '1) 2967 m, 2878 m, 1692 m, 1601 m, 1520 s, 1392 s, 1247 
s, 996 s.
5 h  (CDCI3, 300  M Hz) 7.22 ( d ,  J 8.9, 2H, PhH), 6.77 ( d ,  J 8.9, 2H, PhH), 5.99- 
5.86 (m, 1H, CHCH2 0 ), 5.31-5.10 (m, 2H, CH2 0 ), 4.52-4.31 (m, 4H, S0 2CHCH2, 
CH2 CHCH20 ), 4.15 ( d t ,  J 4.9, 3.0, 1H, S0 2 CH), 3.86 ( d ,  J 6 .8 , 1H, S02 CHCH), 
2.51 (s, 3H, CH3).
90
Experimental Data
8 C (CDCI3, 75  MHz) (Aromatic peaks not observed due to 19F coupling). 164.0 
(PhC), 159.6 (PhC), 133.4 (CHCH2 0 ), 132.7-129.6 (PhCH), 127.8 (PhC), 118.2 
(CH2 CHCH2 0 ), 115.6 (PhCH), 115.4 (PhCH), 74.1 (CHS02), 69.2 (CH2 0), 67.1 
(SO2 CHCH2 ), 53.8 (CHCHSO2 ), 42.9 (CH3).
LRMS (E I+ )  465 (M+, 50 % ), 191 (M+-C6 F5S03, C2 H3, 80 % ), 162 (M+-C6 F5S03, 
C3 H4 0, 70 % ), 120 (PhOCH2 CH2, 42 % ), 105 (PhOCH, 47 % ), 79 (C5H5 N, 55 %), 
41 (C3 H5, 1 0 0  %).
HRMS (E S +) MH+ Calcd for C19H17NO5F5S, 466.0748, found 466.0727.
3-(5-Bromo-furan-2-yl)-2-methyl-isoxazolidine-4-sulfonic acid penta­
fluorophenyl ester [116]
To pentafluorophenyl vinylsulfonate [80] (172 mg, 0.63 mmol) in dry toluene (5 
mL) was added C-(5-bromo-2-furyl)-/V-methylnitrone [95] ( 1 . 2  eq., 154 mg, 0.75 
mmol) and the m ixture was heated to  reflux for 4 hours. The reaction was 
concentrated in vacuo, and the crude residue was purified by flash column 
chromatography (20:1 Petroleum ether 40-60 °C:Ethyl acetate) to give the title 
compound as a yellow oil (166 mg, 0.35 mmol, 55 %).
Rf 0.50 (2:1 P:Et2 0 ).
vmax (th in film , cm"1) 3140 w, 2971 m, 2882 m, 1651 w, 1471 m, 1394 s, 1189 
s, 1122 m, 996 s.
SH (CDCI3, 300  MHz) 6.40 (d, J 3.3, 1H, CHCO), 6.24 (d, J 3.3, 1H, CHCBr),
4.63-4.57 (m, 1 H, CHS02), 4.53-4.37 (m, 2 H, S0 2 CHCH2), 4.03 (bs, 1 H, 
SO2CHCH), 2.69 (s, 3H, CH3).
8 C (CDCI3, 75 MHz) (Aromatic peaks not observed due to 19F coupling). 149.1 
(CO), 124.1 (CBr), 114.2 (CHCBr), 113.0 (CHCO), 70.0 (CHS02), 67.8 
(CHCHSO2 ), 67.1 (CH2), 43.2 (CH3).
LRMS (E I+ )  479 (M+, H, 70 % ), 433 (M+-CH3NOH, 35 % ), 203 (M+-C6F5S03, 
NCH3, 90 % ), 184 (C6F5OH, 75 % ), 117 (C4H7NOS, 17 %), 84 (C4H6NO, 100 %). 
HRMS (E S +) MH+ Calcd fo r C i4H i0NO5F5SBr, 477.9383, found 477.9378.
3-(3-B rom o-phenyl)-2-m ethyl-isoxazo lid ine-4-su lfon ic  acid pentafluoro­
phenyl ester [1 1 7 ]
To pentafluorophenyl vinylsulfonate [80] (1.25 g, 4.56 mmol) in dry toluene (10 
mL) was added C-(3 -bromophenyl)-/V-methylnitrone [92] (1.2 eq., 1.17 g, 5.47 
mmol) and the m ixture was heated to reflux for 1 hour. The reaction was 
concentrated in vacuo, and the crude residue was purified by flash column 
chromatography (8:1 Petroleum ether 40-60 °C:Ether) to give the title  compound 
as a yellow oil (1.34 g, 2.74 mmol, 60 %).
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Rf 0.55 (2:1 P:Et2 0 ).
Vmax (th in  film , cm -1) 2966 m, 2928 m, 2879 m, 1572 m, 1520 s, 1474 m, 1394 
s, 1184 s, 998 s, 792 m.
SH(CDCI3, 300  M Hz) 7.62-7.19 (m, 4H, PhH), 4.62-4.52 (m, 1H, S0 2CH), 4.50- 
4.38 (m, 1H, S 0 2 CHCH2), 4.30-4.20 (m, 1H, S0 2 CHCH2), 4.01 (bs, 1H, 
S02 CHCH), 2.70 (s, 3H, CH3).
6 C (CDCI3, 75 MHz) (Aromatic peaks not observed due to 19F coupling). 138.4 
(PhC), 132.8-127.3 (PhCH), 123.5 (PhC), 74.1 (CHS02), 73.6 (S0 2 CHCH), 67.2 
(CH2), 43.1 (CH3).
LRMS (E I+ )  489 (M+, 8 1 Br, 78 % ), 487 (M+, 7 9 Br, 77 %), 240 (Ci0 HuNO7 9 Br, 67 
%), 212 (C8 H7 N07 9 Br, 47 % ), 197 (C7 H4 N07 9 Br, 36 %), 183 (C6 F50 , 42 %), 155 
(C6 H4 7 9 Br, 49 % ), 116 (C9 H8, 100 % ), 102 (C3 H4 NOS, 33 %), 85 (C4 H7 NO, 46 %), 
42 (CNO, 54 %).
HRMS (E S +) MH+ Calcd for C i6 H1 2 N04 F5 SBr, 487.9591, found 487.9610.
3.4.3 Am ino lys is procedures fo r isoxazolid ine su lfonate  esters 6 6
2-M ethyl-3-phenyl-isoxazolid ine-4-sulfonic acid 4-m ethyl-benzylam ide  
[122]
To 2-methy!-3-phenyl-isoxazolidine-4-sulfonic acid pentafluorophenyl ester [105] 
(94 mg, 0.23 mmol) in dry tetrahydrofuran (5 mL) was added 4- 
methylbenzylamine (3.0 eq., 0.09 mL, 0.69 mmol) followed by DBU (1.4 eq., 
0.05 mL, 0.33 mmol), and the mixture was refluxed for 2 hours. The reaction was 
diluted with dichloromethane (20 mL) and washed with 2M HCI (2 x 20 mL), 
water (2 x 20 mL) and brine (2 x 20 mL). The organic phase was separated, dried 
(MgS04), filtered and the filtra te  concentrated in vacuo. The crude residue was 
purified by flash column chromatography (2:1 Petroleum ether 40-60 °C:Ethyl 
acetate) to give the title  compound as a yellow oil (58 mg, 0.17 mmol, 73 %).
Rf 0.50 (2:1 P:EtOAc).
Vmax (th in  film , cm-1) 3546 m, 3292 s, 2875 m, 2254 m, 1603 w, 1516 m, 1455 
m, 1328 s, 1149 s, 1043 m, 911 m.
SH (CDCI3, 300  MHz) 7.40-7.18 (m, 5H, PhH), 7.07-6.81 (m, 4H, CH3 PhH), 
4.42-4.33 (m, 1H, S0 2 CH), 4.20 (t, J 9.1, 1H, NH), 4.17-4.03 (m, 2H, 
S02 CHCH2), 4.00-3.90 (m, 1H, S0 2 CHCH), 3.85-3.65 (m, 2H, NHCH2), 2.50 (s, 
3H, NCH3), 2.20 (s, 3H, CH3).
8 C (CDCI3, 75 MHz) 138.3-133.5 (PhC), 129.8-128.4 (PhCH), 73.6 (CHS02),
6 8 . 8  (S0 2 CHCH), 67.2 (S 0 2 CHCH2), 47.5 (NHCH2), 43.1 (NCH3), 21.5 (PhCH3).
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LRMS (E I+ )  346 (M+, 15 %), 160 (M+-CH3 PhCH2 NHS02, 2H, 95 %), 134 
(PhCHCHCH2 0 , H, 75 % ), 117 (PhCHCHCH2, 100 % ), 91 (CH3 Ph, 65 %), 77 (Ph, 
45 %).
HRMS (E S +) MH+ Calcd for C iiH i7 N2 0 4 S, 347.1429, found 347.1423.
2-M ethyl-3-phenyl-isoxazolidine-4-sulfonic acid 4-m ethyl-benzaldehyde  
[133]
To 2-methyl-3-phenyl-isoxazolidine-4-sulfonic acid pentafluorophenyl ester [105] 
(105 mg, 0.26 mmol) in dry tetrahydrofuran (5 mL) was added phenylalanine 
ethyl ester (3.0 eq., 149 mg, 0.77 mmol) followed by DBU (1.3 eq., 0.05 mL, 
0.33 mmol), and the m ixture was refluxed for 2 hours. The reaction was diluted 
with dichloromethane (20 mL) and washed with 2M HCI (2 x 20 mL), water (2 x 
20 mL) and brine (2 x 20 mL). The organic phase was separated, dried (MgS04), 
filtered and the filtra te  concentrated in vacuo. The crude residue was purified by 
flash column chromatography (2:1 Petroleum ether 40-60 °C:Ethyl acetate) to 
give the title  compound as a yellow oil (63 mg, 0.15 mmol, 58 %).
Rf 0.65 (20:10:1 P:EtOAc:AcOH).
Vmax (th in  film , cm"1) 3274 s, 2929 s, 2255 w, 1738 s, 1604 w, 1455 m, 1331 
m.
SH (CDCI3, 300  MHz) 7.40-6.90 (m, 1 0 H, PhH), 5.10 (dd, J 24.5, 9.4, 1 H, 
S02CHCH2), 4.20-4.00 (m , 6 H, S0 2 CHCH2, NH, CH3CH2, PhCH2), 3.90-3.75 (m, 
1H, S0 2CH), 2.82 (d, J 6.2, 1H, S 0 2CHCH), 2.80-2.72 (m, 1H, NHCH), 2.53 (s, 
3H, NCH3), 1.09 (s, 3H, CH3).
8 C (CDCI3, 75 MHz) 137.4-135.3 (PhC), 129.7-127.8 (PhCH), 74.5 (CHS02),
76.6 (S0 2CHCH2), 62.5 (PhCH2), 58.0 (S0 2CHCH), 57.5 (NHCH), 43.1 (NCH3),
39.7 (CH3 CH2), 14.4 (CH3 CH2).
LRMS (E I + ) 418 (M+, 45 % ), 161 (PhC4 H6 NO, 100 %), 146 (PhC3 H3 NO, 30 %), 
134 (PhC2 H3 NO, 65 % ), 117 (PhCHCHN, 82 %), 91 (PhCH2, 80 %), 77 (Ph, 20
%).
HRMS (E S +) MH+ Calcd for C2 iH 2 7 N2 0 5 S, 419.1641, found 419.1635.
3 - F u r a n -2 -y l -2 -m e th y l- is o x a z o l id in e -4 -s u lfo n ic  a c id  a l ly la m id e  [ 1 2 5 ]
To 3 -furan-2 -y l- 2 -methyl-isoxazolidine-4 -sulfonic acid pentafluorophenyl ester 
[108] (97 mg, 0.24 mmol) in dry tetrahydrofuran (5 mL) was added allylamine 
(3.0 eq., 0.05 mL, 0.73 mmol) followed by DBU (1.4 eq., 0.05 mL, 0.33 mmol), 
and the mixture was refluxed for 2 hours. The reaction was diluted with 
dichloromethane (20 mL) and washed with 2M HCI (2 x 20 mL), water (2 x 20 
mL) and brine (2 x 20 mL). The organic phase was separated, dried (MgS04),
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filtered and the filtra te  concentrated in vacuo. The crude residue was purified by 
flash column chromatography ( 1 : 1  Petroleum ether 40-60 °C :Ethyl acetate) to 
give the title  compound as a yellow solid (52 mg, 0.19 mmol, 80 %).
Rf 0.25 (2:1 P:EtOAc).
Mp 56-61 °C
Vmax (th in  film , cm-1) 3432 s, 2095 m, 1645 s, 1438 w, 1322 s, 1248 w, 1150 s, 
1038 w.
5h (CDCI3, 300  MHz) 7.38 (s, 1H, CHO), 6.40 (d, J 3.2, 1 H, CHCHCHO), 6.32- 
6.29 (m, 1H, CHCHO), 5.60-5.42 (m, 1H, CHCH2 NH), 5.16-5.02 (m, 2H, NHCH2), 
4.80 (s, 1 H, NH), 4.35-4.20 (m, 3H, NHCH2CHCH2, S0 2 CHCH2), 3.85 (s, 1 H, 
NHCH2 CHCH2), 3.69-3.57 ( m, 1H, S0 2 CH), 3.49-3.35 ( m, 1H, S0 2 CHCH), 2.59 
(s, 3H, NCH3).
6 c (CDCI3, 75 M Hz) 148.8 (CO), 143.8 (CHO), 133.5 (CHCH2 NH), 118.4 
(CH2 CHCH2 NH), 111.2 (CHCO), 110.8 (CHCHO), 69.6 (CHS02), 68.2 (CHCHS02),
67.1 (S0 2 CHCH2), 46.2 (NHCH2), 43.3 (CH3).
LRMS (E I+ )  272 (M+, 15 % ), 150 (M+-C3 H8 N02 S, 100 %), 125 (C6 H7 N02, 75 %), 
107 (C6 H5 NO, 90 % ), 79 (C5 H3 0, 55 %), 57 (CHNOCH2, 75 %), 43 (CHNO, 95 
%).
HRMS (E S +) M H+ Calcd for C u H i7N20 4S, 273.0909, found 273.0903.
3-Furan-2-y l-2-m ethyl-isoxazo lid ine-4-su lfon ic  acid 4-m ethyl-benzyl- 
amide [1 1 8 ]
To 3-furan-2-yl-2~methyl-isoxazolidine-4-sulfonic acid pentafluorophenyl ester 
[108] (115 mg, 0.29 mmol) in dry tetrahydrofuran (5 mL) was added 4- 
methylbenzylamine (3.0 eq., 0.11 mL, 0.86 mmol) followed by DBU (1.1 eq., 
0.05 mL, 0.33 mmol), and the m ixture was refluxed for 2 hours. The reaction was 
diluted with dichloromethane (20 mL) and washed with 2M HCI (2 x 20 mL), 
water (2 x 20 mL) and brine (2 x 20 mL). The organic phase was separated, dried 
(MgS04), filtered and the filtra te  concentrated in vacuo. The crude residue was 
purified by flash column chromatography (2:1 Petroleum ether 40-60 °C:Ethyl 
acetate) to give the title  compound as a yellow oil (84 mg, 0.25 mmol, 8 6  %).
Rf 0.30 (2:1 P:EtOAc).
Vmax (th in  film , cm '1) 3550 w, 3291 s, 2877 s, 2255 w, 1732 m, 1616 m, 1516 
w, 1435 m, 1327 s, 1148 s.
8 h (CDCI3, 300  MHz) 7.07-6.90 (m, 5H, CH3 PhH, CHO), 6.30 (s, 2H, CHCHO, 
CHCHCHO), 4.95 (s, 1H, NH), 4.40-4.00 (m, 4H, S0 2 CHCH2, S0 2 CHCH, S0 2 CH), 
3.82 (d, J 13.8, 2H, NHCH2), 2.55 (s, 3H, NCH3), 2.21 (s, 3H, CH3).
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5C (CDCh, 75 M Hz) 148.9 (CO), 143.8 (CHO), 138.2 (PhC), 133.7 (PhC), 129.8 
(PhCH), 128.3 (PhCH), 111.2 (CHCO), 110.7 (CHCHO), 69.6 (CHS02), 68.1 
(CHCHSO2 ), 67.1 (S 0 2 CHCH2), 47.4 (NHCH2), 43.4 (NCH3), 21.4 (PhCH3).
LRMS (E I+ )  336 (M +, 15 %), 150 (M +-C8H i2N 0 2S, 60 %), 125 (C 6H7N 0 2, 30 %), 
107 (C 6H5NO, 45 % ), 84 (C 4H6NO, 75 %), 49 (SO , H, 100 %).
HRMS (E S +) MH+ Calcd for C i6 H2 iN 2 0 4 S, 337.1222, found 337.1209.
2-M ethyl-3 -(4 -n itro -phenyl)-isoxazo lid ine-4-su lfon ic  acid allylamide 
[131]
To 2-methyl-3-(4-nitro-phenyl)-isoxazolidine-4-sulfonic acid pentafluorophenyl 
ester [106] (151 mg, 0.33 mmol) in dry tetrahydrofuran (5 mL) was added 
allylamine (3.0 eq., 0.07 mL, 1.00 mmol) followed by DBU (1.0 eq., 0.05 mL, 
0.33 mmol), and the m ixture was refluxed for 1 hour. The reaction was diluted 
with dichloromethane (20 mL) and washed with 2M HCI (2 x 20 mL), water (2 x 
20 mL) and brine (2 x 20 mL). The organic phase was separated, dried (MgS04), 
filtered and the filtra te  concentrated in vacuo. The crude residue was purified by 
flash column chromatography (1:1 Petroleum ether 40-60 °C:Ethyl acetate) to 
give the title  compound as a yellow solid (51 mg, 0.15 mmol, 47 %).
Rf 0.40 (2:1 P:EtOAc).
Mp 148-153 °C
Vmax ( th in  f i lm , c m -1)  3432 s, 2098 w, 1643 s, 1522 w, 1350 w, 1149 w.
SH (CDCI3, 300  M Hz) 8.18 (d, J 8.7, 2H, PhH), 7.61 (d, J 8.7, 2H, PhH), 5.72-
5.59 (m, 1H, NHCH2 CH), 5.10 (t, J 13.2, 2H, NHCH2), 4.68-4.59 (m, 1H, 
NHCH2CHCH2), 4.32-4.24 (m, 2H, S 0 2 CHCH2), 4.02-3.85 (m, 2H, S0 2CH, NH),
3.60 (d, J 3.2, 2H, S0 2 CHCH, NHCH2 CHCH2), 2.60 (s, 3H, NCH3).
5C (CDCI3, 75 MHz) 148.4 (PhC), 145.4 (PhC), 133.5 (CHCH2 NH), 129.4 (PhCH),
124.5 (PhCH), 118.7 (CH2 CHCH2 NH), 74.5 (CHS02), 73.4 (S0 2CHCH), 67.5 
(S02 CHCH2), 46.4 (NHCH2), 43.4 (CH3).
LRMS (E I+ )  327 (M+, 15 % ), 205 (N 0 2 PhC4 H5 N0, 100 % ), 179 (N0 2 PhC2 H3 N0, 
25 %), 116 (C4 H6 NOS, 60 %).
HRMS (E S +) MH+ Calcd for C i3 Hi8 N3 0 5S, 328.0967, found 328.0964.
2 -M e t h y l -3 - ( 4 -n i t r o -p h e n y l ) - is o x a z o l id in e -4 -s u l fo n ic  a c id  4 -m e th y l-  
b e n z y la m id e  [ 1 2 8 ]
To 2 -m ethyl-3 -( 4 -nitro-phenyl)-isoxazolidine-4 -sulfonic acid pentafluorophenyl 
ester [106] (155 mg, 0.34 mmol) in dry tetrahydrofuran (5 mL) was added 4- 
methylbenzylamine (3.0 eq., 0.13 mL, 1.02 mmol) followed by DBU (1.0 eq., 
0.05 mL, 0.34 mmol), and the m ixture was refluxed for 1 hour. The reaction was
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diluted with dichloromethane (20 mL) and washed with 2M HCI (2 x 20 mL), 
water (2 x 20 mL) and brine (2 x 20 mL). The organic phase was separated, dried 
(MgSO^, filtered and the filtra te  concentrated in vacuo. The crude residue was 
purified by flash column chromatography (2:1 Petroleum ether 40-60 °C:Ethyl 
acetate) to give the title  compound as a yellow solid (67 mg, 0.17 mmol, 50 %). 
Rf 0.50 (2:1 P:EtOAc).
Mp 146-150 °C
Vmax (th in  film , cm '1) 3436 s, 1641 s, 1521 m, 1349 m, 1148 m, 1042 w.
8 h (CDCI3, 300  M Hz) 8.10 (d, J 8.9, 2H, PhH), 7.50 (d, J 8.7, 2H, PhH), 7.02- 
6.90 (m, 4H, CH3 PhH), 4.28 (dd, J 9.8, 3.8, 1H, S0 2 CHCH2), 4.18-4.07 (m, 4H, 
S02CHCH2, NH, S0 2 CH, S0 2 CHCH), 3.90 (d, J 6 .8 , 1H, NHCH2), 3.65 (dt, J 8.1,
3.8, 1H, NHCH2), 2.52 (s, 3H, NCH3), 2.20 (s, 3H, CH3).
5C (CDCI3, 75 M Hz) 148.3-133.6 (PhC), 129.9-124.4 (PhCH), 74.4 (CHS02),
73.3 (S0 2CHCH), 67.5 (S 0 2 CHCH2), 47.5 (NHCH2), 43.3 (NCH3), 21.5 (PhCH3). 
LRMS (E I+ )  391 (M+, 10 % ), 205 (M+-CH3 PhCH2 NHS02, 2 H, 100 %), 120 
(CH3 PhCH2 NH, 87 % ), 105 (CH3 PhCH2, 100 % ), 91 (CH3 Ph, 32 %), 69 (C3 H3 NO, 
60 %), 57 (C2 H3 NO, 35 % ), 43 (C2 H3 0, 30 %).
HRMS (E S +) MH+ Calcd for C i8 H2 2 N3 0 5S, 392.1280, found 392.1269.
3-(4-M ethoxy-phenyl)-2 -m ethyl-isoxazo lid ine-4-su lfon ic  acid allylamide 
[126]
To 3-(4-m ethoxy-phenyl)-2-m ethyl-isoxazolidine-4-sulfonic acid pentafluoro­
phenyl ester [107] (145 mg, 0.33 mmol) in dry tetrahydrofuran (5 mL) was 
added allylamine (3.0 eq., 0.07 mL, 0.99 mmol) followed by DBU (1.0 eq., 0.05 
mL, 0.33 mmol), and the m ixture was refluxed for 1 hour. The reaction was 
diluted with dichloromethane (20 mL) and washed with 2M HCI (2 x 20 mL), 
water (2 x 20 mL) and brine (2 x 20 mL). The organic phase was separated, dried 
(MgS04), filtered and the filtra te  concentrated in vacuo. The crude residue was 
purified by flash column chromatography (2:1 Petroleum ether 40-60 °C:Ethyl 
acetate) to  give the title  compound as a yellow oil (84 mg, 0.27 mmol, 81 %).
Rf 0.30 (2:1 P:EtOAc).
vmax (th in  film , cm '1) 3293 s, 2875 s, 1612 s, 1515 s, 1440 m, 1326 s, 1250 s, 
1178 m, 1149 s, 1033 s, 923 m, 838 s.
8 h (CDCI3, 300  M H z) 7.30 (d, J 8.7, 2H, PhH), 6.82 (d, J 8.7, 2H, PhH), 5.63- 
5.40 (m, 1H, NHCH2 CH), 5.12-5.02 (m, 2H, NHCH2), 4.75 (t, J 5.9, 1 H, NH), 
4.37-4.25 (m, 2H, S 0 2 CHCH2), 4.00-3.90 (m, 1H, S0 2 CH), 3.74 (s, 3H, OCH3), 
3.57-3.20 (m, 3H, SQ2 CHCH, NHCH2 CHCH2), 2.51 (s, 3H, NCH3).
96
Experimental Data
8 C (CDCI3/ 75 M Hz) 160.3 (PhC), 133.6 (CHCH2 NH), 130.9 (PhCH), 129.8 
(PhCH), 128.8 (PhC), 118.3 (CH2 CHCH2 NH), 114.3 (PhCH), 73.4 (CHS02), 67.1 
(S0 2 CHCH2), 55.7 (CHCHS02), 46.1 (NHCH2), 43.0 (NCH3), 14.6 (OCH3).
LRMS (E I+ )  312 (M+, 45 % ), 190 (M+-CH3 OPhCH3, 100 %), 165 (C9 Hn N02, 90 
%), 147 (CH3 OPhCHCHN, 95 %), 91 (OPh, 25 %), 41 (CH2 CHCH2, 25 %).
HRMS (E S +) MH+ Calcd for C i4 H2 iN 2 0 4 S, 313.1222, found 313.1217.
3-(4-M ethoxy-phenyl)-2-m ethyl-isoxazo lid ine-4--su lfonic acid 4-m ethyl- 
benzylamide [1 2 3 ]
To 3-(4-methoxy-phenyl)-2-methyl-isoxazolidine-4-sulfonic acid pentafluoro­
phenyl ester [107] (136 mg, 0.31 mmol) in dry tetrahydrofuran (5 mL) was 
added 4-methylbenzylamine (3.0 eq., 0.12 mL, 0.93 mmol) followed by DBU (1.1 
eq., 0.05 mL, 0.33 mmol), and the mixture was refluxed for 1 hour. The reaction 
was diluted with dichloromethane (20 mL) and washed with 2M HCI (2 x 20 mL), 
water (2 x 20 mL) and brine (2 x 20 mL). The organic phase was separated, dried 
(MgS04), filtered and the filtra te  concentrated in vacuo. The crude residue was 
purified by flash column chromatography (1:1 Petroleum ether 40-60 °C:Ethyl 
acetate) to give the title  compound as a colourless oil (107 mg, 0.28 mmol, 91 
%).
Rf 0.45 (2:1 P:EtOAc).
Vmax (th in film , cm '1) 3307 m, 2923 m, 1614 m, 1515 m, 1456 m, 1149 w. 
8h (CDCI3, 300  MHz) 7.08-6.72 (m, 8 H, PhH), 4.35-4.25 (m, 1 H, S0 2CH), 4.20 
(t, J 8.3, 1H, NH), 4.10-4.00 (m, 3H, S0 2 CHCH2, S0 2 CHCH), 3.92-3.82 (m, 2H, 
NHCH2), 3.72 (s, 3H, OCH3  ), 2.48 (s, 3H, NCH3), 2.22 (s, 3H, CH3).
8 C (CDCI3, 75 MHz) 171.6-133.7 (PhC), 130.9-114.3 (PhCH), 73.3 (CHS02),
67.0 (S0 2CHCH2), 55.7 (CHCHS02), 47.4 (NHCH2), 42.9 (NCH3), 21.5 (PhCH3),
14.6 (OCH3).
LRMS (E I+ )  376 (M+, 15 %), 190 (CH3 OPhC4 H5 NO, 89 %), 165
(CH3OPhCHNOCH3, 75 % ), 147 (CH3 OPhCHCHCH2, 100 %), 120 (CH3 PhCH2 NH, 62 
%), 105 (CH3 PhCH2, 70 %), 91 (CH3 Ph, 30 % ), 77 (Ph, 20 %).
HRMS (E S + ) MH+ Calcd for C i9 H2 4 N2 0 4 S, 377.1535, found 377.1535.
3 -(2 -F lu o ro -p h e n y l) -2 -m e th y l- is o x a z o lid in e -4 -s u lfo n ic  acid  4 -m e th y l-  
b e n zy la m id e  [1 2 4 ]
To 3 - ( 2 -fluoro-phenyl)-2 -methyl-isoxazolidine-4 -sulfonic acid pentafluorophenyl 
ester [110] (143 mg, 0.33 mmol) in dry tetrahydrofuran (5 mL) was added 4- 
methylbenzylamine (3.0 eq., 0.13 mL, 1.00 mmol) followed by DBU (1.0 eq., 
0.05 mL, 0.33 mmol), and the m ixture was refluxed for 3 hours. The reaction was
97
Experimental Data
diluted with dichloromethane (20 mL) and washed with 2M HCI (2 x 20 mL), 
water (2 x 20 mL) and brine (2 x 20 mL). The organic phase was separated, dried 
(MgS04), filtered and the filtrate concentrated in vacuo. The crude residue was 
purified by flash column chromatography (2:1 Petroleum ether 40-60 °C:Ethyl 
acetate) to give the title  compound as a colourless oil ( 7 3  mg, 0 . 2 0  mmol, 61 %). 
Rf 0.55 ( 2 : 1  P:EtOAc).
Vmax (th in film , cm-1) 3546 w, 3293 s, 2877 m, 1733 w, 1587 m, 1517 m, 1493 
m, 1329 m, 1148 m, 1044 m.
8h(CDCI3/ 3 00  MHz) 7.35-6.80 (m, 8 H, PhH), 4.34-4.23 (m, 1H, S0 2CH), 4.19 
(t, J 8.1, 1 H, NH), 4.12-4.05 (m, 2H, S0 2CHCH2), 3.98-3.85 (m, 3 H, NHCH2, 
S02CHCH), 2.50 (s, 3H, NCH3), 2.20 (s, 3H, PhCH3).
8 C (CDCI3, 75 MHz) 163.1-133.7 (PhC), 129.8-116.3 (PhCH), 72.5 (CHS02),
68.5 (S0 2 CHCH), 67.6 (CH2 CHS02), 47.4 (NHCH2), 43.2 (NCH3), 21.5 (PhCH3). 
LRMS (E I+ )  364 (M+, 15 % ), 178 (M+-FPh, CH3 Ph, 100 %), 135 (CH3 PhCH2 NH, 
CH3, 85 % ), 120 (CH3 PhCH2 NH, 75 % ), 105 (CH3 PhCH2, 85 % ), 91 (CHNS02, 30 
%), 42 (CH3 NCH, 30 %).
HRMS (E S + ) MH+ Calcd for C1 8 H2 2 N2 0 3 S, 365.1335, found 365.1322.
3-(3-C hloro-phenyl)-2 -m ethyl-isoxazo lid ine-4-su lfon ic  acid allylamide 
[135]
To 3-(3-chloro-phenyl)-2-methyl-isoxazolidine-4-sulfonic acid pentafluorophenyl 
ester [109] (154 mg, 0.35 mmol) in dry tetrahydrofuran (5 mL) was added 
allylamine (3.0 eq., 0.08 mL, 1.04 mmol) followed by DBU (1.0 eq., 0.05 mL, 
0.35 mmol), and the m ixture was refluxed for 2 hours. The reaction was diluted 
with dichloromethane (20 mL) and washed with 2M HCI (2 x 20 mL), water (2 x 
20 mL) and brine (2 x 20 mL). The organic phase was separated, dried (MgS04), 
filtered and the filtra te  concentrated in vacuo. The crude residue was purified by 
flash column chromatography (2:1 Petroleum ether 40-60 °C:Ethyl acetate) to 
give the title  compound as a colourless oil (64 mg, 0.20 mmol, 58 %).
Rf 0.45 (2:1 P:EtOAc).
Vmax (th in film , cm '1) 3302 s, 2875 m, 1709 w, 1646 w, 1575 m, 1519 m, 1434 
m, 1323 s, 1149 m.
8h (CDCI3, 300  MHz) 7.40 (s, 1H, PhH), 7.30-7.15 (m, 3H, PhH), 5.60-5.45 (m, 
1H, NHCH2CH), 5.14-5.02 (m, 2H, NHCH2), 4.61 (t, J 6.2, 1H, NH), 4.35-4.20 
(m, 2H, S0 2 CHCH2), 3.90 (dt, J 7.5, 4.0, 1H, S0 2CH), 3.62-3.38 (m, 2H, 
CH2 CHCH2), 2.55 (s, 3H, NCH3).
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8 c (CDCI3, 75  MHz) 139.6 (PhC), 135.2 (PhC), 133.4 (CHCH2 NH), 130.6-128.5 
(PhCH), 126.9 (CHCHSO2 ), 118.6 (CH2 CHCH2 NH), 73.9 (S0 2CH), 67.3
(CH2 CHSO2 ), 46.3 (NHCH2), 43.2 (NCH3).
LRMS (E I+ )  316 (M+, 3 5 CI, 40 % ), 194 (PhC4H7NOS, H, 100 %), 168 
(CIPhCHNOCH2, 55 % ), 151 (CIPhCHCHN, 70 % ), 115 (C4H5NOS, 67 %), 84 
(C4H6NO, 45 % ), 56 (C3H40, 35 % ), 28 (CO, 60 %).
HRMS (E S +) MNa+ Calcd for Ci3 H i7 N2 0 3 SCINa, 339.0546, found 339.0547.
3-(3-C hloro-phenyl)-2 -m ethyl-isoxazo lid ine-4-su lfon ic  acid 4 -m ethyl- 
benzylamide [1 2 7 ]
To 3-(3-chloro-phenyl)-2-methyl-isoxazolidine-4-sulfonic acid pentafluorophenyl 
ester [109] (1.23 g, 2.77 mmol) in dry tetrahydrofuran (15 mL) was added 4- 
methylbenzylamine (3.0 eq., 1.06 mL, 8.32 mmol) followed by DBU (1.05 eq., 
0.44 mL, 2.91 mmol), and the m ixture was refluxed for 1 hour. The reaction was 
diluted with dichloromethane (50 mL) and washed with 2M HCI (2 x 50 mL), 
water (2 x 50 mL) and brine (2 x 50 mL). The organic phase was separated, dried 
(MgS04), filtered and the filtra te  concentrated in vacuo. The crude residue was 
purified by flash column chromatography (2:1 Petroleum ether 40-60 °C:Ethyl 
acetate) to give the title  compound as a white solid (540 mg, 1.93 mmol, 69 %). 
Rf 0.50 (2:1 P:EtOAc).
Mp 89-93 °C
Vmax (th in  film , cm '1) 3366 s, 2091 m, 1638 s, 1433 w, 1323 w, 1147 w, 1040 
w.
8 h (CDCI3, 300  MHz) 7.30-6.80 (m, 8 H, PhH), 4.49 (s, 1H, S02 CH), 4.24-4.16 
(m, 1H, NH), 4.12-3.98 (m, 2H, S 0 2CHCH2), 3.93-3.84 (m, 1H, S0 2CHCH), 3.66 
(bs, 2 H, NHCH2), 2.49 (s, 3H, NCH3), 2.20 (s, 3H, PhCH3).
8 C (CDCI3, 75 MHz) 139.6-133.3 (PhC), 130.6-126.9 (PhCH), 74.0 (CHS02),
67.3 (SO2CHCH2 ), 47.7 (NHCH2), 43.2 (NCH3), 21.5 (PhCH3).
LRMS (E I+ )  380 (M+, 3 5 CI, 12 % ), 194 (C i0 H i2 NOS, 100 %), 151 (CIPhCHCHCH2, 
37 %), 120 (CH3 PhCH2 NH, 6 6  % ), 105 (CH3 PhCH2, 62 %).
HRMS (E S +) MNa+ Calcd for Ci8 H2 iN 2 0 3 SCINa, 403.0859, found 403.0859.
2 -M e th y l-3 -p e n ty l - is o x a z o l id in e -4 -s u lfo n ic  a c id  4 -m e th y l-b e n z y la m id e
[129]
To 2 -m ethyl-3 -pentyl-isoxazolidine-4 -sulfonic acid pentafluorophenyl ester [111] 
(140 mg, 0.35 mmol) in dry tetrahydrofuran (5 mL) was added 4- 
methylbenzylamine (3.0 eq., 0.13 mL, 1.04 mmol) followed by DBU (1.0 eq., 
0.05 mL, 0.35 mmol), and the mixture was refluxed for 5 hours. The reaction was
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diluted with dichloromethane (20 mL) and washed with 2M HCI (2 x 20 mL), 
water (2 x 20 mL) and brine (2 x 20 mL). The organic phase was separated, dried 
(MgS04), filtered and the filtrate concentrated in vacuo. The crude residue was 
purified by flash column chromatography (2:1 Petroleum ether 40-60 °C:Ethyl 
acetate) to give the title  compound as a yellow oil ( 7 3  mg, 0 . 2 1  mmol, 61 %).
Rf 0.40 (2:1 P:EtOAc).
Vmax (th in  film , cm '1) 3547 w, 3286 s, 2928 s, 1749 w, 1650 m, 1516 m, 1458 
s, 1323 s, 1146 s, 1068 m.
Sh (CDCI3, 300  MHz) 7.18-7.02 (m, 4H, PhH), 4.20-4.13 (m, 2 H, NHCH2), 4.07- 
3.98 (m, 1 H, S0 2 CHCH2), 3.83 (t, J 8.9, 1 H, S0 2 CHCH2), 3.50-3.40 (m, 1 H, 
S02CH), 2.95 (s, 1H, SO2 CHCH), 2.62 (s, 3H, NCH3), 2.49 (s, 1H, NH), 2.22 (s, 
3H, PhCH3), 1.57-1.40 (m, 2H, CH2 CHNCH3), 1.31-1.12 (m, 6 H, CH3 CH2/ 
CH3CH2 CH2, CH2 CH2 CHNCH3), 0.78 (s, 3H, CH2 CH3).
8 C (CDCI3, 75 M Hz) 138.4 (PhC), 134.3 (PhC), 130.0-128.4 (PhCH), 71.7 
(CHS02), 69.5 (SO2 CHCH), 66.7 (S 0 2CHCH2), 47.6 (CH2 CHNCH3), 47.3 (NHCH2),
44.5 (NCH3), 32.2 (CH2 CH2 CHNCH3), 25.7 (CH3 CH2CH2), 23.0 (CH3CH2), 21.5 
(PhCH3), 14.4 (CH3 CH2).
LRMS (E I+ )  340 (M+, 10 % ), 269 (M +-C 5H n , 95 % ), 120 (CH3PhCH2NH, 85 %), 
105 (CH3PhCH2, 100 % ), 85 (C4H7NO, 98 %), 42 (CH3CH2CH, 45 %).
HRMS (E S +) MH+ Calcd for C i7H29N20 3S, 341.1899, found 341.1904.
2-M ethyl-3-naphthalen-2-y l-isoxazo lid ine-4-su lfon ic  acid allylamide 
[121]
To 2-m ethyl-3-naphthalene-2-yl-isoxazolid ine-4-su lfon ic acid pentafluorophenyl 
ester [113] (132 mg, 0.29 mmol) in dry tetrahydrofuran (10 mL) was added 
allylamine (3.0 eq., 0.06 mL, 0.86 mmol) followed by DBU (1.0 eq., 0.04 mL, 
0.29 mmol), and the m ixture was refluxed for 3 hours. The reaction was diluted 
with dichloromethane (20 mL) and washed with 2M HCI (2 x 20 mL), water (2 x 
20 mL) and brine (2 x 20 mL). The organic phase was separated, dried (MgS04), 
filtered and the filtra te  concentrated in vacuo. The crude residue was purified by 
flash column chromatography (1:1 Petroleum ether 40-60 °C:Ethyl acetate) to 
give the title  compound as a yellow oil (60 mg, 0.18 mmol, 62 %).
Rf 0.40 (2:1 P:EtOAc).
Vmax (th in  film , cm '1) 3306 m, 1645 w, 1436 w, 1317 w, 1149 w.
8 h (CDCI3, 300  MHz) 7.72-7.60 (m, 4H, PhH), 7.39-7.23 (m, 3H, PhH), 5.32- 
5.20 (m, 1H, NHCH2CH), 4.78-4.67 (m, 2H, S0 2 CHCH2), 4.57 (t, J 6.0, 1H, 
NHSO2 ), 4.28-4.15 (m, 2H, NHCH2), 4.00-3.90 (m, 1H, S0 2CH), 3.85-3.78 (m,
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IH , S02 CHCH), 3.40-3.30 (m, 1H, NHCH2CHCH2), 3.19-3.08 (m, 1H,
NHCH2CHCH2) 2.44 (s, 3H, CH3).
8C (CDCI3, 75 M Hz) 134.5-133.6 (PhC), 133.3 (CHCH2 NH), 129.4-125.4 (PhCH),
118.3 (CH2 CHCH2 NH), 75.1 (S 0 2CH), 73.6 (CHCHS02), 67.4 (S02 CHCH2), 46.1 
(NHCH2), 43.2 (CH3).
LRMS (E I+ )  332 (M+, 40 % ), 210 (95 %), 167 (95 % ), 56 (CH2 CHCH2 NH, 56 
%), 41 (CH2 CHCH2 45 % ).
HRMS (E S +) MH+ Calcd for C i7 H2 1 N2 0 3 S, 333.1267, found 333.1262.
3-Cyclohexyl-2-m ethyM soxazolid ine-4-su lfon ic acid allylamide [134 ]
To 3-cyclohexyl-2-methyl-isoxazolidine-4-sulfonic acid pentafluorophenyl ester 
[112] (115 mg, 0.28 mmol) in dry tetrahydrofuran (10 mL) was added allylamine 
(3.0 eq., 0.06 mL, 0.83 mmol) followed by DBU (1.0 eq., 0.04 mL, 0.28 mmol), 
and the m ixture was refluxed for 2 hours. The reaction was diluted with 
dichloromethane (20 mL) and washed with 2M HCI (2 x 20 mL), water (2 x 20 
mL) and brine (2 x 20 mL). The organic phase was separated, dried (MgS04), 
filtered and the filtra te  concentrated in vacuo. The crude residue was purified by 
flash column chromatography (2:1 Petroleum ether 40-60 °C:Ethyl acetate) to 
give the title  compound as a yellow solid (56 mg, 0.19 mmol, 69 %).
Rf 0.45 (2:1 P:EtOAc).
Mp 73-76 °C
Vmax (th in  film , cm-1) 3445 s, 2926 s, 1645 m, 1448 m, 1319 m, 1148 m.
8 h (CDCI3, 300  MHz) 5.90-5.75 (m, 1H, NHCH2 CH), 5.30-5.11 (m, 2H, NHCH2), 
4.77-4.68 (m, 1H, NH), 4.30-4.20 (m, 1H, S0 2 CH), 3.99 (t, J 9.8, 1H, 
S02 CHCH2), 3.82-3.67 (m, 3H, NHCH2 CHCH2, S0 2 CHCH2), 2.95-2.90 (m, 1H, 
S02CHCH), 2.68 (s, 3H, CH3), 1.78-1.58 (m, 4H, CH2), 1.42-1.30 (m, 1 H, 
CHCHN), 1.21-0.92 (m, 6 H, CH2).
8C (CDCI3, 75 MHz) 134.0 (CHCH2 NH), 118.4 (CH2CHCH2 NH), 74.0 (S0 2CH),
69.7 (S0 2 CHCH), 69.0 (S 0 2 CHCH2), 46.5 (NHCH2), 45.6 (CHCHN), 42.1 (CH3), 
30.1-26.5 (CH2).
LRMS (E I+ )  288 (M+, 20 % ), 205 (M+-C6 Hi0, 100 %), 85 (CHCHCH2ONCH3, 95 
%), 55 (CH2 CHCH2 N, 35 % ), 41 (CH2 CHCH2, 50 %).
HRMS (E S +) MH+ Calcd for C i3 H2 5 N2 0 3 S, 289.1580, found 289.1582.
Elemental analysis: Anal, calcd for C i3 H2 4 N2 0 3 S: C 54.14, H 8.39, N 9.71, S
II .1 2 ; found: C 54.35, H 8.55, N 9.49, S 10.78.
3 -C y c lo p ro p y l-2 -m e th y l- is o x a z o lid in e -4 “S ulfon ic  acid a lly la m id e  [1 2 0 ]
To 3 -cyclopropyl-2 -methyl-isoxazolidine-4 -sulfonic acid pentafluorophenyl ester
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[114] (105 mg, 0.28 mmol) in dry tetrahydrofuran (5 mL) was added allylamine 
(3.0 eq., 0.06 mL, 0.84 mmol) followed by DBU (1.05 eq., 0.04 mL, 0.30 mmol), 
and the m ixture was refluxed for 2 hours. The reaction was diluted with 
dichloromethane (20 mL) and washed with 2M HCI (2 x 20 mL), water (2 x 20 
mL) and brine (2 x 20 mL). The organic phase was separated, dried (MgS04), 
filtered and the filtra te  concentrated in vacuo. The crude residue was purified by 
flash column chromatography (1:1 Petroleum ether 40-60 °C:Ethyl acetate) to 
give the title  compound as a colourless oil (58 mg, 0.24 mmol, 84 %).
Rf 0.40 (1:1 P:EtOAc).
Vmax (th in  film , cm-1) 3564 m, 3292 s, 2924 s, 2451 m, 1738 m, 1646 s, 1436 
s, 1317 s, 1147 s.
8h (CDCI3, 300  MHz) 6.90-5.77 (m, 1H, NHCH2 CH), 5.32-5.15 (m, 2H, NHCH2),
4.43 (bs, 1H, NH), 4.26-4.07 (m, 3H, S0 2 CHCH2, S0 2 CH), 3.87 (bs, 1H, 
S02 CHCH), 3.81-3.74 (m, 2H, NHCH2 CHCH2), 2.76 (s, 3H, CH3), 0.98-0.88 (m, 
1H, CH2 CH2CH), 0.73 (d, 3 8.1, 1H, CH2 CH2), 0.65-0.52 (m, 2H, CH2CH2), 0.40- 
0.29 (CH2 CH2).
8 C (CDCI3, 75 MHz) 131.7 (CHCH2 NH), 115.9 (CH2CHCH2 NH), 71.6 (S0 2CH),
70.0 (S0 2 CHCH), 64.7 (S 0 2 CHCH2), 44.1 (NHCH2), 42.3 (CH3), 11.7 (CH2CH2CH),
2.5 (CH2 CH2), 0.0 (CH2 CH2).
LRMS (E I+ )  246 (M+, 35 % ), 205 (M +-C3H5, 20 %), 124 (C7H10NO, 99 %), 99 
(C5H9NO, 40 % ), 81 (C6H9, 100 %), 41 (C3H5, 6 8  %).
HRMS (E S +) MH+ Calcd for C i0 Hi9 N2 O3 S, 247.1111, found 247.1110.
3-(5-B rom o-furan-2-y l)-2-m etliy l-isoxazo lid ine-4-su lfon ic  acid allylamide
[130]
To 3-(5-bromo-furan-2-yl)-2-methyl-isoxazolidine-4-sulfonic acid pentafluoro­
phenyl ester [116] (133 mg, 0.28 mmol) in dry tetrahydrofuran (5 mL) was 
added allylamine (3.0 eq., 0.06 mL, 0.83 mmol) followed by DBU (1.05 eq., 0.04 
mL, 0.29 mmol), and the m ixture was refluxed for 3 hours. The reaction was 
diluted with dichloromethane (20 mL) and washed with 2M HCI (2 x 20 mL), 
water (2 x 20 mL) and brine (2 x 20 mL). The organic phase was separated, dried 
(MgS04), filtered and the filtra te  concentrated in vacuo. The crude residue was 
purified by flash column chromatography (2:1 Petroleum ether 40-60 °C:Ethyl 
acetate) to give the title  compound as a colourless oil (63 mg, 0.18 mmol, 64 %). 
Rf 0.50 (2:1 P:EtOAc).
Vmax (th in  film , cm-1) 3292 m, 2924 m, 1646 w, 1503 w, 1435 w, 1317 m, 1149 
m.
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8h (CDCI3, 3 0 0  MHz) 6.35 (d, J 3.2, 1H, CHCO), 6.21 (d, J 3.4, 1H, CHCBr),
5.63-5.50 (m, 1H, CHCH2 NH), 5.18-5.04 (m, 2H, NHCH2), 4.80 (bs, 1H, NH), 
4.34-4.15 (m, 3H, S0 2 CHCH2, S0 2 CH), 3.78 (bs, 1H, SO.CHCH), 3.63-3.45 (m, 
2H, CH2 CHCH2 NH), 2.60 (s, 3H, CH3).
8c (CDCI3/ 75  MHz) 150.9 (CO), 133.4 (CHCH2 NH), 123.4 (CBr), 118.7 
(CH2 CHCH2 NH), 113.5 (CHCBr), 112.9 (CHCO), 69.6 (S0 2 CH), 68.1 (S0 2 CHCH),
67.1 (S0 2 CHCH2), 46.3 (NHCH2), 43.4 (CH3).
LRMS (E I+ )  352 (M+, H, 20 % ), 230 (M+-C3 H5 NH2 S02, 100 % ), 203 
(BrC6 H5 N02, 30 % ), 187 (BrC7 H70 , 35 % ), 159 (BrC5 H3 0, 15 %), 78 (C5 H20, 40 
%).
HRMS (E S +) MH+ Calcd for C u H i6N 20 4B rS, 351.0014, found 351.0011.
3-(4-A lly loxy-phenyl)-2-m ethyl-isoxazolid ine-4-sulfonic  acid 4-m ethyl- 
benzylamide [1 1 9 ]
To 3-(4-allyloxy-phenyl)-2-methyl-isoxazolidine-4-sulfonic acid pentafluorophenyl 
ester [115] (1.07g, 2.30 mmol) in dry tetrahydrofuran (15 mL) was added 4- 
methylbenzylamine (3.0 eq., 0.88 mL, 6.90 mmol) followed by DBU (1.05 eq., 
0.36 mL, 2.42 mmol), and the m ixture was refluxed for 3 hours. The reaction was 
diluted with dichloromethane (50 mL) and washed with 2M HCI (2 x 50 mL), 
water (2 x 50 mL) and brine (2 x 50 mL). The organic phase was separated, dried 
(MgS04), filtered and the filtra te  concentrated in vacuo. The crude residue was 
purified by flash column chromatography (2:1 Petroleum ether 40-60 °C:Ethyl 
acetate) to give the title  compound as a yellow oil (818 mg, 2.03 mmol, 8 8  %).
Rf 0.45 (2:1 P:EtOAc).
Vmax (th in  film , cm '1) 3544 w, 3291 s, 2923 s, 1735 w, 1611 s, 1456 s, 1328 s, 
1245 s, 1149 s.
8 h (CDCI3, 3 00  MHz) 7.27-6.74 (m, 8 H, PhH), 6.05-5.82 (m, 1H, CHCH2 0), 
5.40-5.12 (m, 2H, CH2 0 ), 4.69 (bs, 1H, NH), 4.40-4.21 (m, 2H, S02 CHCH2), 
4.08-3.92 (m, 3H, CH2 CHCH2 0 , PhCH2), 3.88-3.76 (m, 2H, S02CH PhCH2), 3.68-
3.61 (m, 1H, S0 2CHCH), 2.47 (s, 3H, NCH3), 2.20 (s, 3H, PhCH3).
8C (CDCI3, 75 MHz) 159.4 (PhC), 138.2 (PhC), 133.4 (CHCH2 0), 130.9-128.4 
(PhCH), 125.1 (PhC), 118.3 (CH2 CHCH2 0 ), 115.5 (PhCH), 115.1 (PhCH), 73.3 
(CHS02), 69.2 (CH2 0 ), 67.1 (S 0 2 CHCH2), 59.4 (CHCHS02), 47.4 (PhCH2), 43.0 
(NCH3), 21.5 (PhCH3).
LRMS (E I + ) 402 (M+, 45 % ), 216 (M+-C8 Hi2 N02 S, 100 %), 173 (Cn HuNO, 77 
%), 150 (C4 H8 N0 3 S, 50 % ), 120 (CH3 PhCH2 NH, 70 %), 105 (CH3 PhCH2, 85 %), 
91 (CH3 Ph, 46 %), 77 (Ph, 40 % ), 41 (C3 H5, 60 %).
HRMS (E S +) MH+ Calcd for C2 iH 2 7 N2 0 4 S, 403.1686, found 403.1679.
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3-(3-B rom o-phenyl)-2-m ethyl-isoxazo lid ine-4-su lfon ic  acid 4-m ethyl- 
benzylamide [1 3 2 ]
To 3-(3-bromo-phenyl)-2-methyl-isoxazolidine-4-sulfonic acid pentafluorophenyl 
ester [117] (1.24 g, 2.54 mmol) in dry tetrahydrofuran (10 mL) was added 4- 
methylbenzylamine (3.0 eq., 0.97 mL, 7.62 mmol) followed by DBU (1.05 eq., 
0.40 mL, 2.67 mmol), and the m ixture was refluxed for 2 hours. The reaction was 
diluted with dichloromethane (50 mL) and washed with 2M HCI (2 x 50 mL), 
water (2 x 50 mL) and brine (2 x 50 mL). The organic phase was separated, dried 
(MgSCU), filtered and the filtra te  concentrated in vacuo. The crude residue was 
purified by flash column chromatography (6:1 Petroleum ether 40-60 °C:Ethyl 
acetate) to give the title  compound as a white solid (603 mg, 1.42 mmol, 56 %). 
Rf 0.55 (2:1 P:EtOAc).
Mp 93-95 °C
V m a x  (th in  film , cm-1) 3293 s, 2082 w, 1640 m, 1430 m, 1324 m, 1042 w. 
8h (CDCI3, 3 0 0  M Hz) 7.52-6.91 (m, 8 H, PhH), 4.44 (bs, 1 H, S0 2CH), 4.32-4.26 
(m, 1H, NH), 4.22-4.06 (m, 2H, S0 2 CHCH2), 4.02-3.92 (m, 1 H, S02 CHCH), 3.74 
(bs, 2H, NHCH2), 2.55 (s, 3H, NCH3), 2.25 (s, 3H, PhCH3).
8C (CDCI3, 75 MHz) 132.2-127.4 (PhCH), 74.0 (CHS02), 67.3 (S0 2 CHCH2), 47.7 
(NHCH2), 43.4 (NCH3), 21.5 (PhCH3).
LRMS (E I+ )  426 (M+, 8 1 Br, 52 % ), 240 (M+7 9 Br-MePhCH2 NHS02, 100 %), 212 
(7 9 BrPhCHNOCH2, 36 % ), 197 (8 1 BrPhCHCHCH2, 42 % ), 120 (CH3 PhCH2 NH, 78 
%), 105 (CH3 PhCH2, 64 % ), 91 (CH3 Ph, 43 % ), 77 (Ph, 36 %), 42 (CNO, 33 %). 
HRMS (E S + ) MNa+ Calcd for C1 8 H2 1 N2 0 3 SBrNa, 447.0354, found 447.0360. 
Elemental analysis: Anal, calcd for C1 8 H2 iN 2 0 3SBr: C 50.83, H 4.98, N 6.59, S 
7.54, Br 18.79; found: C 51.01, H 5.04, N 6.46, S 7.30, Br 18.55.
3 .4 .3 .1  A m ino lys is  p rocedures inco rpo ra ting  m icrow ave techniques 7 3
3-(4-M ethoxy-phenyl)-2 -m ethyl-isoxazo lid ine-4-su lfon ic  acid benzyl- 
m ethylamide [1 3 6 ]
To 3-(4-methoxy-phenyl)-2-m ethyl-isoxazolidine-4-sulfonic acid pentafluoro­
phenyl ester (78 mg, 0.18 mmol) in dry tetrahydrofuran (5 mL) in a microwave 
reaction vessel was added /V-benzylmethylamine (3.0 eq., 0.07 mL, 0.53 mmol) 
followed by DBU (2.0 eq., 0.05 mL, 0.36 mmol), and the mixture was subjected 
to microwave irradiation at 110 °C for 45 minutes. The reaction was diluted with 
dichloromethane (20 mL) and washed with 2M HCI (2 x 10 mL), water (2 x 10 
mL) and brine (2 x 10 mL). The organic phase was separated, dried (MgS04), 
filtered and the filtra te  concentrated in vacuo. The crude residue was purified by
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flash column chromatography (1:1 Petroleum ether 40-60 °C:Ethyl acetate) to 
give the title  compound as a colourless oil (36 mg, 0 . 1 0  mmol, 5 3  %).
Rf 0.30 (2:1 P:EtOAc).
8h (CDCI3/ 300  MHz) 7.46-6.88 (m, 9H, PhH), 4.52-4.41 (m, 2H, S02 CHCH2), 
4.39-4.22 (m, 2H, S0 2 CH, S 0 2CHCH), 4.19-4.02 (m, 2H, PhCH2), 3.82 (s, 3H, 
OCH3), 2.60 (s, 3H, ONCH3), 2.53 (s, 3H, CH2 NCH3).
8 C (CDCI3, 75 MHz) 160.0 (PhC), 135.8-113.7 (PhCH), 73.9 (CHS02), 67.2 
(S0 2 CHCH2), 55.2 (S 0 2 CHCH), 53.1 (PhCH2), 34.2 (ONCH3), 21.1 (CH2 NCH3),
14.2 (OCH3).
3-Cyclopropyl-2-m ethyl-isoxazolidine-4-sulfonic acid methylcyclohexyl- 
amide [1 3 7 ]
To 3-cyclopropyl-2-methyl-isoxazolidine-4-sulfonic acid pentafluorophenyl ester 
(90 mg, 0.24 mmol) in dry tetrahydrofuran (5 mL) in a microwave reaction vessel 
was added /V-methylcyclohexylamine (3.0 eq., 0.09 mL, 0.72 mmol) followed by 
DBU (2.0 eq., 0.09 mL, 0.48 mmol), and the mixture was subjected to microwave 
irradiation at 110 °C for 45 minutes. The reaction was diluted with 
dichloromethane (20 mL) and washed with 2M HCI (2 x 10 mL), water (2 x 10 
mL) and brine (2 x 10 mL). The organic phase was separated, dried (MgS04), 
filtered and the filtra te  concentrated in vacuo. The crude residue was purified by 
flash column chromatography (2:1 Petroleum ether 40-60 °C:Ethyl acetate) to 
give the title  compound as a pale yellow oil (51 mg, 0.17 mmol, 70 %).
Rf 0.25 (2:1 P:EtOAc).
8h (CDCI3, 300  MHz) 4.20-4.04 (m, 2H, S0 2 CHCH2), 3.92-3.81 (m, 1H, S0 2 CH),
3.63 (t, J 8.4, 1H, S 0 2CHCH), 2.83 (s, 3H, ONCH3), 2.78 (s, 3H, CHNCH3), 1.87- 
0.67 (m, 16H, 7 x CH2, 2 x CH).
8 C (CDCI3, 75 MHz) 66.3 (S 0 2 CHCH2), 57.4 (S0 2 CHCH), 31.1-25.3 (CH2).
2 -M e th y l-3 -n a p h th a le n -2 -y l- is o x a z o lid in e -4 -s u lfo n ic  acid  m e th y l- t -b u ty l-  
am id e  [1 3 8 ]
To 2-methyl-3-naphthalen-2-yl-isoxazolidine-4-sulfonic acid pentafluorophenyl 
ester (61 mg, 0.13 mmol) in dry tetrahydrofuran (3 mL) in a microwave reaction 
vessel was added tert-butylm ethylam ine (3.0 eq., 0.05 mL, 0.40 mmol) followed 
by DBU (2.0 eq., 0.04 mL, 0.27 mmol), and the mixture was subjected to 
microwave irradiation at 110 °C for 30 minutes. The reaction was diluted with 
dichloromethane (20 mL) and washed with 2M HCI (2 x 10 mL), water (2 x 10 
mL) and brine (2 x 10 mL). The organic phase was separated, dried (MgS04), 
filtered and the filtra te  concentrated in vacuo. The crude residue was purified by
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flash column chromatography (2:1 Petroleum ether 40-60 °C:Ethyl acetate) to 
give the title  compound as a colourless oil ( 1 2  mg, 0.03 mmol, 25 %).
Rf 0.75 (2:1 P:EtOAc).
8 h (CDCI3 , 300  MHz) 7.93-7.81 (m, 4H, PhH), 7.59-7.47 (m, 3H, PhH), 4.52-
4.44 (m, 1H, S 0 2 CHCH2), 4.39 (t, J 6 .6 , 1H, S0 2CH), 4.22 (dt, J 2.8, 1.9, 1 H, 
SO2 CHCH2 ), 3.93 (d, J 8.4, 1 H, S0 2 CHCH), 2.81 (s, 3H, ONCH3), 2.67 (s, 3H, 
CNCH3 ), 1.12 (s, 9H, (CH3)3).
3-(2-F luoro -phenyl)-2 -m ethyl-isoxazo lid ine-4-su lfon ic  acid m ethylallyl- 
amide [1 3 9 ]
To 3-(2-fluoro-phenyl)-2-m ethyl-isoxazolidine-4-sulfonic acid pentafluorophenyl 
ester (54 mg, 0.13 mmol) in dry l-m ethyl-2-pyrro lid inone (NMP) (3 mL) in a 
microwave reaction vessel was added /V-methylallylamine (3.0 eq., 0.04 mL, 0.38 
mmol) followed by DBU (2.0 eq., 0.04 mL, 0.25 mmol), and the mixture was 
subjected to microwave irradiation at 80 °C for 45 minutes. The reaction was 
diluted with dichloromethane (20 mL) and washed with 2M HCI (2 x 10 mL), 
water (2 x 10 mL) and brine (2 x 10 mL). The organic phase was separated, dried 
(MgS04), filtered and the filtra te  concentrated in vacuo. The crude residue was 
purified by flash column chromatography (2:1 Petroleum ether 40-60 °C:Ethyl 
acetate) to give the title  compound as a yellow oil (22 mg, 0.07 mmol, 54 %).
Rf 0.40 (2:1 P:EtOAc).
§H (CDCI3, 300  MHz) 7.49-7.05 (m, 4H, PhH), 5.61-5.45 (m, 1H, NCH3CH2CH), 
5.17-5.09 (m, 2H, NCH3 CH2), 4.47-4.31 (m, 2H, S0 2 CHCH2), 4.24 (dt, J 4.7, 3.8, 
1H, S0 2 CH), 4.17-4.09 (m, 1H, S0 2 CHCH), 3.75 (dd, J 7.5, 6 .6 , 1H,
NCH3CH2CHCH2), 3.52 (dd, J 7.5, 6 .6 , 1 H, NCH3CH2 CHCH2), 2 . 6 8  (s, 3H, ONCH3),
2.63 (s, 3H, CH2 NCH3 ).
8 C (CDCI3 , 75 MHz) 162.8 (PhC), 159.5 (PhC), 132.4 (CHCH2 NCH3), 130.7-123.3 
(PhCH), 119.3 (CH2 CHCH2 NCH3), 8 6 . 6  (S0 2 CHCH), 71.1 (CHS02), 67.0
(S0 2CHCH2), 52.8 (CH2 NCH3), 42.8 (ONCH3), 34.1 (CH2 NCH3).
3.5 Diels-Alder Reactions with Cyclic Dienes
3.5.1 [4+2] cycloaddition procedures
Bicyclo [2 .2 .1 ] h ep t-5 -e n e -2 -sulfonic acid pentafluorophenyl ester 
[157a]
To pentafluorophenyl vinylsulfonate [80] (1.0 g, 3.60 mmol) in dry toluene (20 
mL) was added cyclopentadiene (3.0 eq., 720 mg, 10.90 mmol) and the mixture
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was refluxed at 110 °C for 4 hours. The reaction was concentrated in vacuo, and 
the crude residue was purified by flash column chromatography (20:1 Petroleum 
ether 40-60 °C:Ether) to give the title  compound as a white solid (970 mg, 2.90 
mmol, 78 %).
Rf 0.55 (3:1 P:Et20 ).
Mp 48-49 °C
Vmax (th in  film , cm"1) 3430 s, 2990 s, 1650 s, 1518 m, 1378 m.
5h (CDCI3, 300  M Hz) 6.25 (dd, J 5.7, 3.2, 1H, S02CHCHCH), 6.02 (dd, J 5.5,
2.8, 1H, S 02CHCH2CHCH), 4.02-3.99 (m, 1H, S02CH), 3.42 (s, 1H, S02CHCH),
3.02 (s, 1H, S02CHCH2CH), 2.25 (dt, J 5.7, 3.6, 1H, CH2CHCH2), 1.54-1.50 (m, 
2H, S02CHCH2), 1.33 (d, J 9.0, 1H, CH2CHCH2).
8C (CDCI3, 75 MHz) (Aromatic peaks not observed due to 19F coupling). 138.8 
(S02CHCHCH), 131.4 (S 02CHCH2CHCH), 63.3 (S 02CH), 50.0 (CH2CHCH2), 46.3 
(S02CHCH), 43.1 (S02CHCH2CH), 30.3 (S02CHCH2).
LRMS (E I+ )  340 (M+, 20 % ), 155 (S 02C6F, 10 %), 93 (M+-C6F50S 02, 100 %), 
77 (S02CH, 42 % ), 66 (S 02, 2H, 23 %).
HRMS (E S +) MNa+ Calcd for CisHgOsFsSNa, 363.0085, found 363.0074.
Bicyclo [2 .2 .2 ] oct-5-ene-2-su lfon ic  acid pentafluorophenyl ester [160a]
To pentafluorophenyl vinylsuifonate [80 ] (155 mg, 0.57 mmol) in dry toluene (5 
mL) was added 1,3-cyclohexadiene (3.0 eq., 0.16 mL, 1.70 mmol) and the 
mixture was refluxed at 110 °C for 24 hours. The reaction was concentrated in 
vacuo, and the crude residue was purified by flash column chromatography (20:1 
Petroleum ether 40-60 °C:Ether) to give the title  compound as a white solid (94 
mg, 0.27 mmol, 47 %).
Rf 0.60 (3:1 P:Et20 ).
Mp 52-54 °C
Vmax (th in  film , cm '1) 3434 s, 2954 m, 1649 m, 1519 s, 1372 s, 1186 s, 996 s.
8h (CDCI3, 3 00  MHz) 6.36 (t, J 7.1, 1H, S02CHCHCHCH), 6.22 (t, J 7.1, 1H, 
S02CHCHCH), 3.65 (m, 1H, S 02CH), 3.17 (s, 1H, S02CHCH), 2.68 (s, 1H, 
S02CHCH2CH), 2.05 (dt, J 9.8, 2.6, 1H, S 02CHCH2), 1.85-1.73 (m, 1H, 
S02CHCH2), 1.62-1.52 (m, 1H, S02CHCH2), 1.50-1.15 (m, 3H,
c h 2c h c h 2s o 2c h c h 2).
8C (CDCI3, 75 MHz) (Aromatic peaks not observed due to 19F coupling). 135.4 
(CHCHCHS02), 130.2 (CHCHCHCHS02), 62.9 (S 02CHCH2), 31.0 (S02CHCHCH),
30.1 (S02CHCH2), 29.4 (S 02CHCH2CH), 26.2 (S02CHCHCH2), 23.1 (CH2CHCH2). 
LRMS (E I+ )  355 (M+, H, 15 % ), 183 (C6F50, 40 % ), 155 (M+-C6F50 2, 60 %), 
108 (C6F50 3, H, 85 % ), 91 (C7 H7 , 90 % ), 78 (C6H6, 100 %).
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HRMS (E S + ) MNa+ Calcd for C i4 H ii0 3 F5SNa, 377.0247, found 377.0228.
1-Methoxy-bicyclo [ 2 .2 .2 ] oct-5-ene-2-sulfonic acid pentafluorophenyl 
ester [161a ]
To pentafluorophenyl vinylsulfonate [80] (116 mg, 0.42 mmol) in dry toluene (5 
mL) was added l-m ethoxy-l,3-cyclohexadiene (5.0 eq., 0.25 mL, 2.12 mmol) 
and the m ixture was refluxed at 110 °C for 2 hours. The reaction was 
concentrated in vacuo, and the crude residue was purified by flash column 
chromatography (20:1 Petroleum ether 40-60 °C:Ether) to give the title 
compound as a colourless oil (140 mg, 0.36 mmol, 87 %).
Rf 0.50 (3:1 P:Et2 0 ).
Vmax (th in film , cm-1) 3412 w, 2951 s, 2666 w, 2459 w, 1519 s, 1389 m, 995 s. 
SH (CDCI3, 300 M Hz) 6.29-6.20 (m, 2H, CHCHCOCH3, CHCOCH3), 3.91 (dd, J 
10.0, 5.8, 1H, S0 2 CH), 3.30 (s, 3H, OCH3), 2.62 (s, 1H, CHCH2), 2.21 (dt, J
10.2, 2.5, 1H, S0 2 CHCH2), 2.05-1.94 (m, 1H, S0 2CHCH2), 1.70-1.57 (m, 3H, 
CHCH2, CH2 COCH3 ), 1.47-1.35 (m, 1 H, CHCH2).
8 c (CDCI3, 75 MHz) (Aromatic peaks not observed due to 19F coupling). 133.3 
(CHCOCH3 ), 132.2 (CHCHCOCH3 ), 78.5 (COCH3 ), 66.5 (S0 2 CH), 51.6 (OCH3),
32.6 (S0 2 CHCH2), 29.4 (CH3COCH2), 28.9 (S0 2CHCH2 CH), 24.3 (CH2CHCH2). 
LRMS (E I+ )  384 (M+, 30 % ), 356 (M+-CO, 63 %), 201 (M+-C6 F50, 40 %), 183 
(C6 F5 0, 80 % ), 155 (M+-C6 F50 3, CH2, 95 %), 138 (M+-C6 F5S03/ H, 65 %), 108 
(C8 H12, 100 % ), 94 (C7H i0/ 98 % ), 77 (C6 H5, 94 %).
HRMS (E S +) MNa+ Calcd for C i5 Hi3 0 4 F5SNa, 407.0352, found 407.0338.
7-Oxa-bicyclo [2 .2 .1 ] hept-5-ene-2-su lfonic  acid pentafluorophenyl ester 
[175 & 176]
To pentafluorophenyl vinylsulfonate [80] (104 mg) in furan (0.5 mL) was added 
Znl2 (36 mg) and stirred at 40 °C for 4 d. The reaction was diluted with ethyl 
acetate (10 mL) and washed with aqueous Na2 S2 0 3 solution (2 x 10 mL). The 
organic phase was separated, dried (MgS04), filtered and the filtrate concentrated 
in vacuo. The crude residue was purified by flash column chromatography (6:1 
Petroleum ether 40-60 °C:Ether) to give the exo cycloadduct [175] as a pale 
yellow solid (56 mg, 0.16 mmol, 43 % ), and the endo cycloadduct [176] as a pale 
yellow solid (46 mg, 0.13 mmol, 35 %).
Exo product:
Rf 0.20 (2:1 P:Et2 0).
Mp 83-86 °C
Vmax (th in  film , cm"1) 3434 s, 2093 m, 1651 s, 1520 m, 1385 m.
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5H(CDCI3, 300  M Hz) 6.50 (dd, J 5.7, 1.5, 1H, S02CHCHCHCH), 6.35 (dd, J 5.7,
1.5, 1H, S02CHCHCH), 5.48-5.40 (m, 1H, S02CHCH), 5.21-5.10 (s, 1H, CHCH2), 
3.41-3.30 (m, 1H, S 02CH), 2.40-2.28 (m, 1H, CH2), 1.91-1.80 (m, 1H, CH2).
5C (CDCh, 75 MHz) (Aromatic peaks not observed due to 19F coupling). 138.5 
(S02CHCHCHCH), 131.7 (S 02CHCHCH), 80.0 (CHCH2), 78.9 (S02CHCH), 60.3 
(S02CH), 29.6 (CH2).
LRMS (E I+ )  343 (M+, 35 %), 183 (C6F50, 45 %), 155 (57 %), 95 (C6H70, 60 
%), 68 (100 % ), 41 (65 % ), 27 (57 % ).
HRMS (E S +) MNa+ Calcd for C i2H70 4F5SNa, 364.9883, found 364.9895.
Endo product:
Rf 0.40 (2:1 P:Et20 ).
5h (CDCI3, 300 M Hz) 6.51 (dd, J 5.7, 1.5, 1H, S02CHCHCHCH), 6.33 (dd, J 5.7,
1.5, 1H, S02CHCHCH), 5.30 (dd, J 5.7, 1.5, 1H, S02CHCH), 5.10 (dd, J 5.7, 1.5, 
1H, S02CHCH2CH), 4.17-4.00 (m, 1H, S02CH), 2.50-2.38 (m, 1H, S02CHCH2), 
1.68. (dd, J 12.0, 2.4, 1H, S02CHCH2).
5c (CDCI3, 75 MHz) (Aromatic peaks not observed due to 19F coupling). 138.5 
(S02CHCHCHCH), 131.7 (S 02CHCHCH), 80.0 (S02CHCH2CH), 78.9 (S02CHCH),
60.3 (S02CH), 29.7 (CH2).
3.5.2 Aminolysis procedures for bicyclic sulfonate esters66
Bicyclo [2 .2 .1 ] hept-5-ene-2-su lfon ic  acid allylam ide [157b ]
To bicyclo [2 .2 .1 ] hept-5-ene-2-sulfonic acid pentafluorophenyl ester [157a] (104 
mg, 0.31 mmol) in dry toluene (10 mL) was added allylamine (3.0 eq., 0.07 mL, 
0.92 mmol) followed by DBU (1.1 eq., 0.05 mL, 0.34 mmol), and the mixture was 
refluxed for 2 hours. The reaction was diluted with dichloromethane (30 mL) and 
washed with 2M HCI (2 x 15 mL), water (2 x 20 mL) and brine (2 x 20 mL). The 
organic phase was separated, dried (MgS04), filtered and the filtrate concentrated 
in vacuo. The crude residue was purified by flash column chromatography (1:1 
Petroleum ether 40-60 °C:Ether) to give the title  compound as a yellow solid (34 
mg, 0.16 mmol, 52 %).
Rf 0.25 (2:1 P:Et20 ).
Mp 51-56 °C
Vmax (th in  film , cm-1) 3285 w, 2978 s, 2871 s, 1645 m, 1429 m, 1320 m, 1290 
m, 1146 s.
5h (CDCI3, 300  MHz) 6.21 (dd, J 5.5, 3.0, 1H, S02CHCHCH), 6.06 (dd, J 5.7,
2.8, 1H, S02CHCH2CHCH), 5.86-5.73 (m, 2H, CH2CHCH2NH), 5.25-5.10 (ddd, J
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10.2, 1.32, 1H, CHCH2 NH), 5.00-4.93 (q, J 5.5, 1H, NH), 4.33-4.31 (m, 1H, 
S0 2CH), 3.22 (s, 1H, S0 2 CHCH), 2.92 (s, 1H, S02 CHCH2 CH), 2.05 (dt, J 9.4, 3.8, 
1 H, CH2CHCH2), 1.49-1.14 (m, 3H, S0 2 CHCH2, CH2 CHCH2).
8 C (CDCI3, 75 MHz) 137.5 (S0 2 CHCHCH), 134.2 (CHCH2 NH), 131.9 
(S0 2CHCH2CHCH), 117.5 (CH2 CHCH2 NH), 62.7 (S 0 2CH), 50.0 (CH2 CHCH2), 46.0 
(CH2 NH), 45.6 (S 0 2 CHCH), 43.0 (S 0 2 CHCH2CH), 29.7 (S0 2 CHCH2).
LRMS (E I+ )  214 (M+, H, 20 % ), 148 (C7H9, C3H5N, 25 %), 108 (S02NHC2H5, 15 
%), 91 (S02NHC, 65 % ), 83 (C3NHS, 55 %), 77 (SONHCH2, 50 %), 6 6  (C5H6, 100 
%), 56 (C3H5NH, 10 % ), 41 (C3H5, 25 %).
HRMS (E S +) MH+ Calcd for C i0 H i5 NO2 S, 214.0896, found 214.0892.
2-(Bicyclo [2 .2 .1 ] hept-5-ene-2-su lfonylam ino)-4-phenyl butyric acid 
ethyl ester [1 5 8 ]
To bicyclo [2 .2 .1 ] hept-5-ene-2-sulfonic acid pentafluorophenyl ester [157a] (105 
mg, 0.31 mmol) in dry toluene (10 mL) was added phenylalanine ethyl ester (3.0 
eq., 179 mg, 0.93 mmol) followed by DBU (1.1 eq., 0.05 mL, 0.34 mmol), and 
the m ixture was refluxed for 3 hours. The reaction was diluted with 
dichloromethane (30 mL) and washed with 2M HCI (2 x 15 mL), water (2 x 20 
mL) and brine (2 x 20 mL). The organic phase was separated, dried (MgS04), 
filtered and the filtra te  concentrated in vacuo. The crude residue was purified by 
flash column chromatography (1:1 Petroleum ether 40-60 °C:Ether) to give the 
title compound as a yellow oil (47 mg, 0.13 mmol, 44 %).
Rf 0.50 (2:1 P:EtOAc).
Vmax (th in  film , cm’1) 3303 w, 3064 s, 2980 s, 1731 m, 1604 m, 1497 m, 1455 
m.
5h (CDCI3, 300M H z) 7.30-7.10 (m, PhH), 6.16-6.10 (m, 1H, S02 CHCHCH), 5.98- 
5.90 (m, 1H, S 0 2 CHCH2CHCH), 4.70-4.60 (m, 1H, NH), 4.30-4.20 (m, 1H, 
S02 CH), 3.99 (dq, J 7.2, 3.0, 2H, CH3 CH2), 3.30-3.12 (m, 1H, S0 2CHCH), 3.10- 
2.95 (m, 2H, PhCH2), 2.82 (s, 1H, S 0 2 CHCH2 CH), 1.77 (dq, J 9.2, 3.8, 1H, 
NHCH), 1.40-1.32 (m, 1H, CH2CHCH2), 1.17 (dt, J 7.2, 2.6, 4H, CH3, CH2 CHCH2),
1.10-1.02 (m, 2H, S0 2 CHCH2).
8c (CDCI3, 75M H z) 172.2 (CO), 137.6 (S0 2 CHCHCH), 136.1 (PhC), 136.0 (PhC), 
131.9 (S0 2 CHCH2 CHCH), 130.0-127.7 (PhC), 63.4 (S0 2 CH), 62.3 (CH2 CH3), 57.6 
(CHNH), 50.0 (CH2CHCH2), 45.6 (S0 2 CHCH), 43.0 (S0 2CHCH2CH), 40.3 
(CH2CHNH), 29.8 (S 0 2 CHCH2), 14.5 (CH3).
LRMS (E I+ )  214 (M+, H), 148 (C1 0 H1 4 N), 108 (S 0 2 NHC2 H3, 2H), 91 (S0 2 NHC), 
83 (C3 NHS), 77 (SONHCH2), 6 6  (C5 H6), 56 (C3 H5 NH), 41 (C3 H5 ).
HRMS (E S +) MNa+ Calcd for Ci8 H2 3 N04 SNa, 372.1245, found 372.1240.
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Bicyclo [2 .2 .1 ] hept-5-ene-2-su lfon ic  acid (4-ethyl-phenyl)-am ide [1 5 9 ]
To bicyclo [2 .2 .1 ] hept-5-ene-2-sulfonic acid pentafluorophenyl ester [157a] (90 
mg, 0.26 mmol) in dry toluene (10 mL) was added 4-methylbenzylamine (3.0 
eq., 0.10 mL, 0.79 mmol) followed by DBU (1.3 eq., 0.05 mL, 0.34 mmol), and 
the mixture was refluxed for 24 hours. The reaction was diluted with 
dichloromethane (30 mL) and washed with 2M HCI (2 x 15 mL), water (2 x 20 
mL) and brine (2 x 20 mL). The organic phase was separated, dried (MgS04), 
filtered and the filtra te  concentrated in vacuo. The crude residue was purified by 
flash column chromatography (1:1 Petroleum ether 40-60 °C:Ether) to give the 
title compound as a white solid (48 mg, 0.17 mmol, 67 %).
Rf 0.20 (2:1 P:EtOAc).
Mp 105-109 °C
Vmax (th in  film , cm-1) 3434 w, 2978 s, 1644 m, 1426 m, 1319 m, 1292 m, 1140 
w.
§H (CDCI3, 3 00  MHz) 7.20-7.04 (m, 4H, PhH), 6.14 (m, 1H, S0 2 CHCHCH), 6.00 
(m, 1H, SO2 CHCH2 CHCH), 4.52 (m, 1H, NH), 4.16 (m, 2H, CH2 NH), 3.48 (m, 1H, 
S02CH), 3.14 (s, 1H, SO2 CHCH), 2.86 (s, 1H, S0 2CHCH2CH), 2.24 (s, 3H, CH3),
2.00-1.88 (dt, J 9.2, 3.6, 1 H, S0 2 CHCHCH2), 1.43 (d, J 8.9, 1 H, S0 2CHCHCH2),
I.38-1.21 (m, 1 H, SO2 CHCH2 ), 1.18 (d, J 8.5, 1H, S0 2 CHCH2).
8 C (CDCI3, 75 MHz) 138.0 (PhC), 137.6 (S0 2 CHCHCH), 134.7 (PhC), 132.1 
(SO2CHCH2 CHCH), 129.8 (PhC), 128.2 (PhC), 62.9 (S 0 2 CH), 50.2 (CH2 CHCH2),
47.4 (CH2 NH), 45.7 (S 0 2 CHCH), 43.1 (S 0 2 CHCH2CH), 29.8 (S0 2CHCH2), 21.5 
(CH3).
LRMS (E I+ )  278 (M+, H, 10 % ), 213 (M+-S 02, 50 %), 170 (CH3CH2 PhNHSO, 2H, 
20 %), 120 (CH3 CH2 PhNH, 85 % ), 105 (CH3 CH2 Ph, 100 %), 91 (S0 2 NHC, 65 %), 
77 (Ph, 45 % ), 6 6  (S 02, 2 H, 55 %).
HRMS (E S +) MH+ Calcd for C1 5 H1 9 NO2 S, 278.1209, found 278.1203.
Elemental analysis: Anal, calcd for C1 5 H1 9 NO2 S: C 64.95, H 6.90, N 5.05, S
II .5 6 ; found C 65.05, H 7.02, N 4.91, S 11.40.
Bicyclo [2 .2 .2 ] oct-5 -e n e -2 -sulfonic acid 4 -m ethyl-benzylam ide [160b ]
To bicyclo [2 .2 .2 ] oct-5 -ene-2 -sulfonic acid pentafluorophenyl ester [160a] (50 
mg, 0.14 mmol) in dry tetrahydrofuran (5 mL) was added 4 -methylbenzylamine 
(3.0 eq., 0.05 mL, 0.42 mmol) followed by DBU (1.05 eq., 0.02 mL, 0.15 mmol), 
and the m ixture was refluxed for 2 hours. The reaction was diluted with 
dichloromethane (30 mL) and washed with 2M HCI (2 x 15 mL), water (2 x 20 
mL) and brine (2 x 20 mL). The organic phase was separated, dried (MgS04), 
filtered and the filtra te  concentrated in vacuo. The crude residue was purified by
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flash column chromatography (4:1 Petroleum ether 40-60 °C:Ethyl acetate) to 
give the title  compound as a white solid (27 mg, 0.09 mmol, 6 6  %).
Rf 0.45 (4:1 P:EtOAc).
Mp 92-95 °C
V m a x  (th in  film , cm-1) 3293 s, 2103 w, 1641 m, 1314 w, 1140 w.
8 h (CDCI3, 300  M Hz) 7.18-6.99 (m, 4H, PhH), 6.27-6.18 (m, 1 H,
S02 CHCHCHCH), 6.17-6.09 (m, 1H, S0 2 CHCHCH), 4.40-4.32 (m, 1H, NH), 4.19-
4.10 (t, J 4.7, 2H, NHCH2), 3.05 (t, J 7.7, 1H, S0 2CH), 2.93 (bs, 1H, S02 CHCH), 
2.55 (bs, 1H, S0 2 CHCH2 CH), 2.24 (s, 3H, CH3), 1.85-1.72 (m, 1H, S0 2CHCH2), 
1.57-1.45 (m, 1H, S 0 2 CHCH2), 1.41-1.11 (m, 4H, S0 2CHCHCH2 CH2,
S02 CHCHCH2 CH2).
8 C (CDCI3, 75 MHz) 138.1 (PhC), 134.5 (S0 2 CHCHCHCH), 131.2 (S0 2 CHCHCH), 
129.8 (PhCH), 128.3 (PhCH), 61.8 (S 0 2CH), 47.6 (NHCH2), 30.9 (S02CHCH),
30.3 (S0 2 CHCH2), 29.8 (S 0 2 CHCH2 CH), 26.7 (S0 2 CHCHCH2), 23.3
(S0 2CHCHCH2 CH2), 21.5 (CH3).
LRMS (E I+ )  291 (M+, 60 % ), 227 (CuH17N02S, 64 %), 186 (M+-CH3PhCH2, 25 
%), 120 (CH3PhCH2NH, 100 % ), 105 (CH3PhCH2, 95 %), 91 (CH3Ph, 65 %), 79 
(C6H7, 93 %).
HRMS (E S + ) MH+ Calcd for C i6 H2 2 N0 2 S, 292.1366, found 292.1364.
1-Methoxy-bicyclo [2 .2 .2 ] oct-5-ene-2-sulfonic  acid allylamide [161b ]
To 1 -methoxy-bicyclo [2 .2 .2 ] oct-5-ene-2-sulfonic acid pentafluorophenyl ester 
[161a] (148 mg, 0.39 mmol) in dry tetrahydrofuran (5 mL) was added allylamine 
(3.0 eq., 0.09 mL, 1.16 mmol) followed by DBU (1.0 eq., 0.06 mL, 0.39 mmol), 
and the m ixture was refluxed for 2 hours. The reaction was diluted with 
dichloromethane (30 mL) and washed with 2M HCI (2 x 15 mL), water (2 x 20 
mL) and brine (2 x 20 mL). The organic phase was separated, dried (MgS04), 
filtered and the filtra te  concentrated in vacuo. The crude residue was purified by 
flash column chromatography (1:1 Petroleum ether 40-60 °C:Ethyl acetate) to 
give the title  compound as a white solid (56 mg, 0.22 mmol, 56 %).
Rf 0.40 (2:1 P:EtOAc).
Mp 48-52 °C
Vmax (th in  film , cm '1) 3435 s, 2088 w, 1644 m, 1320 w, 1151 w.
8 h (CDCIs, 300  MHz) 6.31-6.15 (m, 2H, CHCHCOCH3, CHCOCH3), 5.88-5.72 (m, 
1H, NHCH2 CH), 5.22 (d, J 17.1, 1H, NHCH2), 5.10 (d, J 10.2, 1H, NHCH2), 4.66 
(t, J 10.2, 5.8, 1H, S 0 2 CH), 3.70-3.53 (m, 2H, NHCH2 CHCH2), 3.30 (s, 3H, 
OCH3), 2.52 (bs, 1H, S0 2 CHCH2 CH), 1.97 (dt, J 13.4, 3.6, 1H, S0 2 CHCH2), 1.78-
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1.60 (m, 1H, S0 2 CHCH2), 1.57-1.48 (m, 1H, CH2 COCH3), 1.41-1.29 (m, 3H, 
CH2COCH3, CH2 CH2 COCH3).
8C (CDCI3, 75 MHz) 134.4 (CHCH2 NH), 132.9 (CHCOCH3), 131.5 (CHCHCOCH3),
117.5 (CH2 CHCH2 NH), 79.2 (COCH3), 62.7 (S0 2 CH), 51.9 (OCH3), 46.6 (NHCH2),
31.5 (S02CHCH2), 29.4 (S 02CHCH2CH), 29.3 (CH3COCH2), 24.4 (CH2CHCH2). 
LRMS (E I + ) 257 (M+, 30 % ), 165 (CgHuNS, 75 % ), 137 (M+-CH2CHCH2NHS02, 
55 %), 108 (C8 H i2/ 100 % ), 94 (C7 H i0, 67 %), 77 (C6H5/ 65 %), 41 (C3H5/ 52 %). 
HRMS (E S +) MH+ Calcd for C i2 H2 0 NO3 S, 258.1158, found 258.1158.
1-Methoxy-bicyclo [2 .2 .2 ] oct-5-ene-2-sulfonic  acid 4-m ethyl-benzyl- 
amide [1 6 2 ]
To 1-methoxy-bicyclo [2 .2 .2 ] oct-5-ene-2-sulfonic acid pentafluorophenyl ester 
[161a] (158 mg, 0.41 mmol) in dry tetrahydrofuran (5 mL) was added 4- 
methylbenzylamine (3.0 eq., 0.16 mL, 1.23 mmol) followed by DBU (1.0 eq., 
0.06 mL, 0.41 mmol), and the m ixture was refluxed for 2 hours. The reaction was 
diluted with dichloromethane (30 mL) and washed with 2M HCI (2 x 15 mL), 
water (2 x 20 mL) and brine (2 x 20 mL). The organic phase was separated, dried 
(MgS04), filtered and the filtra te  concentrated in vacuo. The crude residue was 
purified by flash column chromatography (2:1 Petroleum ether 40-60 °C:Ethyl 
acetate) to give the title  compound as a white solid (69 mg, 0.22 mmol, 53 %).
Rf 0.45 (2:1 P:EtOAc).
Mp 110-114 °C
Vmax (th in  film , cm '1) 3433 s, 2094 w, 1638 m, 1323 w, 1151 w.
5h (CDCI3, 300  MHz) 7.18-6.96 (m, 4H, PhH), 6.28-6.09 (m, 2H, CHCHCOCH3, 
CHCOCH3), 4.91-4.81 (m, 1H, S0 2 CH), 4.20-4.01 (m, 2H, NHCH2), 3.19 (s, 3H, 
OCH3 ), 3.15 (m, 1H, NH), 2.49 (bs, 1H, S0 2CHCH2 CH), 2.18 (s, 3H, PhCH3),
1.99-1.83 (m, 1H, S 0 2 CHCH2), 1.76-1.55 (m, 1H, S0 2CHCH2), 1.51-1.42 (m, 1H, 
CH2COCH3), 1.32-1.21 (m, 3H, CH2 COCH3, CH2 CH2 COCH3).
8C (CDCI3, 75 MHz) 137.8 (PhC), 134.6 (PhC), 132.9 (CHCOCH3), 131.6 
(CHCHCOCH3), 129.7 (PhCH), 128.5 (PhCH), 79.2 (COCH3), 62.4 (S0 2CH), 51.8 
(OCH3), 47.9 (NHCH2), 31.5 (S 0 2 CHCH2), 29.2 (S0 2 CHCH2 CH), 29.0 (CH3COCH2),
24.4 (CH2 CHCH2), 21.5 (PhCH3).
LRMS (C I+ )  339 (M+, NH4, 83 % ), 322 (M+, H, 6 8  %), 122 (C8 Hi0 O, 26 %), 120
(CH3PhCH2NH, 100 % ), 110 (C7 H i0 O, 28 %).
HRMS (E S +) MH+ Calcd for Ci 7 H2 4 N0 3 S, 322.1471, found 322.1470.
Elemental analysis: Anal, calcd for C i7 H2 3 N0 3 S: C 63.52, H 7.21, N 4.36, S
9.98; found C 62.97, H 7.35, N 4.23, S 9.54.
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7-Oxa-bicyclo [2 .2 .1 ] hept-5-ene-2-su lfonic  acid allylam ide [1 7 7 ]
To exo 7-oxa-bicyclo [2 .2 .1 ] hept-5-ene-2-sulfonic acid pentafluorophenyl ester
[175] (59 mg, 0.17 mmol) in dry tetrahydrofuran (5 mL) was added allylamine 
(3.0 eq., 0.04 mL, 0.51 mmol) followed by DBU (1.05 eq., 0.03 mL, 0.18 mmol), 
and the m ixture was refluxed for 3 hours. The reaction was diluted with 
dichloromethane (30 mL) and washed with 2M HCI (2 x 15 mL), water (2 x 20 
mL) and brine (2 x 20 mL). The organic phase was separated, dried (MgS04), 
filtered and the filtra te  concentrated in vacuo. The crude residue was purified by 
flash column chromatography (1:1 Petroleum ether 40-60 °C:Ethyl acetate) to 
give the exo title  compound as a white solid (28 mg, 0.13 mmol, 76 %).
Rf 0.20 (2:1 P:EtOAc).
Mp 61-64 °C
Vmax (th in  film , cm '1) 3435 s, 2093 m, 1642 s, 1313 w, 1146 w.
8 h (CDCI3, 300  MHz) 6.49-6.40 (m , 1H, S0 2CHCHCHCH), 6.39-6.30 (m, 1H, 
S02 CHCHCH), 5.88-5.70 (m, 1H, NHCH2 CH), 5.22-5.03 (m, 4H, S02CHCH, 
CH2CH, NHCH2), 4.77-4.68 (m, 1H, NH), 3.73-3.61 (m, 2H, NHCH2CHCH2), 3.08- 
2.99 (m, 1H, S0 2 CH), 2.11-1.98 (m, 1H, S0 2 CHCH2), 1.72-1.59 (m, 1H, 
S02CHCH2).
8C (CDCI3, 75  MHz) 138.5 (S0 2 CHCHCHCH), 134.8 (CHCHCHS02), 134.4 
(CHCH2 NH), 117.8 (CH2CHCH2 NH), 80.0 (S 0 2CHCH2 CH), 78.5 (S0 2CHCH), 61.9 
(S02CH), 46.4 (NHCH2), 28.9 (S 0 2CHCH2).
LRMS (E I+ )  199 (M+-0 , 35 % ), 95 (M+-CH2CHCH2 NHS02, 62 %), 6 8  (C4 H4 O, 
100 %), 56 (CH2 CHCH2 NH, 69 % ), 41 (CH2 CHCH2, 76 %), 28 (CO, 52 %).
HRMS (E S +) MNa+ Calcd for C9 H i3 N 0 3 SNa, 238.0514, found 238.0506.
7-Oxa-bicyclo [2 .2 .1 ] hept-5-ene-2-su lfon ic  acid 4-m ethyl-benzylam ide  
[178]
To endo 7-oxa-bicyclo [2 .2 .1 ] hept-5-ene-2-sulfonic acid pentafluorophenyl ester
[176] (47 mg, 0.14 mmol) in dry tetrahydrofuran (5 mL) was added 4- 
methylbenzylamine (3.0 eq., 0.05 mL, 0.41 mmol) followed by DBU (1.05 eq., 
0.02 mL, 0.14 mmol), and the m ixture was refluxed for 3 hours. The reaction was 
diluted with dichloromethane (30 mL) and washed with 2M HCI (2 x 15 mL), 
water (2 x 20 mL) and brine (2 x 20 mL). The organic phase was separated, dried 
(MgS04), filtered and the filtra te  concentrated in vacuo. The crude residue was 
purified by flash column chromatography (1:1 Petroleum ether 40-60 °C:Ethyl 
acetate) to give the exo title  compound as a pale yellow solid ( 2 1  mg, 0.08 mmol, 
54 %).
Rf 0.25 (2:1 P:EtOAc).
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Mp 122-125 CC
V m a x  (th in  film , cm-1) 3430 s, 2090 m, 1644 s, 1319 w, 1135 w.
8h (CDCI3/ 300  MHz) 7.20-7.03 (m, 4H, PhH), 6.32 (dd, J 5.8, 1 .7 , 1 H, 
SO2 CHCHCHCH), 6.18 (dd, J 5.7, 1.5, 1H, S0 2 CHCHCH), 5.19 (s, 1H, S0 2 CHCH),
5.05 (d, J 4.1, 1H, S0 2 CHCH2CH), 4.81-4.71 (m, 1H, NH), 4.21 (d, J 5.8, 2H, 
PhCH2), 2.97-2.90 (m, 1H, S0 2 CH), 2.25 (s, 3H, CH3), 2.10-2.00 (m, 1H, 
S02 CHCH2), 1.66-1.57 (m, 1 H, S0 2CHCH2).
8C (CDCI3, 75 MHz) 138.4 (S 0 2CHCHCHCH), 134.8 (CHCHCHS02), 132.3 (PhC),
130.0-128.2 (PhCH), 79.9 (S 0 2 CHCH2 CH), 78.6 (S 0 2CHCH), 61.9 (S0 2 CH), 47.7 
(PhCH2), 28.9 (S 0 2 CHCH2), 21.5 (PhCH3).
LRMS (E I+ )  279 (M+, 12 % ), 148 (C4 H6 N03 S, 50 % ), 120 (CH3 PhCH2 NH, 83 %), 
105 (CH3 PhCH2, 100 % ), 95 (C6 H7 0 , 61 % ), 6 8  (C4 H4 O, 77 %), 28 (CO, 41 %). 
HRMS (E S + ) MNa+ Calcd for Ci4 H i7 N03 SNa, 302.0827, found 302.0847.
3.6 Procedures for 1,3-Dipoles and Dienes Unsuccessful in 
Cycloaddition w ith PFP Vinylsulfonate
3.6.1 General procedures for the preparation of aromatic azides111
a) Aryl azides: To the corresponding amine (1.0 eq.) in a 50 % sulfuric acid 
solution (10 mL) at -5  °C was added dropwise sodium nitrite (1.2 eq.) in water (2 
mL). The reaction was stirred for 10 minutes at -5  °C then filtered. The filtrate 
was added to a stirred slurry of sodium azide (1.5 eq.) and sodium acetate (20.0 
eq.) in ice water (25 mL) The suspension was stirred for 30 minutes, extracted 
into ether (2 x 20 mL) and washed with sodium carbonate solution (20 mL). The 
organic fraction were combined, dried (MgS04) and concentrated in vacuo to give 
the crude aryl azide as a solid which did not require further purification
l-A zido-4-m ethoxy-benzene [1 4 0 ]
8h (CDCI3, 3 00  M Hz) 6.80-6.62 (m, 4H, PhH), 3.58 (s, 3H, CH3). 
l-A zid o -4-n itro -benzene [1 4 1 ]
8h (CDCI3, 3 00  MHz) 8.04 (d, J 9.2, 2H, PhH), 6.94 (d, J 9.2, 2H, PhH).
b) Benzyl azides: To the corresponding bromide (1.0 eq) in acetonitrile (10 mL) 
was added sodium azide ( 2 . 0  eq.) followed by potassium iodide (0 . 0 2  eq.) and 
stirred at reflux for 16 hours. The solution was then concentrated in vacuo and 
the resulting residue was dissolved in water (10 mL) and dichloromethane (10 
mL), and then shaken with sodium sulfite (0.1 eq.). The organic layer was
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isolated, dried (MgS04), and concentrated in vacuo to give the crude benzyl 
azide, which did not require further purification.
Azidom ethyl-benzene [1 4 2 ]
5h (CDCI3/ 3 0 0  M Hz) 7.36-7.11 (m, 5H, PhH), 4.22 (s, 2 H, CH2). 
l-A z id o m eth y l-4 -fluoro-benzene [ 143]
8h (CDCI3, 300  MHz) 7.20-7.05 (m, 2H, PhH), 6.92-6.80 (m, 2H, PhH), 4.10 (s, 
2H, CH2).
l-A zidom ethyl-4-m ethoxy-benzene [ 144]
8 h (CDCI3, 300  M Hz) 7.06 (d, J 8.7, 2H, PhH), 6.75 (d, J 8.7, 2H, PhH), 4.08 (s, 
2H, CH2), 3.60 (s, 3H, CH3).
3.6.2 General procedures for the preparation of nitrile oxides and 
precursors
a) Formation of hydroxam ic acid chlorides using TiCI4 [1 4 6 ]:83 To
benzaldehyde (2.00 mL, 19.70 mmol) in methanol (5 mL) was added 
nitromethane (1.2 eq., 1.28 mL, 23.64 mmol) at -10  °C. Sodium hydroxide 
solution (1.2 eq., 900 mg, 23.64 mmol in 2 mL water) was added dropwise, and 
the reaction was stirred for 15 minutes. Water (10 mL) was added to dissolve any 
precipitate, and the solution was poured slowly into 4M HCI (10 mL). The solid 
formed was filtered and washed with ice-cold water, and dried with suction to 
give the crude nitro-olefin as a yellow solid, which did not require further 
purification (1.57 g, 10.54 mmol, 53 %).
To the nitro-olefin (509 mg, 3.42 mmol) and triethylsilane (1.1 eq., 0.60 mL, 
3.76 mL) was added TiCU (1.2 eq., 4.10 mL of a 1M solution in dichloromethane,
4.10 mmol) dropwise. The reaction was then stirred at r.t. for 1 hour, quenched 
with water (10 mL), and extracted with dichloromethane (2 x 20 mL). The organic 
fraction was washed with water (10 mL), dried (MgS04) and concentrated in 
vacuo to give the crude nitrile oxide precursor as a white solid, which did not 
require further purification (321 mg, 1.89 mmol, 55 %).
5h (CDCI3, 300  MHz) 7.25-7.08 (m, 5H, PhH), 3.65 (s, 2H, CH2).
b) N itrile oxide form ation via  oxidation of aldoximes :81 To the
corresponding aldehyde (1.0 eq.) in ethanol (10 mL) and water (10 mL) was 
added hydroxylamine hydrochloride ( 1 . 2  eq.) and sodium hydrogen carbonate 
(2.0 eq.). The reaction was stirred at r.t. for 2 hours and then extracted with
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ether (2 x 20 mL). The organic fractions were dried (MgS0 4 ) and concentrated in 
vacuo to give the crude aldoxime, which did not require further purification.
To the aldoxime (1.0 eq.) in 2M sodium hydroxide (10 mL) at 0 °C was added 
bromine (1.05 eq.) in carbon tetrachloride (9 mL) dropwise over 1 hour. The 
reaction was stirred at r.t. for 30 minutes, and then extracted into ether (2 x 20 
mL), washed with water (20 mL), dried, (MgSCU) and then concentrated in vacuo 
to give the crude nitrile oxide, which did not require further purification.
2.4 .6 -Trim ethyl-benzonitrile  /V-oxide [1 5 2 ]
8h(CDCI3, 300  M H z) 6.82 (s, 2H, PhH), 2.35 (s, 6 H, CH3), 2.20 (s, 3 H, CH3).
2.4 .6-Trim ethoxy-benzon itrile  /V-oxide [1 5 3 ]
8h(CDCI3/ 300  M Hz) 6.20 (s, 2H, PhH), 3.98 (s, 9H, CH3).
8C (CDCI3, 75 MHz) 163.8 (PhC), 90.9 (PhCH), 56.4-56.0 (CH3).
3.6.3 Procedure for the preparation of 2-azadiene [163]90
To LiHMDS (10 mL/1.67 g of a 1M solution in tetrahydrofuran, 10.00 mmol) in 
dry ether (50 mL) at 0 °C was added dropwise benzaldehyde (1.0 eq.) in dry 
ether (5 mL). The reaction was stirred at 0 °C for 1 hour, followed by addition of 
triethylamine ( 1 . 1  eq.) and dropwise addition of acetyl chloride ( 1 . 0  eq.) in dry 
ether (5 mL). The reaction was stirred at r.t. for 2 hours, filtered through Celite- 
545, and the filtra te  concentrated in vacuo to give the crude product as a yellow 
oil which did not require fu rther purification 1.51 g, 6.89 mmol, 34 %.
8h (CDCI3, 300  MHz) 8.40 (s, 1H, CH), 7.80-7.70 (m, 2H, PhH), 7.31-7.21 (m, 
3H, PhH), 4.61 (s, 1H, CH), 4.23 (s, 1H, CH), 0.20 (s, 9H, CH3).
3.6.4 Procedure for the preparation of 4-methyl-2,5-diphenyl-oxazole 
[169]91,92
To norephedrine (411 mg, 2.72 mmol) in dichloromethane (10 mL) at 0 °C was 
added triethylam ine ( 1 . 0  eq.) followed by dropwise addition of benzoyl chloride 
(1.0 eq.) in dichloromethane (5 mL). The reaction was stirred at r.t. for 3 hours 
followed by addition of water (10 mL). The organic phase was separated and 
washed with brine (2 x 20 mL). The organic phase was separated, dried (MgS04) 
filtered and the filtra te  concentrated in vacuo to give a white solid which did not 
require further purification (470 mg, 1.84 mmol, 6 8  %). To this precursor (1.0 
eq.) in dichloromethane (10 mL) was added Dess-Martin periodinane (1.2 eq.) 
and stirred at r.t. fo r 1 hour. The solution was filtered through a plug of Grade 1 
aluminium oxide and sand, and washed with dichloromethane into a pre-prepared
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solution of triphenylphosphine ( 2 . 0  eq.) and iodine ( 2 . 0  eq.) in triethylamine (4 . 0  
eq.). The reaction was stirred at r.t. for 12 hours, washed with saturated sodium 
thiosulfate solution and extracted with ether. The organic phase was separated 
and washed with saturated sodium bicarbonate solution, the organic phase was 
separated, dried (MgS04), filtered and the filtrate concentrated in vacuo. The 
crude residue was purified by flash column chromatography (4:1 Petroleum ether 
40-60 °C:Ethyl acetate) to  give the title  compound as a yellow oil (279 mg, 1.19 
mmol, 50 %).
8 h(CDCI3, 3 00  M Hz) 7.98-7.20 (m, 1 0 H, PhH), 1.40 (s, 3H, CH3).
3.6.5 Procedure for the synthesis of pyran-2-one [ 173]96 
To /V-bromosuccinimide (890 mg, 5.00 mmol) in carbon tetrachloride (30 mL) 
was added 5,6-dihydro-2/7-pyran-2-one (1.0 eq.) and benzoyl peroxide (0.1 eq.), 
and the reaction was refluxed for 2 hours. The solution was filtered, concentrated 
in vacuo and diluted with triethylam ine (15 mL). The reaction was refluxed for 30 
minutes, concentrated in vacuo and purified by flash column chromatography 
(6:1 Petroleum ether 40-60 °C:Ethyl acetate) to give the title  compound as a 
yellow oil (179 mg, 1.87 mmol, 37 % ).
SH (CDCI3/ 3 0 0  M Hz) 7.45-7.21 (m, 2H, CH), 6.25-6.10 (m, 2H, CH).
8 C (CDCI3, 75 MHz) 162.4 (CO), 152.4 (CH), 143.6 (CH), 116.9 (CH), 106.5 
(CH).
3.7 Formation of Vinyl Sulfonamides
4-Methylbenzyl vinylsulfonam ide [1 8 3 ]
To pentafluorophenyl vinylsulfonate [80] (154 mg, 0.56 mmol) in dry 
tetrahydrofuran (5 mL) was added 4 -methylbenzylamine (1.0 eq., 0.07 mL, 0.56 
mmol) followed by DBU (1.0 eq., 0.08 mL, 0.56 mmol) and the reaction was 
stirred at ambient temperature for 10 minutes. The reaction was concentrated in 
vacuo, and the crude residue was purified by flash column chromatography ( 1 : 1  
Hexanes:Ethyl acetate) to  give the title  compound as a pale brown solid (69 mg, 
0.33 mmol, 58 %).
Rf 0.70 (2:1 H:EtOAc).
8h (CDCI3, 300  MHz) 7.28-7.11 (m, 4H, PhH), 6.52-6.45 (m, 1H, S0 2CH), 6.26 
(d, J 23.2, 1H, S0 2 CHCH2), 5.92 (d, J 19.0, 1H, S0 2 CHCH2), 4.59 (bs, 1H, NH), 
4.16 (dd, J 6.3, 2 H, NHCH2), 2.34 (s, 3H, CH3).
8 C (CDCI3, 75 MHz) 135.9 (S 0 2 CH), 129.4 (PhCH), 127.9 (PhCH), 126.8 
(S02 CHCH2), 46.8 (PhCH2), 21.1 (CH3).
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Benzylmethyl vinylsulfonam ide [1 8 4 ]
To pentafluorophenyl vinylsulfonate [80] (411 mg, 1.50 mmol) in dry 
tetrahydrofuran (7 mL) was added benzylmethylamine (1.0 eq., 0.19 mL, 1.50 
mmol) followed by DBU (1.0 eq., 0.22 mL, 1.50 mmol) and the reaction was 
stirred at ambient temperature for 10 minutes. The reaction was concentrated in 
vacuo, and the crude residue was purified by flash column chromatography (6:1 
Hexanes:Ethyl acetate) to give the title  compound as a yellow oil (175 mg, 0.83 
mmol, 55 %).
Rf 0.35 (2:1 H:EtOAc).
8h (CDCI3/ 30 0  MHz) 7.40-7.28 (m, 5H, PhH), 6.51-6.40 (m, 1H, S02CH), 6.28 
(d, J 23.2, 1H, S02CHCH2), 6.00 (d, J 16.9, 1H, S 02CHCH2), 4.24 (s, 2H, PhCH2), 
2.68 (s, 3H, NCH3).
Sc (CDCI3/ 75 M Hz) 133.0 (S 02CH), 128.6-128.0 (PhCH), 127.9 (S02CHCH2),
53.7 (PhCH2), 34.0 (NCH3).
l-V inylsulfonyl-pyrro lid ine-2-carboxylic  acid m ethyl ester [185]
To pentafluorophenyl vinylsulfonate [80] (474 mg, 1.73 mmol) in dry
tetrahydrofuran (10 mL) was added L-proline methyl ester (1.0 eq., 223 mg, 1.73
mmol) followed by DBU (1.0 eq., 0.26 mL, 1.73 mmol) and the reaction was 
stirred at ambient temperature for 10 minutes. The reaction was concentrated in 
vacuo, and the crude residue was purified by flash column chromatography (2:1 
Hexanes:Ethyl acetate) to give the title  compound as a yellow oil (104 mg, 0.47 
mmol, 27 %).
Rf 0.15 (4:1 H:EtOAc).
SH (CDCI3, 300  MHz) 6.65-6.57 (m, 1H, S 02CH), 6.23 (d, J 21.1, 1H, S02CH 
CH2), 5.98 (d, J 19.0, 1H, S 02CHCH2), 3.75 (s, 3H, OCH3), 4.40 (dd, J 10.5, 2.2, 
1H, NCH), 3.49-3.37 (m, 2H, NCHCH2), 2.31-2.18 (m, 1H, NCH2CH2), 2.10-1.92 
(m, 3H, NCH2CH2).
Methylpropyl vinylsulfonam ide [1 8 6 ]
To pentafluorophenyl vinylsulfonate [80] (427 mg, 1.56 mmol) in dry
tetrahydrofuran (7 mL) was added A/-methylpropylamine (1.0 eq., 0.16 mL, 1.56
mmol) followed by DBU (1.0 eq., 0.23 mL, 1.56 mmol) and the reaction was 
stirred at ambient temperature for 10 minutes. The reaction was concentrated in 
vacuo, and the crude residue was purified by flash column chromatography (4:1 
Hexanes:Ethyl acetate) to give the title  compound as a yellow oil (202 mg, 1.24 
mmol, 79 %).
Rf 0.20 (4:1 H:EtOAc).
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SH (CDCI3, 30 0  MHz) 6.47-6.38 (m, 1 H, S0 2CH), 6.20 (d, J 20.8, 1 H, 
S0 2 CHCH2), 5.98 (d, J 19.0, 1 H, S0 2 CHCH2), 3.10-3.01 (m, 2 H, NCH3 CH2), 2 . 7 5  
(s, 3H, NCH3), 1.64-1.53 (m, 2H, CH3 CH2), 0.09 (s, 3H, CH3).
8 C (CDCI3/ 75 M Hz) 132.8 (S 0 2CH), 127.4 (S0 2CHCH2), 51.5 (CH2 NCH3), 34.2 
(NCH3), 21.1 (CH2 CH3), 10.9 (CH3).
3 .8  P ro ced u res  fo r  th e  F o rm a tio n  o f PFP T h io es ters
3.8.1 Formation of a PFP thioacid
(2-Pentafluorophenyloxysulfonyl-ethylsulfanyl)-acetic acid [191 ]
To pentafluorophenyl vinylsulfonate [80] (1.02 g, 3.72 mmol) in absolute ethanol 
(20 mL) was added mercaptoacetic acid (1.0 eq., 0.26 mL, 3.72 mmol) followed 
by sodium carbonate (2.0 eq., 789 mg, 7.44 mmol). The reaction was stirred for 
15 minutes at ambient temperature, then filtered, washed with absolute ethanol 
(10 mL) and concentrated in vacuo to give the title  compound as a white solid 
(1.36 g, 3.72 mmol, 100 %).
Rf 0.15 (2:1 P:Et20  + 5% AcOH)
8 h (CDCI3, 300  M Hz) 5.26 (bs, 1H, OH), 4.31 (dt, J 10.3, 7.5, 1H, S0 2 CH2), 
3.86-3.80 (m, 1H, S0 2CH2), 3.47-3.39 (m, 1H, S02 CH2 CH2), 3.34 (s, 1H, 
COCH2), 3.27 (s, 1H, COCH2), 3.05-2.98 (m, 1H, S0 2 CH2 CH2).
8 C (CDCI3, 75 MHz) (Aromatic peaks not observed due to 19F coupling). 177.0 
(CO), 51.1 (S 0 2 CH2), 37.9 (COCH2), 26.9 (S0 2CH2CH2).
3.8.2 Formation of thioacid sulfonamides
2 - (4 -M e th y l -b e n z y ls u lfa m o y l) -e th y ls u lfa n y l-a c e t ic  acid  [ 1 9 2 a ]
To ( 2 -pentafluorophenyloxysulfonyl-ethylsulfanyl)-acetic acid [191] (201 mg, 
0.55 mmol) in water (20 mL) was added 4-methylbenzylamine (2.0 eq., 0.14 mL,
I.10  mmol) followed by DBU (2.0 eq., 0.16 mL, 1.10 mmol) and the reaction was 
heated at 65 °C for 1 hour. The m ixture was acidified with conc. HCI (5 drops), 
and the product was extracted into dichloromethane (10 x 20 mL). The organic 
phase was separated, dried (M gSO .4 ) , filtered and the filtrate concentrated in 
vacuo to give the title  compound as a pale yellow solid (58 mg, 0.19 mmol, 55 
%).
Rf 0.30 (2:1 P:Et20  + 5% AcOH)
8h (CDCI3, 300  MHz) 7.25-7.08 (m, 4H, PhH), 4.18 (s, 2H, PhCH2), 3.58 (dt, J
I I .2 ,  4.7, 1H, S0 2 CH2), 3.32 (s, 1H, NH), 3.21-3.14 (m, 2H, CH2 C02 H, S0 2 CH2),
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2.97-2.85 (m, 2H, CH2 C02 H, S0 2 CH2 CH2), 2.69-2.60 (m, 1H, S0 2 CH2 CH2), 2.29 
(s, 3H, PhCH3).
8 C (CDCI3, 75 MHz) 170.0 (CO), 138.6-129.1 (PhCH), 53.6 (S0 2CH2), 47.5 
(PhCH2), 34.6 (COCH2), 27.0 (S 0 2 CH2CH2), 21.1 (PhCH3).
2-(P iperid ine-l-su lfonyl)-e thylsu lfanyl-acetic  acid [192b ]
To (2-pentafluorophenyloxysulfonyl-ethylsulfanyl)-acetic acid [191] (79 mg, 0 . 2 2  
mmol) in water (5 mL) was added piperidine (2.0 eq., 0.04 mL, 0.43 mmol) 
followed by DBU (2.0 eq., 0.06 mL, 0.43 mmol) and the reaction was heated at 
65 °C for 1  hour. The m ixture was acidified with conc. HCI (5 drops), and the 
product was extracted into dichloromethane (10 x 20 mL). The organic phase was 
separated, dried (MgS0 4 ), filtered and the filtrate concentrated in vacuo to give 
the title compound as a yellow oil (24 mg, 0.09 mmol, 41 %).
Rf 0.05 (2:1 P:Et20  + 5% AcOH)
5h (CDCI3, 300  MHz) 5.26 (bs, 1H, OH), 3.38-3.31 (m, 2H, S0 2 CH2), 3.11 (t, J 
3.7, 1H, CH2C02 H), 3.02-2.93 (m, 1H, CH2 C02 H), 2.64 (dt, J 10.3, 8.4, 2H, 
S0 2CH2 CH2), 2.10-1.51 (m, 10H, 5 x CH2).
3.8.3 Procedure fo r  the  p repara tion  o f m ercap to -th ioace tic  acid [1 9 6 ]109 
To chloroacetyl chloride (5.00 mL, 62.83 mmol) in absolute ethanol at -10  °C 
(ice/acetone cold bath) was added sodium hydrosulfide hydrate (3.0 eq., 10.60 g, 
188.50 mmol) in portions over 15 minutes. The reaction mixture was stirred at 
-10 °C for 1 hour, filtered and the filtrate washed with absolute ethanol (20 mL). 
The filtrate was concentrated in vacuo and then purified by flash column 
chromatography (6:1 Petroleum ether 40-60 °C:Ether) to give the title  compound 
as a colourless oil (2.80 g, 25.88 mmol, 41 %)
Rf 0.50 (2:1 P:Et2 0 )
5h (CDCI3, 300  MHz) 4.26-4.11 (m, 2H, CH2).
4 .9  F o rm a tio n  o f B ifu n c tio n a l PFP Esters  
Chloroacetic acid pentafluorophenyl ester [1 9 8 ]
To pentafluorophenol (210 mg, 1.14 mmol) in dry ether (20 mL) was added 
chloroacetyl chloride (1.0 eq., 0.09 mL, 1.14 mmol), followed by triethylamine 
(1.0 eq., 0.16 mL, 1.14 mmol). The reaction was stirred at ambient temperature 
for 1 hour, diluted with dichloromethane (20 mL) and washed with 2M HCI (1 x 20 
mL), water (2 x 20 mL) and brine (2 x 20 mL). The organic phase was separated, 
dried (MgSQ4), filtered and the filtra te  concentrated in vacuo. The crude residue
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was purified by flash column chromatography (20:1 Petroleum ether 40-60 
°C:Ether) to give the title  compound as a colourless oil (107 mg, 0.41 mmol, 36 
%).
Rf 0.80 (3:1 P:Et2 0 )
5h (CDCI3, 300  M Hz) 4.41 (s, 2 H, CH2).
Bromoacetic acid pentafluorophenyl ester [1 9 9 ]
To pentafluorophenol (1.11 g, 6.03 mmol) in dry ether (50 mL) was added 
bromoacetyl bromide (1.05 eq., 0.55 mL, 6.33 mmol), followed by triethylamine 
(1.05 eq., 0.88 mL, 6.33 mmol). The reaction was stirred at ambient temperature 
for 1 hour, diluted with dichloromethane (30 mL) and washed with 2M HCI (1 x 30 
mL), water (2 x 30 mL) and brine (2 x 30 mL). The organic phase was separated, 
dried (MgS04), filtered and the filtra te  concentrated in vacuo. The crude residue 
was purified by flash column chromatography (50:1 Petroleum ether 40-60 
°C:Ether) to give the title  compound as a colourless oil (1.12 g, 3.68 mmol, 61 
%).
Rf 0.80 (3:1 P:Et2 0 )
5H (CDCI3, 300  MHz) 4.14 (s, 2H, CH2).
8 C (CDCI3, 75 MHz) 163.5 (CO), 142.8-136.1 (PhCF), 124.6 (PhC), 23.3 (CH2).
4-Bromobutyric acid pentafluorophenyl ester [2 0 0 ]
To pentafluorophenol (600 mg, 3.26 mmol) in dry ether (15 mL) was added 4- 
bromobutyryl chloride (1.05 eq., 0.40 mL, 3.42 mmol), followed by triethylamine 
(1.05 eq., 0.48 mL, 3.42 mmol). The reaction was stirred at ambient temperature 
for 1 hour, diluted with dichloromethane (30 mL) and washed with 2M HCI (1 x 30 
mL), water (2 x 30 mL) and brine (2 x 30 mL). The organic phase was separated, 
dried (MgS04), filtered and the filtra te  concentrated in vacuo. The crude residue 
was purified by flash column chromatography (50:1 Petroleum ether 40-60 
°C:Ether) to give the title  compound as a colourless oil (920 mg, 2.76 mmol, 85 
%).
Rf 0.90 (3:1 P:Et2 0)
8 h (CDCI3 , 300  MHz) 3.52 (q, J 7.5, 6 .6 , 2H, CH2 Br), 2.89 (q, J 8.4, 6 .6 , 2H, 
COCH2), 2.30 (dt, J 8.4, 5.6, 2H, CH2 CH2 Br).
8 C (CDCI3 , 75 MHz) (Aromatic peaks not observed due to 19F coupling). 168.6 
(CO), 31.8 (CH2 Br), 31.6 (COCH2), 27.4 (CH2CH2 Br).
5 -B ro m o p e n ta n o ic  a c id  p e n ta f lu o ro p h e n y l e s te r  [ 2 0 1 ]
To pentafluorophenol (600 mg, 3.26 mmol) in dry ether (60 mL) was added 5-
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bromovaleryl chloride (1.05 eq., 1.00 mL, 7.47 mmol), followed by triethylamine 
(1.05 eq., 1.04 mL, 7.47 mmol). The reaction was stirred at ambient temperature 
for 1 hour, diluted with dichloromethane (50 mL) and washed with 2M HCI (1 x 50 
mL), water (2 x 50 mL) and brine (2 x 50 mL). The organic phase was separated, 
dried (MgS04), filtered and the filtra te  concentrated in vacuo. The crude residue 
was purified by flash column chromatography (50:1 Petroleum ether 40-60 
°C:Ether) to give the title  compound as a colourless oil (2.16 g, 6.22 mmol, 8 8  
%).
Rf 0.85 (3:1 P:Et2 0 )
SH (CDCU, 300 MHz) 3.46 (q, J 4.7, 3.7, 2H, CH2 Br), 2.71 (q, J 7.5, 4.7, 2H, 
COCH2), 2.04-1.88 (m, 4H, CH2 CH2 CH2 Br).
8 c (CDCI3, 75 MHz) 169.0 (CO), 142.9-136.0 (PhCF), 125.0 (PhC), 32.6 
(CH2 CH2 Br), 32.3 (CH2 Br), 31.5 (COCH2), 23.3 (COCH2 CH2).
3 .1 0  F o rm a tio n  o f PFP P henyl V in y l S u lfo n a te  [1 9 0 ]
To triethylamine (1.5 eq., 1.02 mL, 7.33 mmol) in dichloromethane (35 mL) at 0 
°C was added pentafluorophenol (1.0 eq., 899 mg, 4.88 mmol) dropwise, 
followed by trans-p-styrenesulfonyl chloride (1.0 eq., 990 mg, 4.88 mmol) in 
dichloromethane (5 mL) over a 15 minute period. The reaction was warmed to 
r.t. and stirred for 2 hours, then quenched with 1M HCI (30 mL). The mixture was 
extracted with dichloromethane (3 x 30 mL) then washed with water (2 x 30 mL) 
and brine (2 x 30 mL). The organic phase was separated, dried (MgS04), filtered 
and the filtrate concentrated in vacuo. The crude residue was purified by flash 
column chromatography (10:1 Hexanes:Ether) to give the title compound as a 
white solid (1.16 g, 3.30 mmol, 6 8  %).
Rf 0.50 (4:1 H:Et20 )
8h (CDCI3/ 300  MHz) 7.70 (d, J 21.1, 1H, CHS02), 7.57-7.42 (m, 5H, PhH), 6.94 
(d, J 21.1, 1H, CHPh).
8 C (CDCI3, 75 MHz) 147.8 (CHS02), 132.4 (PhCH), 131.2 (PhC), 129.4-119.6 
(PhCH).
LRMS (E I+ )  373 (MNa+, 35 % ), 325 (M+-C 2 H, 45 % ), 226 (M+-C4 F4, 80 % ), 153 
(PhC2 H4 SO, 100 %), 136 (PhCHCH2 S, 10 %).
3 .1 1  C rysta l S tru c tu re  D ata  fo r  2 -M e th y l-3 - (4 -n it r o -p h e n y l) -  
is o x a z o lid in e -4 -s u lfo n ic  ac id  4 -m e th y l-b e n z y la m id e  [1 2 8 ]
Table 1. Crystal data and structure refinem ent.
Empirical formula C18 H2i N3 O5 S
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Formula weight 
Temperature 
Wavelength 
Crystal system 
Space group 
Unit cell dimensions
105.000(1)°
Volume
Z
Density (calculated)
Absorption coefficient 
F(000)
Crystal size
Theta range for data collection
Index ranges
- 1 2 <  =  l<  =  12
Reflections collected
Independent reflections
Reflections with I>2sigm a(I)
Completeness to theta = 27.53°
Refinement method
Data /  restraints /  parameters
Goodness-of-fit on F2
Final R indices [I>2s igm a(I)]
R indices (all data)
Largest diff. peak and hole
391.44 
2 2 3 (2 )K 
0.71073 A 
Monoclinic 
P2i/n (No.14)
a= 7.8042(1) A a= 90°
b= 25.7850(3) A (3 =
C= 9.8170(1) A y =  90°
1908.17(4) A3 
4
1.36 Mg/m 3 
0 . 2 0  mm 1 
824
0.4 x 0.2 x 0.2 mm 3 
3.81 to 27.53°.
-9< = h< = 1 0 , -33< = k< = 3 3 ,
28749
4337 [R(int) = 0.044]
3734
98.8 %
Full-matrix least-squares on F2
4337 /  0 /  249
1.051
R1 = 0.045, wR2  = 0.111 
R1 = 0.054, wR2  = 0.116
0.39 and -0.38 e.A 3
Data collection KappaCCD, Program package WinGX, Abs correction not applied, 
Refinement using SHELXL-97, Drawing using ORTEP-3 for Windows
Table 2. Atomic coordinates (x lO ^ ) and equivalent isotropic
2 3
displacement param eters (A x 10 ). U(eq) is defined as one third of the trace 
of the orthogonalized U J tensor.
x y z U(eq)
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s 7340(1) 4760(1) 1764(1) 32(1)
0(1) 3425(2) 4213(1) 2112(1) 45(1)
0(2) 6042(2) 5162(1) 1730(1) 40(1)
0(3) 9065(2) 4813(1) 2712(1) 44(1)
0(4) 12500(2) 3266(1) 8568(2) 95(1)
0(5) 11275(3) 2564(1) 7570(2) 104(1)
N (l) 4325(2) 4011(1) 3506(2) 39(1)
N(2) 7570(2) 4717(1) 192(2) 38(1)
N(3) 11361(3) 3034(1) 7678(2) 69(1)
C (l) 6153(2) 4212(1) 3716(2) 32(1)
0(2) 6441(2) 4166(1) 2216(2) 30(1)
0(3) 4575(2) 4046(1) 1296(2) 40(1)
C(4) 3404(3) 4245(1) 4465(3) 61(1)
0(5) 7470(2) 3900(1) 4804(2) 32(1)
0(6) 8854(2) 4148(1) 5756(2) 40(1)
0(7) 10128(3) 3867(1) 6704(2) 46(1)
0(8) 9992(3) 3337(1) 6681(2) 47(1)
0(9) 8636(3) 3076(1) 5752(2) 51(1)
0(10) 7365(3) 3362(1) 4807(2) 43(1)
C (U ) 8939(2) 4390(1) -153(2) 43(1)
0(12) 8495(2) 3818(1) -304(2) 37(1)
0(13) 6940(3) 3645(1) -1222(2) 47(1)
0(14) 6574(3) 3120(1) -1379(2) 53(1)
0(15) 7745(3) 2753(1) -636(2) 50(1)
0(16) 9284(3) 2929(1) 285(2) 52(1)
0(17) 9660(3) 3453(1) 457(2) 45(1)
0(18) 7368(4) 2181(1) -846(3) 72(1)
Table 3. Bond lengths [A] and angles [ ° ] .
S-0(3) 1.4315(13)
S-0(2) 1.4433(12)
S-N(2) 1.6032(16)
S-C(2) 1.7879(15)
0(1)-C(3) 1.417(2)
0(1)-N (1) 1.4636(19)
0(4)-N (3) 1.227(3)
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0(5)-N (3)
N (l)-C (4)
N ( l) -C ( l)
N (2 )-C ( ll)
N(3)-C(8)
C (l)-C (5)
C (l)-C (2)
C(2)-C(3)
C(5)-C(6)
C(5)-C(10)
C(6)-C(7)
C(7)-C(8)
C(8)-C(9)
C(9)-C(10)
C (ll)-C (1 2 )
C(12)-C(17)
C(12)-C(13)
C(13)-C(14)
C(14)-C(15)
C(15)-C(16)
C(15)-C(18)
C(16)-C(17)
0 (3 )-S -0 (2 )
0(3)-S-N(2)
0(2)-S-N(2)
0(3)-S-C(2)
0(2)-S-C(2)
N(2)-S-C(2)
C (3 )-0 (1 )-N (l)
C (4 )-N (l)-0 (1 )
C (4 )-N (l)-C (l)
0(1)-N (1)-C(1)
C (ll)-N (2 )-S
0 (5 )-N (3 )-0 (4 )
0(5)-N (3)-C(8)
0(4)-N (3)-C(8)
N (l)-C (l)-C (5 )
N (l)-C (l)-C (2 )
1.217(3)
1.456(3)
1.482(2)
1.469(2)
1.472(3)
1.508(2)
1.550(2)
1.533(2)
1.388(2)
1.390(2)
1.379(3)
1.370(3)
1.381(3)
1.383(3)
1.513(3)
1.383(3)
1.385(3)
1.383(3)
1.385(3)
1.380(3)
1.508(3)
1.386(3)
118.89(8)
108.18(9)
106.26(8)
106.51(8)
107.58(8)
109.18(8)
101.43(12)
104.96(15)
112.55(15)
102.51(12)
122.07(13)
124.0(2)
117.1(2)
118.9(2)
111.53(13)
102.26(12)
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C (5 )-C (l)-C (2 ) 113.13(13)
C (3 )-C (2 )-C (l) 103.07(13)
C (3)-C (2)-S 113.69(11)
C (l)-C (2 )-S 109.48(10)
0 (1 )-C (3 )-C (2 ) 104.42(13)
C (6)-C (5)-C (10) 119.63(16)
C (6 )-C (5 )-C (l) 120.03(15)
C (10 )-C (5 )-C (l) 120.24(15)
C (7)-C (6)-C (5) 120.78(18)
C(8)-C (7)-C (6) 118.30(18)
C (7)-C (8)-C (9) 122.67(18)
C (7)-C (8)-N (3) 118.6(2)
C (9)-C (8)-N (3) 118.8(2)
C (8)-C (9)-C (10) 118.48(19)
C (9)-C (10)-C (5) 120.14(18)
N (2 )-C (ll)-C (1 2 ) 114.96(15)
C(17)-C (12)-C (13) 118.40(18)
C (17)-C (12)-C (l 1) 120.45(17)
C (1 3 )-C (1 2 )-C (ll) 121.14(17)
C(14)-C (13)-C (12) 120.56(19)
C(13)-C (14)-C (15) 121.39(19)
C(16)-C (15)-C (14) 117.64(19)
C(16)-C (15)-C (18) 121.1(2)
C(14)-C (15)-C (18) 121.2(2)
C(15)-C (16)-C (17) 121.5(2)
C(12)-C (17)-C (16) 120.54(19)
Table 4. Anisotropic displacement param eters (A 2x l 0 3). The anisotropic 
displacement factor exponent takes the form: -27c2[h2a *2U11 + ... + 2 h k a* b*
n
U
22
u u33 u23
13
u u 12
S 34(1) 26(1) 33(1) K D 3(1) -2 (1 )
0 (1 ) 33(1) 53(1) 45(1) 3(1) K D 0(1)
0 (2 ) 48(1) 28(1) 42(1) -1 (1 ) 7(1) 5(1)
0 (3 ) 38(1) 42(1) 45(1) K D -2 (1 ) -10(1)
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0(4) 45(1) 157(2) 71(1) 27(1) -4(1) 21(1)
0(5 ) 119(2) 104(2) 89(2) 48(1) 24(1) 57(2)
N (l) 34(1) 43(1) 40(1) 1(1) 10(1) 0(1)
N(2) 40(1) 37(1) 36(1) 6(1) 9(1) 3(1)
N(3) 58(1) 100(2) 54(1) 33(1) 25(1) 31(1)
C (l) 35(1) 27(1) 33(1) -3(1) 7(1) -1(1)
C(2) 35(1) 24(1) 31(1) -1(1) 6(1) -2(1)
C(3) 42(1) 40(1) 35(1) -4(1) 4(1) -11(1)
0(4) 49(1) 79(2) 62(1) -6(1) 26(1) 8(1)
0(5) 36(1) 34(1) 28(1) 0(1) 9(1) 0(1)
0(6) 41(1) 44(1) 34(1) -3(1) 8(1) -5(1)
0(7) 36(1) 68(1) 34(1) -K D 8(1) -1(1)
0(8) 39(1) 72(1) 34(1) 15(1) 14(1) 16(1)
0(9) 58(1) 40(1) 57(1) 13(1) 19(1) 9(1)
0(10) 46(1) 34(1) 46(1) 1(1) 5(1) -1(1)
C(U) 40(1) 43(1) 51(1) 2(1) 19(1) -2(1)
0(12) 35(1) 41(1) 40(1) -2(1) 17(1) 0(1)
0(13) 39(1) 52(1) 49(1) -10(1) 8(1) 7(1)
0(14) 36(1) 60(1) 64(1) -24(1) 14(1) -5(1)
0(15) 51(1) 45(1) 62(1) -9(1) 32(1) -6(1)
0(16) 53(1) 45(1) 58(1) 6(1) 16(1) 6(1)
0(17) 38(1) 48(1) 48(1) 1(1) 8(1) 0(1)
0(18) 82(2) 47(1) 100(2) -17(1) 46(2) -14(1)
Hydrogen bonds with H..A <r(A) + 2.000 Angstroms and <DHA> 110 deg. 
D-H d(D-H) d(H..A) <DHA d(D..A) A
N2-H2N 0.79 2.20 171 2.974 02 [-x+ 1 , -y+1, -z]
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